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This thesis represents an evolution of ideas originating from our group’s earliest 
exposure to vascular dynamic imaging almost 10 years ago. The final narrative has 
been an interrogation of the relationship between aortic stiffness and coronary blood 
flow through invasive and non-invasive means, in both health and disease. 
 
As per the University of Adelaide guidelines, the format of this thesis is ‘expanded 
publication’. This has allowed a more expansive description of methods and results 
than has been included in submitted manuscripts. Given the interrelationship of 
techniques across Chapters, a concerted attempt has been made to summarise and 
reference back to earlier Chapters where appropriate thereby avoiding large sections 
of repetition.  Similarly, given the common content of concluding remarks across the 
publications, a deliberate effort was made to keep discussion focused on the key 
outcomes of each individual publication, and then to provide more encompassing 
comments as a separate Chapter across the body of work.





Large artery stiffness has been shown to independently predict cardiovascular events 
and all-cause mortality in a broad range of cohorts. Despite its description almost half 
a century ago, the cardiovascular research community continues to grapple with a 
robust model for ventriculo-vascular interactions, let alone a sound basis for its 
predictive strength. A mechanistic understanding of the key sequelae arising from 
increased arterial stiffness is likely to provide instructive pathophysiological insight, 
but also pave the way for novel risk stratification and possible therapeutic targets. One 
powerful, putative effect of increased arterial stiffness is a reduction in coronary blood 
flow, however a reproducible, simultaneous and non-invasive methodology to 
evaluate both has been elusive. This thesis examines the relationship between 
myocardial perfusion and arterial stiffness.   
 
In Chapter 2, invasive assessment of both coronary blood flow and coronary flow 
(velocity) reserve was undertaken with Doppler FloWires and then compared with 
cardiovascular magnetic resonance (CMR) derived assessment of arterial stiffness, 
aortic distensibility. In a cohort of subjects with a favourable traditional risk factor 
profile and no significant angiographic disease, aortic distensibility was linearly 
associated with measures of both resting and hyperaemic coronary blood flow as well 
as coronary flow velocity reserve. Moreover, aortic stiffness was associated with a 
reduced response to adenosine. The validation of this relationship was completed in 
non-invasive methodology by using CMR perfusion imaging (CMR-PI) to evaluate 
indices of myocardial blood flow and myocardial perfusion reserve in Chapter 3. In 
subjects with normal perfusion studies, aortic distensibility was again strongly 
correlated with resting and hyperaemic myocardial blood flow as well as myocardial 
perfusion reserve.  
 




After evaluating ‘normal’ individuals in earlier studies, the later cohorts focused on 
disease states.  In Chapter 4, the behaviour of this relationship in ischaemic and non-
ischaemic myocardium was evaluated in a highly selected group with a single 
perfusion defect on CMR-PI confirmed on subsequent coronary angiography. In this 
group, arterial stiffness (once again, evaluated by CMR derived aortic distensibility) 
remained associated with resting and hyperaemic blood flow despite critical epicardial 
coronary disease. 
 
In Chapter 5, subjects who had received primary percutaneous coronary intervention 
for acute ST elevation myocardial infarction (STEMI) were evaluated with CMR 
perfusion and delayed enhancement imaging on day three and again at three months. 
The myocardium was dichotomised to infarct and non-infarct territories with blood 
flow, perfusion reserve and indices of myocardial injury evaluated on a per segment 
basis. In this cohort, arterial stiffness was associated with reduced early and late 
hyperaemic response to adenosine in both infarct and non-infarct myocardium. On 
multiple linear regression aortic distensibility remained an independent predictor of 
improvement in myocardial perfusion reserve suggesting arterial stiffness may be a 
key feature for worse outcomes post STEMI. 
 
This thesis not only confirms the putative relationship between large artery function 
and coronary blood flow but also establishes CMR-PI as a reproducible and robust 
modality in this space. Non-invasive evaluation of the aorto-coronary haemodynamic 
relationship may provide novel insight, not only as a potential clinical surrogate 
endpoint, but also a manner to evaluate therapeutic efficacy.  
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1.2 ABSTRACT 
Large artery stiffness is an established mediator of cardiovascular disease and is now 
a recognised, independent predictor of both cardiovascular events and all-cause 
mortality. In this Chapter, the anatomy and physiology of large arterial function is 
discussed whilst summarising some of the key models and constructs that underpin 
these ideas. Common definitions and measures of arterial stiffness are outlined as are 
potential sequalae which may explain its mechanistic, integrative strength.  The extent 
to which arterial stiffness may be modified by pharmacological and lifestyle therapy 
is also briefly reviewed. Finally, given the purported aorto-coronary relationship, 
measures and determinants of coronary blood flow are examined with a particular 
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1.3 THE LARGE ARTERIES 
1.3.1 Physiology 
Arteries have two main functions. The first is to transform pulsations generated by the 
high pressure of the left ventricle into near smooth, continuous flow at a capillary level, 
thereby performing a cushion function. The second is to deliver blood from the left 
ventricle to tissues and organ systems in an ordered manner by need, thereby 
performing the role of a conduit.  
Elegant work in animals, largely canines, has demonstrated the efficiency of a young, 
healthy arterial system in both its cushion and conduit function. From a cushion 
perspective, arterial pulsations are effectively dampened in the larger arteries such that 
pulsatile flow is rarely seen in arterioles and capillaries of less than 200 micron 
diameter (Nicholls & O’Rourke 2005). Despite achieving this marked dampening of 
the pulse, there is minimal loss of energy with a fall of less than 5mmHg of mean 
pressure observed from the proximal aorta to a resistive arteriole (Christensen & 
Mulvany 2001). The net result is a progressive reduction of pulsatility through the 
arterial tree to the level of the micro-circulation of high flow renal and cerebral 
vascular beds minimising barotrauma that would result from exposure to pulsations at 
high systolic pressures. 
Conduit function is dynamically mediated largely through shear stress and endothelial 
vasomotor control and characterized by low resistance to flow (Mulvany & Aalkjaer 
1990). In contrast, the cushion function of large arteries is dependent on the structural, 
viscoelastic properties of the wall in addition to their diameter and length (Safar 1996). 
 
1.3.2 Anatomy 
Arteries throughout the human body consists of three walls; tunica adventitia, tunica 
media and tunica intima. The intima has a monolayer of endothelial cells which 
provides a lumen/wall interface and is a dynamic organ. The main components of the 
tunica media are elastin, collagen and smooth muscle. As mentioned, the large arteries 
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are setup for their cushion function by their structural composition which has a 
relatively high proportion of elastin compared to more distal, muscular arteries. As 
one moves distally, there is a progressive reduction in the elastin-collagen ratio– 
elastin representing 60% at the arch but only 20% at the abdominal aorta. This in part, 
forms the anatomical basis for the transition between the predominantly ‘cushion’ and 
reservoir function of the large arteries and the predominantly ‘conduit’ function of the 




A variety of models have been proposed to understand the complexity of the cushion 
and conduit functions. The oldest and most primitive is the Windkessel model, 
conceived by Hales (Hales 1964) and developed by Frank (Frank 1899) named from 
the air filled dome seen on old fire engines that transformed pulsatile flow from a pump 
into a steady stream at the end of the fire hose. This ‘lumped’ model (Figure 1.1), so 
named as it groups the circulation in terms of parallel resistance and capacitance 
components; the resistance corresponding to total peripheral vascular resistance (PVR, 
predominantly at the arteriolar level), and a total arterial compliance (TAC, mostly due 
to the large elastic arteries) (Westerhof & Stergiopulos 2000). This model suggests 
that as the left ventricle contracts, the elastic proximal arteries become distended and 
at the end of systole at aortic valve closure, blood is discharged to the periphery at a 
rate determined by PVR and TAC. Dichotomising resistance and compliance, although 
conceptually attractive, is limited as these functions are often interrelated across the 
entire vascular bed. Moreover, the arterial series of branching networks is 
oversimplified by the assumption that pressure change occurs instantaneously.  
The addition of Fourier analysis to simultaneous pressure and flow signals allowed the 
calculation of input impedance – a measure of the resistance to flow, and a function of 
the proximal aorta subsequently termed characteristic impedance (Zc). The addition 
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of this ‘third’ element to the Windkessel model included components of wave theory 
as Zc is defined by wave speed times blood density divided by cross sectional area.  
The three-element Windkessel (Stergiopulos et al. 1995) remains the prevailing model 
in the literature and although a fourth element, inertance has been added by some 
(Burattini & Gnudi 1982; Stergiopulos et al. 1999), the three element remains 
conceptually attractive.   
 
 
FIGURE 1.1 Three-element Windkessel model. Zc – characteristic 





1.3.3.2 Wave propagation 
Wave propagation is a component of arterial haemodynamic theory that provided some 
of the basis for distributive models of arterial function. The simultaneous measurement 
of central and peripheral arterial waveforms in young healthy individuals reveals a 
lower central arterial systolic blood pressure compared to brachial systolic blood 
pressure whilst mean arterial and diastolic blood pressure tend to be consistent at both 
sites. This phenomenon was termed pulse pressure amplification and can be explained 
by wave reflection and propagative theory. In its most basic form, the ejection of blood 
into the proximal arterial tree, largely the proximal aorta, generates a pressure wave 
that propagates throughout the body. At points of structural or functional discontinuity, 
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specifically the transition between low resistance arteries to high resistance arterioles, 
reflection of this pressure wave occurs in a retrograde fashion towards the aortic valve 
(Figure 1.2). This is perhaps not unexpected as the arterial system top to bottom is 
only 1-2m in length and yet the pulse wave travels between 4 and 15m/s between the 
proximal aorta and the peripheral arteries respectively (O'Rourke et al. 2014). As 
observed in a young vascular tree, this net reflected wave arrives following aortic valve 
closure. Furthermore, the arrival of this net reflected wave within the proximal aorta 
at diastole provides additional efficiency by augmenting coronary perfusion pressure 
– an event that largely occurs during diastole alone. Supportive ideas progressed by 
Taylor, O’Rourke and others with the use of frequency domain, or Fourier, analysis 
suggest the young cardiovascular system is optimally ‘tuned’ for this interaction – not 
only by dispersion of peripheral reflecting sites but also by the inverse relationship 
between heart rate and body length – variables that preserve this optimal ventriculo-
vascular interaction and timing of the reflected wave.  
 
 
FIGURE 1.2 Redrawn and adapted (Georgianos et al. 2018). Forward 
travelling wave in dashed line, reflected wave in dotted line and 
observed pulse wave in solid line. 
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1.3.3.3 Reservoir wave analysis 
Evolution of the ‘single’ reflected wave propagation theory came in the form of 
reservoir wave analysis. Reservoir wave analysis (RWA) was initially proposed in 
2003 and is fundamentally based around Windkessel modelling and on the premise 
that measured pressure (P) is considered to be the sum of two independent 
components: a reservoir pressure (Pres) which relates to arterial compliance and is 
consistent throughout the large arterial system but relative to the wave properties of 
the arteries; and an excess pressure (Pex) which is the difference between the total 
pressure waveform and the reservoir pressure waveform (Figure 1.3). 
A key assumption in RWA is that Pres is the net product of innumerable forward and 
backward waves rather than a net, ‘single’ reflected wave from peripheries. These 
derive from the forward travelling waves that are generated in the aortic root by the 
stroke volume from the left ventricle and undergo modification as they travel through 
the arterial circulation by reflection and re-reflection.  Geographically disparate and of 
varying amplitude, these incident and reflected waves are therefore in constant 





Figure 1.3 Adapted from Tyberg (Tyberg et al. 2014). Observed pressure 
can be directly measured, Pres can be mathematically modelled and then Pex 
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This provides an explanation for a key shortcoming of the single wave reflection 
theory which had to provide the assumption that an equally large reflected wave 
returned in late diastole to ‘cancel’ the forward wave and thus, exponentially reduced 
pressure and flow (Tyberg et al. 2014). This lacks a physiological backing however as 
these waves are not visible during ectopic beats where they ought not have had time 
to decay. The reservoir wave pressure heuristic however, suggests the pressure 
observed in diastole is solely due to Pres which fits with the observation that Pex during 
diastole approaches zero (Hughes, A et al. 2012).  
The field of arterial mechanics remains vigorously debated in the literature with 
variations on multiple-element Windkessels and Fourier impedance modelling all 
providing alternate explanations of this complex physiology (Mynard & Smolich 
2014).   
  
  Chapter 1: Arterial stiffness and coronary blood flow 
 12 
1.4 ARTERIAL STIFFNESS 
1.4.1 Background 
Over the last 20 to 30 years of cardiovascular research, arterial stiffness has evolved 
from being an association to an independent predictor, and now to an established risk 
factor and mediator for a number of cardiovascular, renal and neurological diseases. 
Analogous in some ways to the haemoglobin A1c of diabetes, arterial stiffness appears 
to be a barometer for vascular health being the key interaction between inexorable 
ageing and vascular risk factors.  Rates of increased arterial stiffness grows non-
linearly and variably with age, demonstrating minimal change in the first 30 years of 
life (McEniery et al. 2005; Mitchell et al. 2010; Mitchell et al. 2004) but notably 
accelerates such that its prevalence approaches 70% by 70 years of age (Mitchell, Guo, 
Benjamin, et al. 2007).  Given the high rates of increased stiffness in the elderly and 
an overall population that is ageing, together with greater life expectancy in developing 
nations, direct and indirect sequelae of arterial stiffness are likely to become 
increasingly burdensome on a global scale. 
 
1.4.2 Definitions 
Extrapolated from Hooke’s Law in the setting of physics, stiffness is the relationship 
between a force applied to a material and its resultant deformation.  Assessment 
therefore requires simultaneous measurement of both observed deformation and 
subjected force. In a cylindrical structure such as an artery, the force applied is three 
dimensional (longitudinal, radial and circumferential) and termed ‘stress’ with the 
resultant physical deformation termed ‘strain’. This critical relationship between stress 
and strain defines an artery’s stiffness with its inverse termed, ‘elasticity’. Compliance 
or distensibility represent changes in volume related to changes in pressure, either 
absolute or normalised to initial volume, respectively. Applying Newton’s second law 
of wave theory to a vessel wall, Moens and Korteveg (Korteveg 1878; Moens 1877) 
derived and later simplified by Bramwell and Hill (Bramwell & Hill 1922), that a 
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pressure wave’s propagation speed in a non-compressible, non-viscous fluid is 
proportional to its stiffness. This observation spawned modern day interest in arterial 
haemodynamics and provided the foundation for the non-invasive ‘gold standard’ 
assessment of arterial stiffness today, carotid-femoral ‘Pulse wave velocity’.  
 
1.4.3 Measures of arterial stiffness 
Arterial stiffness can be assessed using a variety of techniques. These broadly fall into 
general, systemic measures of compliance and wave reflection (e.g. pulse pressure, 
augmentation index), regional measures (e.g. pulse wave velocity) and local measures 
(e.g. distensibility and compliance) (Mackenzie et al. 2002). 
 
1.4.3.1 Blood pressure 
Flow and pressure are pulsatile and intrinsically linked to the interaction between the 
ventricle and the vasculature – so called, ventriculo-vascular coupling. The most 
clinically apparent aspect of this pulsatile interaction is blood pressure which has 
remained a cornerstone of every clinical cardiovascular evaluation for well over 100 
years. Seminal work by Mahomed in the late 1880s not only described the pressure 
pulse with a sphygmogram he developed as a medical student, but also linked elevated 
blood pressure to the development of nephrosclerosis (O'Rourke 1992). It is now well 
established that non-invasive blood pressure obtained at the brachial artery is 
associated with cardiovascular events and mortality (WHO 1999). Although there has 
been varying interest in different aspects of the standard brachial blood pressure 
‘measurement’ - initially systolic (Gubner 1962), then diastolic blood pressure 
(Kannel et al. 1971) - pulse pressure remains the most convenient, yet crude measure 
of pulsatile haemodynamics. Brachial pulse pressure (PP) increases with age, 
particularly in the 6th decade, and is more tightly linked to cardiovascular risk in this 
age-group than other metrics of the non-invasive blood pressure reading (Benetos et 
al. 1998; Benetos, Safar, et al. 1997; Franklin et al. 1999; Gasowski et al. 2002). As 
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described, there remains significant contention around the dominant process that 
contributes to increased pulse pressure with age. The prevailing view remains that a 
faster pulse wave generates earlier reflected waves, increasing systolic pressures and 
augmenting PP. A more recent paradigm, mainly driven by Framingham cohort 
observations, is that increased forward wave amplitude (FWA) is generated by aortic 
characteristic impedance – i.e. a mismatch between aortic root properties and peak 
aortic flow (Cooper et al. 2015; Torjesen et al. 2014).  
Regardless of its exact mechanistic basis, guidelines currently suggest that a brachial 
PP of >60mmHg conveys increased risk for asymptomatic end organ damage in the 
elderly (Dart & Kingwell 2001; Mancia et al. 2013) and overall cardiovascular disease 
(Franklin et al. 1999; Mitchell et al. 1997). 
Beyond pulse pressure, central aortic blood pressure is widely acknowledged as being 
haemodynamically and physiologically more relevant as it is the site of systolic left 
ventricular afterload and the origin of coronary diastolic perfusion. Invasive 
assessment, however is impractical for widespread use and thus attempts at correcting 
a peripheral waveform are attractive and have been used as endpoints in clinical trials 
(see below). 
 
1.4.3.2 Pulse waveform analysis  
As described, the arterial waveform is the net outcome of the interaction between the 
forward pressure waveform created by the ventricular stroke volume and reflected 
waves (Figure 1.4). Augmentation of central blood pressure by the return of these 
waves from the peripheral circulation can be quantified by pulse wave analysis (PWA) 
and the calculation of an augmentation index (AIx). Initially described in the 1980s 
(Karamanoglu et al. 1993; Kelly, R et al. 1989), measurement involves discerning a 
shoulder on the upstroke of the pulse wave which corresponds to the forward wave 
(P1). The merging of the forward wave with the incoming reflected wave then 
generates an inflection point. A second systolic peak (P2) is observed as the maximum 
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effect of the reflected wave on the central pressure contour. The degree of 
‘augmentation’ can be calculated mathematically by the equation P2 – P1 and is 
termed Augmentation Pressure (AP) (Davies, JI & Struthers 2003). Augmentation 
pressure, when expressed as a ratio to pulse pressure, (AP/PP) is called Augmentation 
Index (AIx) (Mackenzie et al. 2002).  
 
 
FIGURE 1.4 Arterial pressure waveform allowing calculation of 
augmentation index (AP/PP). AP – augmentation pressure; PP – 
pulse pressure; SBP - systolic blood pressure; DBP – diastolic 
blood pressure. 
 
Augmentation Index depends on the timing of the reflected waves, and thus pulse wave 
velocity and arterial stiffness in addition to the amount of wave reflection which is 
largely governed by resistance of peripheral arteries. A large body of evidence 
demonstrates AIx increases with age (Nicholls & O’Rourke 2005) and is elevated in 
patients with diabetes (Wilkinson et al. 2000), dyslipidaemia (Wilkinson et al. 2002) 
and hypertension (Nicholls & O’Rourke 2005). In the large community-based 
Multiethnic Study of Atherosclerosis (MESA), PWA was performed in 5960 
participants and followed for a median of 7.6 years (Chirinos et al. 2012). After 
adjustment for traditional risk factors, AIx was independently predictive of 
cardiovascular events (HR for 10% increase 1.08; 95%CI 1.01 – 1.14, p = 0.016) 
however, reflection magnitude (the ratio of reflected to forward wave amplitude) was 
a stronger predictor (HR for 10% increase 1.34; 95%CI 1.08 – 1.67, p = 0.009). 
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The central aortic waveform is inaccessible in routine clinical practice and thus there 
has been considerable interest in acquiring a peripheral waveform and reconstructing 
its constituents to not only estimate aortic pressures but also generate a central aortic 
waveform. This is most often performed at the radial artery as it is easily accessible 
and compressible, requires minimal expertise and is reproducible (Wilkinson et al. 
1998). A number of transfer functions have been described (Chen, CH et al. 1997; 
Hope et al. 2003; Pauca et al. 2001) and demonstrate robust validity against aortic 
pressures (Hope et al. 2008) using different modelling and mathematical techniques 
(Fetics et al. 1999). Nonetheless, a significant degree of contention in the literature 
exists about how generalizable the radial waveform is to the central waveform 
(O'Rourke 2007) not only because the properties of the upper limb vasculature are not 
constant in all ages (Millasseau et al. 2002) or can be variably affected by vascular 
disease (McLeod et al. 2004), but also because they are exposed to a single, fixed 
mathematical equation. Whether the transfer function successfully reproduces the 
central waveform or not, radial PWA clearly has predictive capacity (Hope et al. 2008) 
and may instead simply be an integrated measure of arterial stiffness, in and of itself.  
 
1.4.3.3 Pulse wave velocity  
As Bramwell and Hill applied Moens and Korteveg’s equations, the speed of 
propagation of the pulse wave (pressure or flow) in an artery is directly related to the 
stiffness of the vessel. Simply put, this can be assessed by dividing the distance a pulse 
wave travels by its transit time (Figure 1.5). Pulse wave velocity (PWV) is generally 
accepted as the most simple, non-invasive and robust method for determining arterial 
stiffness. Although theoretically assessable in any blood vessel, carotid-femoral PWV 
earned the label of the ‘gold standard’ modality from the 2006 consensus statement 
(Laurent et al. 2006) and has remained so in subsequent statements (Townsend et al. 
2015). 
  Chapter 1: Arterial stiffness and coronary blood flow 
 17 
 
FIGURE 1.5 Adapted from Laurent (Laurent et al. 2006) 
demonstrating concept behind PWV calculation. Carotid 
waveform at top, femoral waveform at bottom. Estimation of 
length, or distance, is a point of contention mentioned in text. 
 
From a cardiac frame of reference, the aorta and its most proximal vessels are exposed 
to the largest amount of pulsatile energy and as described, provide a dominant 
contribution to the arterial cushion function. Thus, assessment of the pulse wave 
velocity in these vessels would likely provide the most information on elastic or 
cushion arterial function, and thus earlier demonstrable changes from increasing 
arterial stiffness. Given the carotid to femoral distance approximates the aortic ‘path’, 
carotid-femoral PWV is occasionally (albeit erroneously) referred to as aPWV, and 
although they are highly correlated (Podolec et al. 2007), aPWV has traditionally been 
measured invasively (Lim et al. 2004) whereas cfPWV is non-invasive. Brachial-ankle 
PWV, described mainly in Asian populations until recently, likely represents a 
composite of both elastic and muscular artery interaction but is strongly correlated to 
cfPWV and has similar prognostic capacity (Ninomiya et al. 2013; Ohkuma et al. 
2017; Sheng et al. 2014; Turin et al. 2010). Femoral-ankle or femoral-tibial however, 
appears of less prognostic value as it assesses muscular rather than elastic vessel 
function (Meyer et al. 2016).   
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Measurement of cfPWV involves recording of pulse waves at the common carotid and 
the femoral artery using pressure sensors (mechanotransducers or applanation 
tonometers) or Doppler ultrasound. The transit time can be measured directly using 
simultaneous recordings at both carotid and femoral sites, or alternatively can be 
derived from the ECG if waveforms are acquired sequentially. Exactly what point 
constitutes the ‘foot’ of the pulse wave varies between algorithms and devices, 
although the most widely used is the intersecting tangent algorithm. The other points 
of contention are the calculation of travel distance (which is usually assimilated to the 
surface distance between the two recording sites) and how readily carotid-femoral 
PWV approximates ‘true’ aortic PWV. Carotid-femoral PWV involves the detection 
of two waves – one heading in a cephalad (carotid) and the other in a caudal direction 
(femoral) whereas true ‘aortic’ PWV ought simply be antegrade flow. This 
complicates the exact determination of not only transit time but also distance. Cardiac 
magnetic resonance imaging which utilises phase-contrast (PC) sequences are able to 
generate flow-time curves at multiple sites and thus can measure directly within the 
aortic course. With multi-planar and cross-sectional imaging afforded by CMR, an 
exact measure of transit distance can be made. Phase contrast imaging remains at risk 
of noise and sampling error which hinders an accurate determination of the ‘foot’ or 
‘peak’ of the pulse wave which is further compounded by the lack of commercially 
available software or standardised guidance (Wentland et al. 2014). Correlation studies 
of cfPWV with aPWV assessed by both  CMR (Huybrechts et al. 2011) and invasive 
(Weber et al. 2011) methods have demonstrated a consistent overestimation by around 
2m/s and thus a correction is made to the carotid-femoral distance. This is achieved 
either by subtracting 20% off the surface distance (Van Bortel et al. 2012) or by 
subtracting the suprasternal notch-carotid distance from the suprasternal notch-
femoral distance (Weber et al. 2009). Inherent limitations to either correction persist 
when there is abdominal obesity or large volumes of breast tissue (Van Bortel et al. 
2002). A variation on the concept of PWV involves evaluating the ‘QKD’ interval 
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which is the time between the onset of the QRS on the ECG, and the last Korotkoff 
sound at the brachial artery. Although initially described in the 1990s (Gosse et al. 
1994), a large longitudinal study has confirmed its independent prognostic capacity 
for CV events (Gosse et al. 2013).    
The growth of cfPWV as the ‘gold standard’ has not only resulted in the development 
of reference values (Arterial Stiffness Reference 2010) but also appears in the current 
(due for updating in 2018) ESC guidelines for hypertension prognostication (Mancia 
et al. 2013) where a cfPWV of >10m/s carries a high risk of both subclinical end organ 
damage and cardiovascular events. 
 
1.4.3.4 Distensibility 
Compared to more general, indirect measures such as cfPWV, arterial distensibility is 
a direct, local measure of a vessel’s stress/strain relationship. Distensibility evaluates 
the normalised change in arterial diameter (or cross-sectional area) in relation to 
distending pressure and has been widely used in a variety of vascular territories 
including the carotid (Barenbrock et al. 2002; Dijk et al. 2005; Paini et al. 2006), 
brachial (Urbina et al. 2002), radial (Giannattasio et al. 1999), aorta (Groenink et al. 
1998; Metafratzi et al. 2002) and recently, the pulmonary arteries (Ray et al. 2018).  
 
1.4.3.4.1 Ultrasound/echocardiography 
Ultrasound has historically been the modality of choice in view of its ability to measure 
superficial arteries with excellent temporal resolution. The spatial resolution however, 
can limit the detection of small luminal diameter changes which, in addition to 
operator dependence, can limit reproducibility particularly with serial evaluations. 
Although the ascending aorta can be visualised with transthoracic windows (Sabia et 
al. 2018), the majority of the thoracic aorta is only visible with transoesophageal 
echocardiography (TOE). Although extensively published in recent years by Nemes et 
al. (Nemes 2008; Nemes et al. 2012; Nemes, Forster & Csanady 2008; Nemes, Forster, 
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Geleijnse, et al. 2008; Nemes et al. 2009; Nemes, Geleijnse, et al. 2008), the use of 
TOE for measurement of aortic dynamic function dates back to the late 1980s (Isnard 
et al. 1989) and aortic distensibility back to the early 1990s (Lang et al. 1994). The 
largest study utilising TOE measures of aortic compliance, aortic stiffness and stiffness 
index involved a review of 500 patients’ studies who underwent a clinically indicated 
procedure and were analysed retrospectively. After a median follow up of just over 5 
years in a high-risk population (44% mortality), tertiles of all indices were predictive 
using Log-Rank Kaplan-Meier survival analysis. Once corrected for traditional risk 
factors however, the independent strength of each measure was attenuated such that 
only stiffness index remained significant (Go OD Echocardiography 2014).  Although 
feasible, its uptake beyond small cross-sectional studies (Nemes et al. 2007) or 
retrospective analysis has been limited as it remains relatively invasive, operator 
dependent and requires a physician to perform the assessment. 
 
1.4.3.4.2 Cardiac magnetic resonance 
First described in the late 1980s (Mohiaddin et al. 1989), cardiac magnetic resonance 
offers the ability to evaluate vascular dynamic function within almost any vascular bed 
and across any plane. CMR is not limited by body habitus (aside from the morbidly 
obese who cannot fit in the tunnel) or vascular calcification, nor does it suffer from 
operator dependence.  
 
Although tonometry cfPWV is able to provide an overall ‘value’ for aortic stiffness, it 
makes assumptions about distance travelled and neglects the ascending aorta. While 
some of this can be overcome using phase contrast, flow-based CMR sequences, the 
value for any assessed segment remains a vessel’s ‘average’ and as our group has 
demonstrated (Nelson et al. 2009), as have others (Kim, EK et al. 2013), there is 
regional heterogeneity. It is therefore of significant interest to evaluate not only an 
‘average’ stiffness for the aorta but also regional changes as it may be a more sensitive 
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marker of disease (Hundley et al. 2001). Similar findings were reported by Redheuil 
et al. (Redheuil et al. 2010) in an asymptomatic population aged 20-50 years (a 
subgroup of their larger analysis) where proximal aortic distensibility fell sharply 
before 50 years of age even after multivariate analysis included cfPWV, carotid 
distensibility and AIx. This highlights its potential utility at detecting early, subclinical 
aortic dysfunction.  
 
Cardiovascular magnetic resonance derived arterial distensibility can be theoretically 
performed at any vascular bed although it has been used most for the measurement of 
aortic distensibility.  In brief (see Chapter 2), cross sectional cine images are acquired, 
and the inner lumen traced throughout the cardiac cycle. Conventionally this is done 
at three levels providing measurements at the ‘ascending aorta (AA)’, ‘proximal 
descending aorta (PDA)’ and ‘distal descending aorta (DDA)’.  Maximum and 
minimum values are obtained, and a relative area change calculated indexed to 
baseline vessel size. This is then indexed to the distending pulse pressure to provide a 
value for distensibility in its final units, 10-3mmHg-1.  Whilst some have advocated for 
a transfer function from the radial artery waveform to deduce central PP (Redheuil et 
al. 2010), thereby reducing the potential impact of pressure amplification and 
subsequent under-estimation of distensibility (particularly in the young), most have 
simply used brachial readings and accepted this limitation (Rerkpattanapipat et al. 
2002). Both methods have been validated against ‘gold standard’ measures of arterial 
stiffness, in particular tonometry-derived cfPWV (all R2 > 0.7, p<0.001) (Lehmann et 
al. 1993; Nelson et al. 2009). CMR aortic distensibility is highly reproducible with a 
coefficient of variation between 1 and 2% for intra- and inter-observer variability, 
respectively (Nelson et al. 2009). In addition, distensibility-specific sequences and 
analysis take less than 5 minutes and although unlikely to be a sole indication for a 
clinical CMR request given its cost and accessibility, could represent a key component 
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of a comprehensive cardiovascular examination or an addition to an otherwise 
clinically indicated scan.   
 
The largest study to date involving aortic distensibility was performed by Maroules et 
al. (Maroules et al. 2014) in the Dallas Heart study. They evaluated 2122 individuals 
without established CVD and performed aortic arch PWV, aortic distensibility and 
total arterial compliance (TAC – calculated as LV stroke volume/pulse pressure 
(Kawaguchi et al. 2003)) and were followed for a mean duration of 7.8 years. Total 
arterial compliance was modestly associated with the composite event endpoint per 
standard deviation (HR 1.07, p = 0.03) however both TAC (HR 1.11, p = 0.011) and 
distensibility (HR 1.45, p = 0.0005) strongly associated with non-fatal cardiovascular 
events where arch PWV did not. Of note there was no significant improvement in the 
c statistic when adding either TAC or distensibility CMR indices into the Framingham 
Risk score. This relatively modest incremental benefit observed may well be explained 
by the low risk of the population and small numbers of events.  
 
1.4.4 Epidemiology 
Almost 100 years after the introduction of the sphygmomanometer in clinical practice 
(O'Brien 1996), appreciation of arterial stiffness as a more specific measure of vascular 
health has grown markedly in the last 20 years. Evidence of this is in the number of 
PubMed listings by year of publication (Figure 1.6). In the early years seminal and 
founding work in the field was largely mechanistic and challenging to synthesize at a 
population or even individual patient level. This was due to myriad methods of 
assessment, variously studied vascular beds and a paucity of reference or ‘normal’ 
values to apply to clinical decision making. In 2006, the European Society of 
Cardiology published a consensus document providing a precis on arterial stiffness 
measurement and more importantly, recognised cfPWV as the ‘gold standard’ method 
for clinical evaluation (Laurent et al. 2006). Used largely in cross sectional or smaller 
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longitudinal studies until that time, this statement called for reference values which 
were subsequently produced by a similar group in 2010 from nearly 17,000 patients, 
of which 1,500 were healthy ‘normal’ controls (Arterial Stiffness Reference 2010). 
The consensus guidelines reported a ‘reference’ PWV by stratum of decade and blood 
pressure status with subsequent modification of the ‘at risk’ cut-off (Van Bortel et al. 
2012). The American Heart Association then published their own consensus statement 
in 2015 and provided a Class IIa recommendation to measure arterial stiffness in 
clinical practice or those with hypertension on the grounds of Level A evidence 
support (Townsend et al. 2015). 
 
 
FIGURE 1.6 Column graph representing items indexed on 
PubMed using ‘arterial stiffness’ search. 
 
Measures of arterial stiffness have been shown to strengthen traditional risk 
assessment and be independent predictors for cardiovascular events, cardiovascular 
death and all-cause mortality. Almost exclusively with cfPWV, given its relative 
simplicity and accessibility, this has been shown across a number of cohorts including 
‘healthy’ volunteers (Mattace-Raso et al. 2006; Mitchell et al. 2010; Willum-Hansen 
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et al. 2006), the elderly (Meaume et al. 2001; Sutton-Tyrrell et al. 2005), those with 
established coronary disease (Kaneko et al. 2013), hypertension (Boutouyrie et al. 
2002; Laurent et al. 2001; Terai et al. 2008), diabetes (Cardoso et al. 2013; Levisianou 
et al. 2013; Roos et al. 2013) and renal disease (Blacher et al. 2002; Pannier et al. 2005; 
Shoji et al. 2001; Zoungas et al. 2007).  
The most comprehensive systematic review of the predictive capacity of cfPWV was 
reported by Ben-Shlomo et al. (Ben-Shlomo et al. 2014) in which they performed an 
individual patient analysis of 17 cohorts totalling 17,635 participants. For inclusion in 
the analysis, studies had to have a) directly measured carotid-femoral PWV, b) 
followed subjects for a minimum of 1 year and c) collected outcome data on all-cause 
mortality, coronary outcomes (MI, revascularization) and stroke events. After 
adjusting for cholesterol, smoking status, diabetes and hypertension, using pooled 
adjusted hazard ratios, a 1 SD increase in loge transformed cfPWV was associated with 
increased risk of all-cause mortality (HR 1.17; 95%CI 1.11-1.22), CV mortality (HR 
1.28; 95%CI 1.15-1.43), CHD events (HR 1.23; 95%CI 1.11-1.35) and CVD events 
(HR 1.30; 95%CI 1.18 – 1.48). The predictive capacity appeared stronger in younger 
individuals although saliently was not modified by hypertension, smoking, gender, 
diabetes or kidney disease.  The addition of cfPWV to standard risk prediction models 
like Framingham, whilst only modestly improving the c statistic, did assist with the 
separation of younger individuals of intermediate risk. These findings were similar to 
an earlier meta-analysis which included just over 15,000 patients for a mean follow up 
of just over 7 years (Vlachopoulos et al. 2010).  
  
  Chapter 1: Arterial stiffness and coronary blood flow 
 25 
1.4.5 Underlying mechanisms of arterial stiffness 
Arterial stiffness is associated with modifications to the properties of load bearing 
structural components of the arterial wall which, in turn, alters the stress and strain 
relationship. The mechanisms that underpin these changes are the result of a complex 
interaction between mechanical (haemodynamic forces) and humoral (hormones such 
as angiotensin II, salt, glucose) factors which impact on the material properties of the 
arterial wall. Dichotomising these into either a) material properties, or ‘passive’ 
mechanisms, or b) cellular or molecular signalling, or ‘active’ mechanisms provides a 
framework for description.  
 
1.4.5.1 Passive 
1.4.5.1.1 ‘Functional’ stiffness 
As described (1.3.2 Anatomy), the anatomical makeup of large arteries generates 
intrinsic functional arterial stiffness (Shadwick 1999; Wagenseil & Mecham 2009); as 
wall tension and distending pressure increases, the load-bearing burden of the arterial 
wall shifts from predominantly elastin recruitment to collagen which is materially 
stiffer and less compliant. An artery’s stiffness, therefore, is fundamentally and non-
linearly pressure dependent (Cox 1975). Applying this observation, an increased 
distending pressure will generate a ‘functionally’ stiffer vessel which in turn will 
increase PWV and pulse pressure thereby providing the substrate for a positive 
feedback loop. Teasing out the direction of causality is inherently challenging with 
these observations.  
 
1.4.5.1.2 Mechanical fatigue 
As described in (1.3.2 Anatomy), elastin has rubber-like characteristics being highly 
resilient, deformable and of comparatively low stiffness; properties which facilitate its 
capacity to store strain energy. The pulsatile nature of blood flow subjects the arteries 
to continuous and repetitive strain throughout life with the aorta, for example, 
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passively dilating up to 15% of its size with each heartbeat (Nicholls & O’Rourke 
2005). Applying the modern engineering principles of rubber fatigue, if distended 15% 
per cycle it would take approximately 1 billion beats to fracture a component of elastin. 
This corresponds to 30 years at a rate of 70 beats/min (O'Rourke & Hashimoto 2007). 
Radiocarbon data shows elastin to have the greatest longevity of any protein in the 
human body with a half-life of between 40-174 years (mean 74 years) (Shapiro, SD et 
al. 1991) supporting a theory that elastin may undergo a qualitative rather than 
quantitative change when exposed to mechanical fatigue. Cross-sectional studies of a 
range of species of varying body size, heart rate and life span show an association 
between the degree of elastin fragmentation, disorganisation and fracture, and the total 
number of cardiac cycles (Avolio, A et al. 1998).  Supporting this underlying 
mechanism comes from an elastin haplodeficient mouse where a functional loss of 
elastin results in the development of precocious arterial stiffness followed by 
hypertension (Le et al. 2011). 
 
1.4.5.2 Active 
1.4.5.2.1 Endothelial cell function 
Once conceived as an inert monolayer forming the interface between the arterial wall 
and circulating blood, it is now recognised that the innermost component of the intima 
is indeed highly functional and dynamic. This has been elegantly described at the small 
vessel level (Furchgott & Zawadzki 1980), although its role in large artery behaviour 
is less certain. More recently, increased pulsatility has been shown to alter the 
phenotypic behaviour of both endothelial and vascular smooth muscle cells via 
complex mechano-transduction pathways (Lehoux et al. 2006; Resnick & Gimbrone 
1995).  In bovine endothelial cell culture, increased amplitude and frequency of 
mechanical forces were associated with increased expression of endothelin-1 and 
reduced expression of endothelial nitric oxide synthase (Ziegler et al. 1998); changes 
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which themselves would generate arterial stiffness and through increased pulse 
pressure, perpetuate a positive feedback loop.  
 
1.4.5.2.2 Vascular smooth muscle cell function 
A large body of evidence supports the role of vascular smooth muscle cell (VSMC) 
activity in small vessels regulating vascular tone and peripheral resistance, however, 
their role in large artery stiffness appears phenotypically, and potentially adaptively, 
different (Campbell & Campbell 2012; Cox 1979). The predominant change in 
vascular smooth muscle cell behaviour is a trans-differentiation leading to 
osteogenesis and calcium deposition largely in the media of the arterial wall (Johnson, 
RC et al. 2006). The exact precipitants of this change remain elusive, however a variety 
of mediators including calpain-1, a regulator of MMP activity, (Jiang et al. 2012) and 
transglutimase 2, a cell programmer (Johnson, KA et al. 2008) have been implicated. 
In addition to VSMC direct trans-differentiation, the degradation of elastin appears to 
promote the signalling pathway for vascular calcification and ultimately the process 
of elastocalcinosis, a finding seen even in presumed ‘healthy’ individuals (Atkinson 
2008; McEniery et al. 2009). As with other mechanisms of arterial stiffness, the 
directional relationship between calcification and arterial stiffness is complex.  
Evidence of a bidirectional or positive feedback process comes from a recent study by 
Guo et al. (Guo et al. 2017) who evaluated the aorto-iliac arteries in just over 600 
middle aged men over a period of six years. In this study, the annual increase in 
calcification was strongly associated with an increase in baPWV; moreover, in those 
without initial calcification, baseline elevated baPWV predicted the development of 
calcification. 
 
1.4.5.2.3 Extracellular matrix 
As described, the arterial wall comprises extracellular matrix (ECM) proteins which 
include collagen, elastin, proteoglycans and glycoproteins; the collagen and elastin 
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providing most of the structural integrity and elasticity, respectively. The ECM is in a 
constant state of tension between the inter and intramolecular cross-linking of collagen 
and elastin which is catalysed by lysyl oxidase (LOX) and their turnover by matrix 
metalloproteinases (MMPs) into advanced glycation end-products (AGEs). Formation 
of AGE in the ECM leads to increased arterial stiffness, a feature commonly observed 
with increasing age (Bailey 2001). Conditions that either down-regulate LOX such as 
obesity (Chen, JY et al. 2013) or up-regulate MMP expression (Galis & Khatri 2002) 
or activity via haemodynamic stressors (Galis & Khatri 2002), inflammation (Visse & 
Nagase 2003) or reactive oxygen species (Rajagopalan et al. 1996), therefore, have 
been shown to increase arterial stiffness. Promotion of fibrosis within the ECM, 
potentially driven by the pro-inflammatory cardiotropin-1, has also been implicated in 
increased arterial stiffness (Lopez-Andres et al. 2013).  
 
1.4.5.2.4 Neuroendocrine 
Remodelling of the arterial wall in arterial stiffness, particularly in aging, appears to 
be associated with a pro-inflammatory milieu (Lakatta & Levy 2003) and for the most 
part, mediated by increased levels of angiotensin II.  The multiple effects of increased 
angiotensin II include the stimulation of collagen production (Benetos, Levy, et al. 
1997), VSMC expression, endothelin receptor signalling and reactive oxygen species 
in addition to a reduction in NO-dependent signalling (Wang, M et al. 2010).  These 
effects have been closely associated with ageing implicating a variety of mediators 
such as transforming growth factor beta 1, monocyte chemoattractant protein-1 and 
matrix metalloproteinases (Lakatta et al. 2009; Wang, M & Lakatta 2002; Wang, M et 
al. 2007). 
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1.4.5.2.5 Genetics 
1.4.5.2.5.1 Genome-wide association  
Closely linked with arterial stiffness, interest in the genetics of hypertension has 
revealed up to 50% (h2 = 0.5) of individuals may have a hereditary basis to their 
elevated blood pressure (Padmanabhan et al. 2015). Notwithstanding this, 
contributions from epigenetics and behavioural influence are likely to modify single, 
isolated gene effect size and thus the prevailing aetiology of hypertension is felt to be 
multifactorial and probably polygenic (Reich & Lander 2001). Widened brachial pulse 
pressure, a feature of isolated systolic hypertension and a crude measure of arterial 
stiffness, was shown in large genome-wide association studies (GWAS) to have 
modest heritability in Nigerian (Adeyemo et al. 2002) and Mexican-American 
(Atwood et al. 2001) individuals with similar findings demonstrated in the 
Framingham cohort (h2 = 0.5) (DeStefano et al. 2004).  Genetic correlation studies 
have been performed with more specific measures of arterial stiffness parameters 
although these have been either small cross-sectional studies or limited to twin cohorts 
(Snieder et al. 2000; Tarnoki et al. 2012).  Collectively the heritability estimates have 
reached as high as 0.48 (Mitchell et al. 2005) although the individual genetic 
associations have been weak despite a number of potential, biologically plausible 
candidate genes including those coding for Angiotensin II receptors (Benetos et al. 
1995), fibrillin-1 (Medley et al. 2002), endothelin receptors (Lajemi et al. 2001), 
matrix metalloproteinases (Medley et al. 2003), and nitric oxide synthase (Mitchell, 
Guo, Kathiresan, et al. 2007). Given a large number of these studies were 
underpowered, a large GWAS meta-analysis compiled data from over 26,000 
individuals from Europe (Mitchell et al. 2012). A genome-wide association was found 
between cfPWV and a region on chromosome 14, a location coding for human cardiac 
and vascular cell lines suggesting putative relevance. When applied to the Framingham 
cohort, the presence of the allele was associated with increased risk of coronary artery 
disease HR 1.05 (95%CI 1.02 – 1.08, p = 0.0013) and heart failure, HR 1.10 (95%CI 
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1.03 – 1.16, p = 0.004). In GWAS terms, this is a highly significant association but at 
an individual level, these hazard ratios represent only a modest modifier of absolute 
risk.  Nonetheless, it remains of significant interest that this gene, and others, may not 
only reveal instructive pathophysiological insights for arterial stiffness but perhaps 
provide a background to an individual’s variable development of arterial dysfunction 
when exposed to traditional vascular risk factors (Logan et al. 2015). 
 
1.4.5.2.5.2 Single genes 
From an animal model perspective, evidence of genetic causation in arterial stiffness 
has come in the form of the Klotho gene; an antiaging gene which when mutated 
results in a number of aging phenotypes and early death (Kuro-o et al. 1997). 
Overexpression has been shown to reverse ageing, prevent hypertension and extend 
lifespan in mice (Gao et al. 2016; Kurosu et al. 2005; Xiao et al. 2004). Recent 
mechanistic studies by Chen and others with Klotho haplodeficient mice exhibited 
higher aortic PWV compared to wild type animals (Chen, K et al. 2015). Moreover, 
the development of faster PWV preceded the development of hypertension suggesting 
stiffness was causal of hypertension, rather than a sequel of it. At a histological level, 
haplodeficient mice had reduced elastin and increased collagen in the tunica media of 
the aorta; a finding that was not observed in the carotid or femoral arteries of these 
animals.  
 
1.4.6 Causes of arterial stiffness 
A large body of evidence has linked arterial stiffness to the presence of traditional risk 
factors including increasing age (O'Rourke & Hashimoto 2007), hypertension 
(Benetos et al. 1993), diabetes (Wilkinson et al. 2000), dyslipidaemia (Wilkinson et 
al. 2002), smoking (Mahmud & Feely 2004), obesity (Chau et al. 2018), renal disease 
(Blacher et al. 2001; Blacher et al. 2002; London et al. 2001; Mourad et al. 2001) and 
sedentary lifestyle (Tanaka et al. 1998). Whilst these associations do not prove 
  Chapter 1: Arterial stiffness and coronary blood flow 
 31 
causation, a number of these relationships are particularly strong and postulated 
mechanisms deserve noting. 
 
1.4.6.1 Ageing 
Early studies in arterial stiffness suggested a linear relationship with increasing age 
(Avolio, AP et al. 1983; Smulyan et al. 2001; Vaitkevicius et al. 1993). Over the last 
10 years, however, it has become clear that the relationship is more likely curvilinear 
and markedly increases after the fifth decade (Greenwald 2007; McEniery et al. 2005). 
A point of ongoing contention remains whether arterial stiffening is an inexorable 
feature of aging (McEniery et al. 2007) or whether the changes observed are a 
reflection of long term, cumulative comorbidity exposure thereby supporting the 
notion of a ‘vascular age’ versus ‘chronological age’ (Lakatta & Levy 2003; Lee, HY 
& Oh 2010). 
Regardless, the major alterations observed with increasing age characterised by the 
imbalance between collagen and elastin in the ECM. With the largest relative 
abundance of elastin, our group (Nelson et al. 2009), and others (Rogers et al. 2001) 
have shown this process appears to occur preferentially in the proximal aorta. 
Although the traditional view is of cyclical material stress as described earlier 
(O'Rourke & Hashimoto 2007), there is additional evidence of increased matrix 
metalloproteinase (MMP) expression and subsequent elastin degradation in animal 
studies of aged rodents (Li et al. 1999; Wang, M et al. 2005). Not only is there a 
reduction in the elastin quality and quantity, there is a commensurate increase in 
collagen synthesis and deposition which steadily increases after the sixth decade 
(Cattell et al. 1996; Wang, M et al. 2007; Yu & Blumenthal 1963).  
Largely animal based work has demonstrated that age-associated remodelling has a 
pro-inflammatory profile characterized by increased VSMC expression and increased 
secretion of angiotensin II which contributes to both material and structural change 
(Lakatta et al. 2009). The role of amyloid in other age-associated conditions such as 
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dementia, renal dysfunction and more recently diabetes (Westermark 2005) is well 
established, however has more recently also been linked to the arterial wall.  An 
elegant autopsy study from the 1970s proposed this theory with aortic amyloid present 
in 51% of patients in their 40s but 95% of those in their eight decade of life – saliently 
this was geographically distant from atheroma (Iwata et al. 1978). Components of the 
inflammatory milieu implicated in the ‘aging’ vascular phenotype have also been 
observed in animal models of induced obesity, diabetes and hypertension. The 
corollary that these vascular risk factors may be inducing a form of ‘early’ or 
precocious ageing – extending the notion of a ‘vascular age’  (Cunha et al. 2017; Najjar 
et al. 2005). 
 
1.4.6.2 Hypertension 
A large body of evidence supports a strong association between hypertension and 
aortic stiffness (Beltran et al. 2001). The traditional view has been that hypertension 
stimulates aortic remodelling and subsequently stiffening, as an adaptive process to 
increase the wall-to-lumen ratio (La Place’s law) in response to chronic elevation of 
distending pressure (Boutouyrie et al. 1999; Gibbons & Dzau 1994). In vivo aortic 
banding confirms that the aorta materially stiffens in response to increased pressure 
(Fridez et al. 2002) and ex vivo mechanosensitive cell culture studies produce matrix 
when exposed to increased stress (Humphrey et al. 2014). However, the potential for 
bidirectionality of this association, and even subclinical arterial stiffness causing 
hypertension, has been the focus of both population studies and more recently, animal-
based enquiry. Seminal work from Weisbrod et al. demonstrated in a mouse model of 
diet-induced obesity (high fat high sucrose, HFHS) that arterial stiffness (PWV, 
measured invasively and non-invasively) develops rapidly and precedes the onset of 
hypertension and overt diastolic dysfunction (Weisbrod et al. 2013). The most 
compelling human work comes from Kaess et al. (Kaess et al. 2012) who evaluated 
the non-hypertensive offspring cohort from Framingham. In this group they showed 
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that higher baseline PWV was a risk factor for progression of hypertension but also 
predicted incident hypertension during a seven-year period of follow up. When 
evaluating predictors of follow up PWV from baseline PWV, no parameter of BP 
(systolic, diastolic, mean) was significant enough to enter the model suggesting it was 
causal of BP rather than a complication of it. Similar findings were earlier reported by 
Dernellis et al. (Dernellis & Panaretou 2005) in other smaller, association studies 
although of varying ages (Liao et al. 1999; Takase et al. 2011). Whether there is a 
predominant direction of causality or whether there are phenotypes of hypertension 
which are generated by arterial stiffness (isolated systolic hypertension, or resistant 
hypertension) or possibly a degree of positive feedback between the two, remains a 
focus of ongoing research (Humphrey et al. 2016; Laurent & Boutouyrie 2015).  
 
1.4.6.3 Glucose and insulin 
Arterial stiffness is consistently observed across all age groups with diabetes and 
metabolic syndrome: a core feature being insulin resistance (Salomaa et al. 1995; 
Sutton-Tyrrell et al. 2001). Not only do the earliest changes in both arterial stiffness 
and endothelial dysfunction appear in obese children with the metabolic syndrome 
(Tounian et al. 2001), there is evidence of a ‘metabolic derangement’ dose effect 
relationship on indices of arterial stiffness (Scuteri et al. 2004). Mechanistically, 
hyperinsulinaemia and hyperglycaemia induce chronic over-activity of the renin-
angiotensin-aldosterone system (RAAS) which drives expression of angiotensin type 
I receptors in vascular tissue (Nickenig et al. 1998) and subsequently wall hypertrophy 
and fibrosis (Jesmin et al. 2003; Rizzoni et al. 2001). Chronic fasting glycaemia 
appears to promote non-enzymatic glycation of proteins with covalent cross-linking of 
collagen, advanced glycation end-products (AGEs) which result in expansion of the 
media and alteration of the arterial wall mechanics (Brownlee et al. 1988). 
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1.4.7 Implications of arterial stiffness 
A growing body of evidence now suggests that the high flow, low resistance organs 
such as the brain and kidney are most at risk of subclinical complications from large 
artery stiffness. Inefficient damping of the arterial pressure waveform in the large 
arteries allows elevated pulsatile flow and pulse pressure to extend to arterioles 
(Figure 1.7). Not only does this potentially drive vascular remodelling and endothelial 
dysfunction at a smaller artery/arteriolar level but subjects these vascular beds to 
barotrauma.  Description of these changes has established a mechanistic basis for the 
predictive strength of arterial stiffness in these cohorts and has re-shaped it from being 
an ‘association’, to an established ‘risk factor’. 
 
FIGURE 1.7 Adapted from O’Rourke (O'Rourke & Hashimoto 2007) 
demonstrating inadequate dampening of the arterial pulse pressure and 
persistence of pulsatility into small arterioles in those with stiff arteries 
(right) compared to normal (left). 
 
 
1.4.7.1 Neurological sequelae 
The large arteries (i.e. middle cerebral artery calibre) provide over 50% of the 
cerebrovascular resistance (Faraci & Sigmund 1999), however to maintain continuous  
and diastolic flow, even some of the most distal perfusing vessels are exposed to a 
degree of pulsatility. The relatively short vascular distance to achieve this distribution 
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of pressure (Fukasawa 1969) places the microcirculation at risk of barotrauma (Blanco 
et al. 2017; Snyder et al. 2015) and is demonstrably less efficacious with age and the 
presence of traditional vascular risk factors (Toth et al. 2017). Mechanistically, the 
persistence of a pulsatile arterial wave into the small vessels of the brain from 
increased arterial stiffness is believed to directly cause cerebral microvascular damage 
or cerebral small vessel disease (CSVD) (O'Rourke & Safar 2005; Roher et al. 2011; 
Tzourio et al. 2014). Furthermore, the increased pulsatile load may induce a 
remodelling response in the smaller calibre vessels which, although protective initially 
against the intravascular pressure, may potentiate microvascular ischaemia through 
reduced vasoreactivity (O'Rourke & Safar 2005).  
 
Confirmed in a recent meta-analysis (van Sloten et al. 2015), smaller cross-sectional 
studies involving a variety of measures of arterial stiffness have been strongly 
associated with MRI manifestations of CSVD including white matter lesions (WMLs), 
lacunar infarcts and cerebral microbleeds CMB (Hatanaka et al. 2011; Henskens et al. 
2008; Kim, DH et al. 2008; Kuo, HK et al. 2010; Matsumoto et al. 2007). These 
radiological findings are believed to represent the basis for stroke syndromes and a 
loss of cognitive function.   
 
In large community studies of individuals without stroke or dementia, higher cfPWV 
has been associated with lower memory scores and subcortical white matter 
hyperintensities in septuagenarians (Cooper et al. 2016; Hughes, TM et al. 2018; 
Mitchell et al. 2011; Tsao et al. 2016) and in younger individuals (Poels et al. 2012). 
Longitudinally in the Framingham cohort, cfPWV predicted the ten-year incidence of 
both mild cognitive impairment and dementia in the non-diabetic elderly (Pase, Beiser, 
et al. 2016). Evidence of earlier changes comes from studies in middle-aged adults 
aged 45 to 65 where cfPWV was associated with slower processing speed, executive 
function and white matter changes (Pase, Himali, et al. 2016). Furthermore, the change 
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in cfPWV over four years predicted a decline in executive function and memory scores 
after adjustment for measured BP and the presence of hypertension (Hajjar et al. 2016). 
 
1.4.7.2 Renal sequelae 
Autoregulation of blood flow across the kidney is achieved through myogenic tone in 
the afferent arteriole, largely under the control of complex tubule-glomerular feedback 
mechanisms (Loutzenhiser et al. 2002). Through the presence of the efferent arteriolar 
resistance, the mean and pulsatile pressures in the glomerulus are maintained at 
approximately 60% of the medium to large arterial values (Mitchell 2004). This 
relatively low resistance to high pressure preserves glomerular filtration but comes at 
the cost of exposing the glomerular capillary bed to the potentially damaging 
barotrauma of increased peak and pulsatile pressures (Bidani & Griffin 2004). This is 
evidenced by a tight association between both increased SBP (Gosse & Safar 2005) 
and widened PP (Fesler et al. 2007) with an increased rate of decline in renal function. 
Consistent with these findings, arterial stiffness, which is associated with both of these 
coarse haemodynamic consequences, has also been more tightly linked to an increased 
rate of GFR decline across the spectrum of renal disease (Ford et al. 2010; Taal et al. 
2007; Tanaka et al. 1998; Townsend et al. 2018). Given the pathophysiological links, 
it is consistent that arterial stiffness, aside from minor exceptions (Briet et al. 2011; 
Chandra et al. 2014), has independent prognostic capacity with respect to progression 
of renal disease but also cardiovascular and non-cardiovascular mortality in this cohort 
of patients (Baumann et al. 2014; Ford et al. 2010; Guerin et al. 2001; Karras et al. 
2012; Madero et al. 2013; Sedaghat et al. 2016). 
 
1.4.7.3 Cardiac sequelae 
Aortic stiffness, either through increased aortic impedance, reduced aortic reservoir 
function or through return of reflected waves, increases the systolic load on the left 
ventricle. Additional load on the left ventricle (both early and late systolic) through 
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Laplace’s law is offset by concentric hypertrophy, which although initially 
compensatory (Hori et al. 1985; Kohno et al. 1996), ultimately reduces efficiency and 
increases myocardial oxygen demand (Kelly, RP et al. 1992). Through increased 
filling pressures, arterial stiffness and concentric hypertrophy are both associated with 
the development of diastolic dysfunction (Russo et al. 2012) and can result in heart 
failure with preserved ejection fraction, HFpEF (Abhayaratna et al. 2008; Chae et al. 
1999; Dart & Kingwell 2001). Increased filling pressures within the left ventricle are 
translated to the left atrium which is associated with fibrosis and an increased risk of 
atrial fibrillation (Mitchell, Vasan, et al. 2007).   
Increased arterial stiffness, particularly when accompanied with age, broadens pulse 
pressure and reduces mean diastolic pressure relative to mean systolic. As covered 
later, given the coronary vessels are extrinsically compressed during systole, flow 
almost exclusively occurs during diastole. With a reduction in mean diastolic pressure 
observed in stiffer arteries, coronary perfusion may be compromised by a variety of 
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1.4.8 Stiffness as a therapeutic target 
The strength of data linking increased arterial stiffness with a number of 
cardiovascular and non-cardiovascular outcomes makes it an attractive therapeutic 
target. Moreover, its appearance before clinically manifest cardiovascular disease 
raises the potential for not only an early risk stratification but also a biomarker for 




Traditional approaches at reducing arterial stiffness have targeted a reduction in blood 
pressure and as described above, a reduction in operating MAP will reduce ‘functional’ 
stiffness and confound measurement of PWV. Positive control arms which reduce 
operating BP to the same degree as the studied agent are therefore required to prove 
effects on stiffness independent of passive mechanisms.  
 
1.4.8.1.1.1 ACE inhibitors  
Angiotensin converting enzyme (ACE) inhibitors have the strongest evidence which 
is biologically plausible from their anti-fibrotic and anti-inflammatory activity at the 
vessel wall, mediated mainly through angiotensin II activity.  Confirming  earlier 
reviews (Ong et al. 2011), and positive results from shorter term individual studies 
(Mahmud & Feely 2002), the largest meta-analysis (Shahin et al. 2012) of ACE 
inhibitors and PWV included just under 500 individuals and demonstrated an 
improvement in central haemodynamic indices (including AIx) when compared to 
other anti-hypertensive agents although their comparative effect on PWV was modest 
overall. Robust smaller studies, however, suggest these effects are amplified by higher 
dose and longer treatment (Ong et al. 2011) and occur in a variety of vascular territories 
(Tropeano et al. 2006). 
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The largest study to assess the impact of ACE inhibitors on measures of arterial 
stiffness and wave reflection indices and subsequent cardiovascular events was the 
Conduit Artery Function Evaluation (CAFÉ) study (Williams et al. 2006) which was 
an arm of the Anglo-Scandinavian Cardiac Outcomes Trial (ASCOT) (Sever et al. 
2001). In the CAFÉ study the perindopril/amlodipine arm experienced a significant 
improvement in wave reflection indices including aortic systolic pressure and aortic 
PP when compared to the atenolol/thiazide comparator arm. These differences 
occurred despite similar brachial BP measurements between the groups raising a 
potential mechanism for the differential CV outcomes in other BP lowering trials 
(Dahlof et al. 2002; Heart Outcomes Prevention Evaluation Study et al. 2000). 
 
1.4.8.1.1.2 Angiotensin II receptor blockers 
Angiotensin II receptor blockers (ARBs) appear to improve aortic stiffness 
independent of BP, superior to calcium channel blockers (CCBs) (Boutouyrie et al. 
2010) and to an extent that is comparable to ACE inhibitors in both short and long 
term studies (Julius et al. 2004; Laurent et al. 2014; Mahmud & Feely 2000; Peng et 
al. 2015). Smaller trials have suggested the addition of an ARB to an ACE may provide 
incremental reductions in aortic stiffness (Frimodt-Moller et al. 2012) although this 
did not translate to net clinical benefit in a large outcome study secondary to adverse 
drug reactions (Yusuf et al. 2008). 
 
1.4.8.1.1.3 Other agents 
Calcium channel blockers have been used in the comparator arms of most ACE/ARB 
studies and their impact on measures of aortic or arterial stiffness independent of BP 
is uncertain and probably small (Boutouyrie et al. 2011). The effect of beta blockers 
on arterial stiffness is less clear (Salvi et al. 2013) and may differ between agents. A 
reduction in heart rate alone has been shown to alter the visco-elastic properties, 
however a slower heart rate can prolong ejection time and result in increased wave 
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reflection and pressure amplification (Mahmud & Feely 2008). Moreover, the non-
selective atenolol has a vasoconstrictive effect at the peripheries potentially driving 
further wave reflection and providing a mechanistic basis for the superior performance 
of the vasodilating and NO donating agents in this class (Dhakam et al. 2008; 
McEniery et al. 2004). Although mechanistically of potential benefit given their role 
in the RAAS pathway, aldosterone antagonists (eplerenone and spironolactone) have 
shown only modest impact on arterial stiffness indices (Edwards et al. 2009) with their 
BP-independent effects probably no greater than CCBs (Janic et al. 2014). Nitrates, 
although not formally anti-hypertensives, are vasoactive but largely have their effects 
at the muscular and microvascular levels. One relatively large study demonstrated an 
improvement in augmentation index but no significant impact on cfPWV (Stokes et 
al. 2003). 
 
1.4.8.1.2 Lipid lowering therapy 
Data on the ability for statins to modify arterial stiffness is conflicting due to the 
variety of cohorts studied, intensity of therapy and time frame assessed. The largest 
meta-analysis of the impact of statin therapy on PWV included six trials totalling 303 
participants (Upala et al. 2017). Statin use overall was associated with a statistically 
significant reduction in cfPWV despite low to moderate intensity regimens. On 
balance, this was consistent with earlier reviews of smaller trials, some of which 
yielded conflicting results by including measures other than cfPWV (Rizos et al. 
2010). It is likely that patients with an underlying pro-inflammatory phenotype of 
stiffness will derive the most anti-stiffening benefit from statins. Of note, other 
measures of stiffness were also improved by statin therapy in subsequent trials 
evaluating fluvastatin (Lunder et al. 2011) and atorvastatin (Sadat et al. 2013) where 
improvement in carotid stiffness was observed, possibly mediated by reductions in 
oxidative stress (Wang, J et al. 2012) or inflammation (Wallace et al. 2010). 
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1.4.8.1.3 Diabetic drugs 
Improvement in glycaemic control, potentially via reduction in AGE formation 
(Aronson 2003), has demonstrable effects on arterial stiffness (Ikonomidis et al. 2016) 
although it is of interest whether drug-specific, disease modifying pathways can 
enhance this effect. Treatment with the peroxisome proliferator-activated receptor 
gamma – (PPAR-g) glitazone class has been shown to reduce arterial stiffness in 
patients with diabetes, and more recently, chronic inflammatory disease (Marder et al. 
2013). Small studies have shown some potential benefit of metformin on indices of 
arterial stiffness although this has been limited to cohort studies in selected populations 
(Agarwal et al. 2010). Recent positive cardiovascular outcomes trials of the newer 
anti-diabetic agents, independent of their glycaemic control, have generated interest in 
deciphering potential mechanisms of benefit. Improvements in a variety of indices 
measuring arterial stiffness have been demonstrated in small studies involving 
liraglutide (glucagon like peptide-1) (Lambadiari et al. 2018), empagliflozin (sodium-
glucose co-transporter 2 (SGLT-2) inhibitor) (Cherney et al. 2014), tofogliflozin 
(SGLT-2) (Bekki et al. 2018) and anagliptin (dipeptidyl peptidase-4 (DPP-4) inhibitor) 
(Duvnjak & Blaslov 2016; Tahara et al. 2016). The mechanisms behind these benefits 
and whether this will extend to non-diabetic cohorts remains of great interest to the 
field. 
 
1.4.8.1.4 AGE breakers 
Following the non-enzymatic glycation of vascular proteins, particularly collagen, 
AGEs form and facilitate collagen cross-linking. As covered earlier, AGEs are a key 
underlying mechanism behind the development of arterial stiffness, particularly in 
individuals with diabetes and hypertension (Susic 2007). Animal studies (Asif et al. 
2000; Wolffenbuttel et al. 1998) of the successful AGE breaker, algebrium, were 
confirmed in a small human study of hypertensive individuals with diabetes (Kass et 
al. 2001); however, a follow up study in non-diabetics was disappointing (Steppan et 
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al. 2012). Other agents directed at either blocking AGE formation (Corman et al. 
1998), or their activity at the receptor level (Geronikaki et al. 2007) remain in 
development. 
 
1.4.8.1.5 Anti-inflammatory drugs 
Inflammation remains a central component of arterial stiffness associated with 
conditions such as rheumatoid arthritis and inflammatory bowel disease and although 
associated with the aging and hypertensive phenotype (Mahmud & Feely 2005), it is 
unclear how much of this is modifiable in ‘traditional’ arterial stiffness. Antibodies 
against tumour necrosis factor alpha (TNF-alpha) have shown efficacy in patients with 
a demonstrable, diagnosed chronic inflammatory disease (Maki-Petaja et al. 2012; 
Tam et al. 2014; Zanoli et al. 2014) although no such data exist for ‘standard’ cohorts. 
In the atherosclerotic field, recent interest has been buoyed by the results of the 
Canakinumab Anti-inflammatory Thrombosis Outcome Study (CANTOS) which 
showed a significant reduction in cardiovascular events by reducing inflammation 
(Ridker et al. 2017). Whether such potent and non-selective agents will have a net 
clinical benefit targeting what may be a comparatively small component of arterial 
stiffness pathophysiology remains unclear. Moreover whether inflammation can be so 
broadly targeted as being ‘negative’ is also uncertain with an observational study of 
non-steroidal anti-inflammatory drugs (NSAIDs) in patients screened for abdominal 
aortic aneurysms demonstrating a signal towards increased, rather than decreased, 
arterial stiffness (Claridge et al. 2005).  
 
1.4.8.2 Non-pharmacological 
1.4.8.2.1 Weight loss 
The largest meta-analysis evaluating the effect of weight loss looked at 20 studies 
(three were randomised) including 1259 participants with PWV as the measured 
outcome. A modest weight loss (mean 8% from initial weight) achieved through diet 
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and lifestyle measures resulted in a significant reduction in PWV (Petersen et al. 2015) 
although this was significantly confounded by improvements in blood pressure. 
Similar results from a meta-analysis of caloric restriction were reported on indices of 
aortic distensibility and pulse wave analysis (Petersen et al. 2016), again also 
associated with a favourable improvement in blood pressure. 
 
1.4.8.2.2 Exercise 
Increased physical activity is associated with a plethora of cardiometabolic benefits 
which contribute to the observed cardiovascular mortality benefit when compared to 
sedentary individuals (Lavie et al. 2015; Nocon et al. 2008). Repeated bouts of 
cyclical, laminar stress on the vascular wall with increased cardiac output may assist 
with improvements in endothelial function (Joyner & Green 2009) but also 
advantageous vessel remodelling (Dinenno et al. 2001; O'Donovan et al. 2014). One 
of the largest cross-sectional studies involving over 5000 subjects demonstrated that 
the age driven increases in PWV in the control arm could be mitigated by moderate to 
vigorous activity, although not with light activity; an effect that was seen up to 70 
years of age (Ahmadi-Abhari et al. 2017). The benefits of exercise on aortic stiffness, 
however, are less proven in subjects with established hypertension (Kraft et al. 2007; 
Pierce 2017), or those with obesity (Montero et al. 2014). The largest meta-analysis of 
RCTs published to date evaluated 1627 participants and concluded aerobic exercise 
was associated with improvements in both cfPWV and peripheral PWV, with a degree 
of dose dependence observed with higher intensity and in those with higher baseline 
stiffness (Ashor et al. 2014). 
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1.5 CORONARY BLOOD FLOW 
1.5.1 Coronary anatomy 
1.5.1.1 Epicardial vessels 
The two main coronary arteries arise from coronary ostia located within the sinuses of 
Valsalva of the aorta. The left posterior sinus gives rise to the left main coronary artery 
which has daughter vessels, the left anterior descending (LAD) and the left circumflex 
(LCx) arteries. The LAD runs along the interventricular groove from base to apex and 
through its multiple daughter diagonal and septal branches, supplies the anterior and 
anterolateral surface of the LV as well as the anterior septum. The LCx tracks along 
the atrioventricular groove and through its daughter marginal vessels, supplies the left 
atrium and the remainder of the lateral wall.  
Arising from the anterior coronary sinus, the right coronary artery (RCA) tracks along 
the atrioventricular groove and also gives rise to marginal branches. Blood from this 
system supplies the right atrium and right ventricular free wall. 
The posterior descending artery (PDA) runs along the posterior atrioventricular groove 
and in 90% of the population arises from the RCA; in the remaining 10% it arises from 
the LCx where the system is said to be ‘left dominant’. 
 
1.5.1.2 Micro and macro-circulation 
Cardiac blood supply is provided from outside to in, with epicardial vessel calibre 
diminishing as the vessels divide and penetrate the myocardium. As the internal 
diameter reaches 1-3mm, tributaries arise that run perpendicular to the parent vessel. 
Further tributaries then descend (~ 400-1500µm) from the outer epicardium to the 
outer endocardium where a network of smaller arteries and arterioles (100-400µm) 
transition functionally from being ‘macrocirculation’ to feed the coronary 
‘microcirculation’ with diameters of <100µm. At this level, the density of myocardial 
capillaries exceeds 3000 capillaries/mm2 – far denser than is seen in skeletal muscle 
where densities of 600 capillaries/mm2 are observed. 
  Chapter 1: Arterial stiffness and coronary blood flow 
 45 
1.5.1.3 Architecture 
As with the large arteries described above, the coronary vessels each have three layers 
of varying proportions depending on the calibre, and hence function, of the vessel – 
tunica intima, tunica media and tunica adventitia. Although anatomically a simple 
monolayer of cells, the endothelium is physiologically active and is present throughout 
the macro and microcirculation. This monolayer is thromboresistant, anti-
inflammatory and semipermeable. Vasomotor tone is tightly regulated by paracrine 
pathways originating from the endothelium and mediated via secondary messengers 
to nearby smooth muscle cells within the intima and media: the outcome is a dynamic 
state of relaxation or contraction. By way of comparison, the media of the coronaries 
is collagen rich where the media of the aorta is elastin rich – this distinction providing 
one of the key anatomical differences between a resistance and conduit vessel 
respectively.   
The adventitia is a more nebulous layer with connective tissue formed by collagen 
fibrils, fibroblasts and nerve endings providing a mechanism for neurogenic control of 
vasomotor tone. Coronary vessels of >1mm internal diameter receive blood supply 
extrinsically from a dense network of small vessels called vaso vasorum which course 
throughout the adventitia.   
 
1.5.2 Determinants of coronary blood flow 
Coronary flow can be broadly summarised in electrical terms according to Ohm’s law, 
whereby flow is directly proportional to the pressure gradient across the vascular bed 
(arterial to venous) and inversely proportional to the overall resistance of the vascular 
tree. The mechanisms behind these broad determinants are myriad and yet after many 
years of research, many remain elusive or poorly understood. Given the critical nature 
of coronary blood flow to organ function, it is unsurprising there are a number of 
interrelated and complex mechanisms which contribute to its control. Indeed, the 
parallel activity and redundancy probably allows for a degree of compensation during 
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disease whereby other pathways will take up activity from a dysfunctional component. 
Nonetheless, a detailed description of all of these mechanisms is outside the scope of 
this body of work but some key determinants of coronary blood flow deserve review. 
 
1.5.2.1 Structural contributors 
1.5.2.1.1 Extravascular compressive resistance 
Coronary blood flow is dependent on perfusion pressure and resistance to flow within 
the vascular tree. The effective perfusion pressure is the gradient between the input 
aortic pressure and the pressure to outflow in the venous system at the level of the right 
atrium, however there is additional resistance from extravascular forces exerted by the 
contracting myocardium. Seminal work from Gregg et al. (Gregg & Green 1940) 
demonstrated the phasic nature of blood flow with predominant flow occurring in 
diastole and minimal, if not reverse flow, in systole.  An extension of this theory related 
the increased wall tension from the left ventricle extrinsically compressing 
intramyocardial vessels thereby permitting arterial inflow in diastole but impeding it 
during systole (Downey & Kirk 1975). The explanation for increased observed venous 
flow in systole, when one would expect these vessels also to be compressed, came 
from Spaan who described an intramyocardial ‘pump’ (Spaan 1985). In this model the 
microcirculatory vessels are compressed during systole and produce a capacitive 
discharge at both ‘ends’ of the vessel. Directed upstream this impedes coronary inflow, 
and yet simultaneously directed downstream, this accelerates flow into the venous 
system thereby forming a ‘pump’. An extension of this theory reveals a form of 
compliance within the system such that an effective ‘sucking’ or ‘charging’ effect 
occurs during diastole of a healthy microcirculation (Hoffman & Spaan 1990). 
 
1.5.2.1.2 Fixed microvascular resistance 
The effects of systolic contraction appear to be more pronounced on the 
subendocardial compared to the subepicardial vessels (LeGrice et al. 1995) which 
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ought to confer a greater vulnerability to ischaemia. This effect, however, appears to 
be overcome, or at least compensated for, by a lower intrinsic microvascular resistance 
(Chilian 1991) observed within the subendocardium, largely driven by an increased 
density of arterioles and capillaries. This resultant vascular gradient favours transmural 
flow (Goto et al. 1991) to the subendocardium during maximal vasodilatation to the 
point that in a non-beating, maximally vasodilated heart there is comparatively more 
perfusion at the level of the subendocardium than subepicardium (Hoffman & Spaan 
1990). Moreover, there is evidence that this transmural pressure gradient may indeed 
be augmented by microvascular recoil and ‘suction’ (Davies, JE et al. 2006), at which 
time there is a commensurate observed reduction in venous outflow.  
Although in health it appears the effects of extravascular compression are mitigated 
by intrinsic microvascular characteristics, it remains of interest whether this is 
overcome in states of increased effective back pressure (e.g. rise in the pressure at 
which flow = 0, e.g. diastolic dysfunction, LVH) or reduction in antegrade perfusion 
pressure (Duncker & Bache 2008; Duncker et al. 1993) such as significant epicardial 
stenosis or increased pulse pressure. 
 
1.5.2.2 Dynamic microcirculation  
1.5.2.2.1 Autoregulation 
Autoregulation is characterised by a vascular bed’s ability to maintain constant blood 
flow across a breadth of perfusion pressures. The coronary, much like the cerebral and 
the renal vasculature, has an impressive autoregulatory capacity which is controlled 
mainly through changes in the calibre of the microcirculation, and subsequently, 
resistance.  
The prevailing theory is that control of the microcirculation is via three main factors 
although the dominance of each at any one time is dynamic and informed by location: 
1) shear stress, 2) wall stress and 3) metabolism. Small resistance arteries, 100-400µm 
in diameter, appear to regulate their diameter mainly in response to wall shear stress 
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(flow) and vascular wall stress (myogenic) whereas arterioles (<100µm) appear to be 
more sensitive to changes in local metabolism. 
 
1.5.2.2.2 Shear stress and the endothelium 
Small arteries and arterioles respond to changes in local shear stress by increasing their 
calibre; a phenomenon called flow-mediated dilatation. This process appears to be 
predominantly driven by release of nitric oxide, possibly via mechanosensors such as 
integrins, and relies on an intact, functional endothelium (Kuo, L et al. 1995). Also 
associated with this phenomenon is endothelial-derived hyperpolarising factor 
(EDHF) whose identity (or identities) and behaviour remains controversial but is 
thought to be hydrogen peroxide or C-type natriuretic peptide or potentially even 
potassium (Beyer & Gutterman 2012). The relative contribution of each compound 
appears to vary on vessel size (and possibly animal model studied) as well as 
potentially disease states where the role of EDHF could be increased when NO 
pathways are dysfunctional (Miura et al. 2001). Nitric oxide dependent changes appear 
to occur primarily upstream (~100-300µm) as NO synthase inhibition diminishes 
resting epicardial diameter and abolishes shear-mediated dilatation in the ‘larger’ 
arterioles (~150µm). It is unclear whether smaller vessels (<100µm) have the NO 
‘machinery’ to facilitate this response (Sellke et al. 1990), or instead whether any 
potential effects are overwhelmed by other local autoregulatory pathways (Jones et al. 
1996). Regardless, the physiological relevance of this process to baseline coronary 
flow has not been demonstrated in a large number of studies (Altman et al. 1994; 
Bernstein et al. 1996; Davis et al. 1998). Similarly, its role in hyperaemic flow during 
exercise (Quyyumi et al. 1995) and other forms of metabolic vasodilatation has been 
questioned (Duncker & Bache 2008). 
Other contributors to endothelial derived vasodilation include prostacyclin (probably 
in part through NO dependent pathways) in addition to vasoconstrictors such as 
endothelin (Hillier et al. 2001) and thromboxane A2 (Eidt et al. 1989). These all appear 
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to be implicated (Sorop et al. 2008) in disease states such as spasm and following 
ischaemia, although their independent role in governing ‘physiological’ blood flow is 
unclear. 
 
1.5.2.2.3 Wall stress 
The myogenic response is the ability of vascular smooth muscle to respond to changes 
in vascular transmural pressure and thus, changes in wall stress. Present throughout 
vascular tissue, this phenomenon was first described by Bayliss (Bayliss 1902) and 
extrapolated as a mechanism for not only protection from injury but also maintenance 
of flow; increased intravascular pressure results in vasoconstriction and a reduction in 
flow, reduced intravascular pressure leads to vasodilatation and preservation of flow.  
The cellular mechanism is poorly understood, however current theories invoke the role 
of stretch activated L-type Ca channels to instigate smooth muscle responses. 
 
1.5.2.2.4 Metabolic 
Given the highly metabolic nature of cardiac tissue, coronary blood flow must be 
carefully controlled in order to provide oxygen and nutrition to cardiomyocytes which 
in turn permits maintenance of cardiac output and systemic tissue perfusion (Duncker 
& Bache 2008); periods of increased demand must be met with a commensurate 
increase in supply. This is incrementally more important in the myocardium where as 
much as 80% of the arterially delivered O2 is removed from the blood under resting 
conditions, leaving little more efficiency to be derived by mechanisms of increased 
extraction observed in skeletal and other vascular beds. Seminal work from Fick 
(Shapiro, E 1972) confirmed the corollary, now well established, that myocardial 
oxygen demand and coronary blood flow must be near-linearly related. 
Although there is acceptance of the role of locally derived vasodilators in the 
microcirculation, the feedback mechanism from various metabolites remains 
incompletely understood and the subject of ongoing study (Deussen et al. 2012). 
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Various potential metabolic stimuli and pathways felt to increase coronary blood flow 
include hypoxia (Gremels & Starling 1926) – either directly (Gauthier-Rein et al. 
1997) or through a secondary messenger such as adenosine (Deussen et al. 1988) or 
prostaglandins (Busse et al. 1984), hypercapnia – either directly (Case et al. 1978) or 
through acidaemia (Wexels et al. 1985), reactive oxygen species (Saitoh et al. 2006) 
as well as ATP-sensitive potassium channels (Deussen et al. 2006; Farouque et al. 
2002). 
 
1.5.2.2.5 Large artery mechanics  
As described above, a large body of evidence, albeit partially understood, has shown 
the key role of the microcirculation in controlling resistance and flow. Perhaps 
underappreciated in this relationship however, is the potential impact that arterial (and 
in particular, aortic) stiffness may have on coronary blood flow. As described earlier 
(1.4.7.3 Cardiac sequelae), increased aortic stiffness has a number of key sequelae 
which could impact upon coronary blood flow: 1) early systolic augmentation 
increases LV wall stress driving hypertrophy and myocardial oxygen demand, 
potentially reducing maximal absolute coronary flow; 2) increased characteristic aortic 
impedance (and thereby reduced aortic ‘reservoir) or via wave reflection phenomena, 
allows systolic run off and a reduction in diastolic aortic ‘capacitance’ which in turn 
can reduce coronary perfusion pressure; and 3) via direct damage to microcirculation 
through enhanced pulsatility driving capillary and arteriolar rarefaction and 
dysregulation of vasomotor tone. 
 
Until the late 1990s, the basis of this physiology had been tested only in canines 
whereby the aorta was either artificially stiffened (with bandages) or replaced with a 
rigid tube. In Watanabe’s (Watanabe et al. 1992) and Ohtsuka’s (Ohtsuka et al. 1994) 
experiments of aortic bandaging from the same group, a reduction in aortic compliance 
was observed which in turn drove a widening in pulse pressure and an increase in left 
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ventricular cardiac work. The increase in myocardial oxygen demand overall increased 
coronary blood flow, however during periods of increased contractility or heart rate, 
the endocardial/epicardial blood flow ratio was reduced, suggesting a shift in coronary 
blood away from the subendocardium. The findings from Saeki’s group were 
contrasting as although ejecting blood into a rigid tube caused a dramatic increase in 
PP and a demonstrable reduction in DBP, coronary blood flow overall was increased 
without a shift in blood flow away from the subendocardium (Saeki et al. 1995). The 
model in the latter experiment has been criticised for its abrupt and artificial changes 
to the arterial haemodynamics which are unlikely to accurately represent the chronic, 
progressive and compensatory features of large artery stiffening that occurs in human 
disease. 
 
Beyond animal work, there have been a handful of human studies. Fukuda et al. 
evaluated 192 patients following clinically indicated angiography and compared 
epicardial atherosclerotic burden and invasive coronary flow velocity reserve (CFVR) 
with brachial-ankle pulse wave velocity (baPWV) as their measure of arterial stiffness 
(Fukuda et al. 2006). CFVR was obtained in non-diseased arteries of subjects 
classified as ‘normal’, ‘single vessel disease’ or ‘double vessel disease’ (79 in total). 
Regression analysis revealed a moderate relationship between baPWV and CFVR, R 
-0.45, p < 0.0001. In multiple linear regression, baPWV was independently predictive 
of CFVR across the studied cohort (b -0.44 , p < 0.01). Of note, atherosclerotic burden 
correlated with measures of arterial stiffness but did not correlate with CFVR. 
Moreover, this study did not report on the relative association with resting or 
hyperaemic blood flow. 
 
Leung et al. compared invasive coronary blood flow with both aortic PWV and 
carotid-femoral PWV in 18 subjects with angiographically severe coronary disease pre 
and post percutaneous coronary intervention (PCI) (Leung et al. 2006). Aortic PWV 
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was strongly associated with resting and hyperaemic CBF (R2 > 0.5 both pre and post, 
p < 0.01) although the relationship with resting CBF was stronger pre- (R2 0.452, p < 
0.01) than it was post-PCI (R2 0.261, p = 0.043). Additionally, after dividing their 
cohort into ‘stiff’ and ‘non-stiff’, hyperaemic blood flow was reduced in the former 
group compared to the latter suggesting improvement from PCI in the context of a stiff 
aorta may be attenuated. Of particular interest was that cfPWV did not correlate with 
any measure of coronary blood flow, nor did it correlate with aPWV. Also, it is unclear 
whether these aorto-coronary relationships can be extended out to non-stented, native 
vessels. 
 
In the non-invasive arena, there have been two key studies. Saito et al studied 102 
hypertensive subjects and obtained baPWV, augmentation index (calculated from a 
carotid tracing) as well as resting and hyperaemic coronary flow velocity 
measurements by echocardiogram (Saito et al. 2008). Coronary flow velocity reserve 
was associated with baPWV (R -0.46, p < 0.001) and AIx (R -0.41, p < 0.001) although 
on multivariate analysis only AIx remained significant (R -0.32, p < 0.001). There 
were a number of key limitations. None of these subjects had angiography and thus 
epicardial disease couldn’t be excluded. Although baPWV has independent prognostic 
capacity, it measures the interface of elastic and muscular arteries and thus, may not 
be a sensitive parameter to evaluate more specific changes in elastic, cushion arterial 
function where stiffness has been documented to occur preferentially in a proximal 
distribution (Nelson et al. 2009). 
 
Extending observations into a clinical cohort, Kingwell et al. sought to determine 
whether large artery stiffness impacted upon ischaemic threshold in patients with 
coronary artery disease (Kingwell et al. 2002). Ninety-six patients with 
angiographically proven coronary artery disease (mean, maximum stenosis, 85%; 
mean vessels stenosed > 50%, 1.6) underwent carotid applanation tonometry where 
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augmentation index, distensibility index, cfPWV and systemic arterial compliance 
were obtained. Each subject then underwent treadmill exercise test and time to ST 
segment depression was analysed. All indices of arterial stiffness listed above 
correlated in univariate analysis with time to ischaemia (R -0.25 to 0.27, all p < 0.05). 
On multivariate analysis, distensibility index, AIx and systemic arterial compliance 
continued to be independently predictive however cfPWV was not independent of age. 
An extension of this finding is that restriction of hyperaemic flow through a stiff aorta 
in the context of a mild to moderate epicardial stenosis could simulate a severe stenosis 
in the context of a ‘non-stiff’ aorta. 
 
1.5.3 Invasive methods of evaluating coronary blood flow 
1.5.3.1 Coronary flow reserve 
The notion of ‘reserve’ within the coronary circulation was proposed in seminal work 
from Gould (Gould & Lipscomb 1974). These studies asserted that resting coronary 
blood flow was effectively maintained until the stenosis became critical 
(approximately 85% of cross-sectional area). It was at this point that additional 
demand would exceed supply, as the microvasculature was fully ‘compensated’ or had 
exceeded its ‘reserve’. Coronary flow reserve (CFR), as it was first described, is 
expressed as the quotient of maximal flow to resting flow and encompasses the entire 
vessel’s capacity (epicardial to microcirculation) to increase blood flow. With 
preserved microvascular function in the absence of epicardial stenosis, the maximum 
or hyperaemic flow is approximately five-fold that of resting flow, providing a CFR 
of 4-5. In the clinical context of a chest pain evaluation, inducing maximal hyperaemia 
of the distal coronary microcirculation can reveal a flow limiting epicardial stenosis. 
While a stenosis may need to exceed 85% narrowing of a coronary vessel before it 
reduces resting blood flow, in the context of hyperaemia, even a 50% stenosis can 
reduce hyperaemic blood flow (Gould et al. 1990).  
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Given CFR is a ratio, one of its strengths (and inherent weaknesses), is that vessel 
diameter and flow stream are not required for its derivation although the assumption 
is made that these do not change between resting and hyperaemic assessment. Given 
the ease of obtaining flow measurements, the CFR is generally obtained with the use 
of an intracoronary Doppler velocity guidewire (or Doppler FloWire) which provides 
a measure of flow ‘velocity’. By obtaining a flow ‘velocity’ at rest and another at 
hyperaemia, the quotient can be performed which provides an index, coronary flow 
velocity reserve (CFVR). Values of 2 and 2.5 have been used as a cut-off point for an 
inadequate hyperaemic response although 3 has been shown in young healthy controls 
to be ‘normal’ (Chauhan et al. 1993; Perchet et al. 1995). There exists, therefore a 
reasonably large ‘grey zone’ between 2 and 3 which has been a weakness of the 
modality, particularly when trying to assess discrete epicardial lesions. In the absence 
of flow-limiting epicardial disease, the CFVR therefore is a robust measure of 
microcirculatory function. Wider application of CFVR has been limited due to its 
invasive nature and in the context of assessing epicardial disease, its sensitivity to 
haemodynamic changes such as HR and BP.  
 
1.5.3.2 Coronary blood flow 
Coronary blood flow can be assessed with either Doppler velocity or via 
thermodilution methods however both require engaging a coronary artery and placing 
a guidewire. As described above, the coaxial positioning of the Doppler FloWire will 
provide a value for flow ‘velocity’. The derivation of flow requires an assessment of 
vessel size which can be obtained through intravascular ultrasound (IVUS) (Puri et al. 
2012) or more commonly through quantitative coronary angiography (QCA). Using 
QCA, coronary blood flow can then be derived with the formula π x [Coronary 
Diameter]2 x Average Peak Velocity x 0.125 (Deanfield et al. 2005). Limitations 
include the sensitivity of the Doppler wire to movement and turbulence, in addition to 
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the potential error multiplication by deducing cross sectional area from a 2D diameter 
method.  
 
1.5.4 Non-invasive methods of evaluating myocardial blood flow 
1.5.4.1 Myocardial perfusion reserve 
The physiological basis for perfusion imaging rests on the concept of coronary flow 
reserve covered above. Although intrinsically related, where blood flow is volume per 
unit time, perfusion is indirectly measured as blood flow through mass (or volume) 
per unit time. Flow through mass can be measured via high fidelity nuclear cardiology 
by labelling blood and observing the signal intensity changes as it passes through the 
myocardium. Alternatively, a blood-borne detectable tracer can be introduced and its 
passage through the myocardium observed.  Techniques have been described using 
both echocardiography (Wei et al. 1998) and computed tomography (George et al. 
2007) however spatial resolution and ionising radiation, respectively, are key 
limitations. Magnetic resonance imaging using gadolinium is now increasingly 
available, has sufficient spatial resolution to detect regional defects, and is safe.  
As gadolinium passes through blood, there is shortening of the T1 signal making the 
agent appear ‘white’. During its passage through the microcirculation of perfused 
myocardium, the myocardial signal becomes ‘brighter’, however in an area of reduced 
or absent perfusion, the T1-shortening is reduced, and the tissue appears hypo-intense 
or ‘darker’. The change in myocardial ‘brightness’ or signal over time during the ‘first 
pass’ of gadolinium is a measure of myocardial blood flow and thus, perfusion. In 
vessels with a significant epicardial stenosis, adenosine has reduced capacity to 
augment flow as the downstream microvasculature is already maximally dilated in a 
compensatory manner to reduce microcirculatory resistance. In this context, the 
administration of a contrast agent will be preferentially distributed to regions of 
relative hyperaemia due to coronary ‘steal’ phenomenon. This will leave areas of 
delayed contrast wash-in which appear dark and are termed ‘perfusion defects’. 
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By evaluating the change in signal over time, one can generate signal-intensity time 
curves for both myocardium and blood pool at rest and with hyperaemia. The maximal 
upslope of this curve has been shown to be sensitive to changes in blood flow. 
Evaluating the quotient of the maximal upslope at hyperaemia and with the maximal 
upslope at rest, provides an index of myocardial perfusion – termed myocardial 
perfusion reserve (MPR) or myocardial perfusion reserve index (MPRI). This value is 
analogous to the CFVR, covered above. Studies comparing CMR-derived MPR with 
microsphere-derived MPR have demonstrated a strong relationship in normal swine 
coronaries (R = 0.88, p<0.01). Similarly comparing MPR with intracoronary Doppler 
FloWire CFVR in normal human coronaries there was a robust agreement between the 
modalities (R = 0.80, p<0.01) (Wilke et al. 1997). In ischaemic segments, MPR 
demonstrated a strong correlation with both positron emission tomography (PET) 
perfusion reserve (R = 0.76, p<0.01) (Schwitter et al. 2001) and Doppler CFVR (R = 
0.87, p<0.01) (Kurita et al. 2009). 
 
1.5.4.1.1 Myocardial blood flow quantification 
Quantitative myocardial blood flow can be derived from signal intensity curves of the 
myocardium and of the blood pool, as described above, and can be obtained with CT, 
PET or CMR. A variety of models can be used to estimate the behaviour of contrast in 
the circulatory system with each having strengths and weaknesses. The ‘linear shift 
invariant’ models are simpler (and thus attractive for potential clinical use) and assume 
the circulatory response is linear and does not vary over time – i.e. if two contrast 
boluses are administered, the uptake is the linear sum had they been given separately; 
and if a second bolus is given after a period of time, its uptake is shifted by the same 
amount of time. By making these assumptions, the system can be described by a 
transfer function, i.e. the myocardial time intensity curve is equal to the arterial input 
(LV blood pool time intensity curve) merged with the transfer function by 
deconvolution. Where convolution is a mathematical technique that folds two curves 
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together, deconvolution is the process of ‘unfolding’ the curves to approximate a shape 
that defines its behaviour. Complex mathematical derivation can show that the 
myocardial blood flow can be approximated to the maximal value of Fermi function 
which, itself, is governed by delay, amplitude, shift and decay (Figure 1.8). This 
technique has been validated extensively in animals (Christian et al. 2009; Jerosch-
Herold et al. 2002; Jerosch-Herold et al. 2000) with robust correlation against 
microspheres (R >0.9) (Schmitt et al. 2005) and studied widely in humans (Arnold et 




FIGURE 1.8. Adapted from (Lee, DC & Johnson 2009). Representative image 
of myocardial time intensity curve (left), blood pool time intensity curve (middle) 
convolved with Fermi transfer function (right).  The maximum amplitude of the 
transfer function equals absolute myocardial blood flow (MBF). 
 
 
1.5.4.2 Adenosine activity 
Adenosine is a nonselective ligand for four receptors: A1, A2A, A2B, A3 (Olanrewaju et 
al. 2000). It appears to be released during periods of hypoxaemia and ischaemia 
although its role in ‘physiology’ or health is unclear as described earlier.  The exact 
biological action of adenosine remains elusive. The main effect is vasodilation of the 
microcirculation which reduces resistance and increases coronary blood flow, up to 
fivefold in healthy individuals.  The mechanism is widely felt to be largely endothelial-
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independent and triggered through membrane bound 2A and 2B receptors (Morrison 
et al. 2002) located on smooth muscle cells (Shryock & Belardinelli 1997) and 
mediated by cyclic AMP pathways (Hussain & Mustafa 1993).  
Some degree of endothelial-dependence is postulated, however, as animal studies of 
denuded coronary arteries have an attenuated hyperaemic response to adenosine, 
particularly in canines (Nees et al. 1985). Whether this is as a result of the loss of 
‘secondary’ flow mediated dilatation owing to an increase in blood flow is also 
unclear. Cell culture studies have demonstrated endothelial-based adenosine receptors 
assist with mediating NO release (Olanrewaju & Mustafa 2000), although the 
functional studies supporting or elucidating the role of this pathway in vasodilation are 
sparse (Abebe et al. 1995).  
Adenosine has a very short half-life making it an ideal agent for hyperaemic stress 
imaging. Whilst it can be administered intravenously, dosing for intracoronary routes 
is well established and reliably generates hyperaemia (De Bruyne et al. 2003; Farouque 
et al. 2002). There is minimal effect on heart rate or blood pressure (Wilson et al. 
1990). There is no direct action on the epicardial vessel (Sudhir et al. 1993) although 
some have observed the indirect effects of flow-mediated dilatation (Lupi et al. 1997). 
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1.6 AIM OF THESIS 
The aim of this thesis is to investigate the relationship between aortic stiffness and 
coronary blood flow through invasive and non-invasive means in both health and 
disease. The specific aims are as follows: 
• To evaluate the relationship between invasive, gold-standard measures of both 
resting and hyperaemic blood flow with cardiovascular magnetic resonance 
derived aortic distensibility in subjects free from epicardial coronary disease 
• To validate the relationship between resting and hyperaemic coronary blood 
flow in a completely non-invasive methodology in subjects with normal 
myocardial perfusion studies 
• To validate a novel measure of aortic distensibility which can be obtained from 
standard, clinically indicated CMR studies 
• To evaluate the relationship between resting and hyperaemic coronary blood 
flow with aortic distensibility in subjects with confirmed perfusion defects, 
allowing a comparison of this relationship in both ischaemic and non-
ischaemic territories 
• To evaluate the relationship between resting and hyperaemic coronary blood 
flow with aortic distensibility in subjects who have sustained an acute 
myocardial infarct allowing a comparison between recently infarcted 
myocardium and remote, non-infarct myocardium 
• To evaluate whether increased aortic stiffness is predictive of myocardial blood 
flow at three months post myocardial infarction. 
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2.2 ABSTRACT 
Background: A large body of data supports the independent prognostic capacity of 
arterial stiffness for not only cardiovascular events, but all-cause mortality. An 
unfavourable aorto-coronary relationship is felt to be a key mechanistic factor driving 
these events, however human studies that confirm this association are lacking. This 
study sought to evaluate the relationship between coronary blood flow (Doppler 
FloWire) and cardiac magnetic resonance (CMR) derived aortic distensibility. 
Methods: Following clinically indicated coronary angiography, a 0.014-inch Doppler 
FloWire and infusion catheter were advanced into the study vessel. Average peak 
velocity (APV) was acquired at baseline and following intracoronary adenosine 
administration to derive coronary flow velocity reserve (CFVR = peak APV/baseline 
APV), and coronary blood flow (CBF) (π x [Coronary Diameter]2 x Average Peak 
Velocity x 0.125).  Directly after angiography, patients underwent CMR for evaluation 
of aortic distensibility at the ascending aorta (AA), proximal descending aorta (PDA) 
and distal descending aorta (DDA) as previously described. 
Results: Fifteen subjects (53 ±13 years) with only minor epicardial disease (<30%) 
were enrolled. Baseline CBF for the cohort was 62.6±16mL/min and hyperaemic CBF 
was 192.7 ± 66.2mL/min respectively. Coronary flow velocity reserve for the cohort 
was 3.15 ± 0.48. Aortic distensibility was 3.89 ± 1.72·10-3mmHg-1 at the AA, 4.08 ± 
1.80·10-3mmHg-1 at the PDA and 4.42 ± 1.67·10-3mmHg-1 at the DDA. All levels of 
distensibility correlated with rCBF (R2 0.350 – 0.373, p < 0.05), hCBF (R2 0.453 – 
0.464, p < 0.01), and CFVR (R2 0.442 – 0.511, p < 0.01).  
Conclusion: Extending prior observations in animal models and other invasive 
cohorts, there was a strong correlation between CMR-derived aortic distensibility and 
CFVR. There was a modest correlation with rCBF although hCBF was more strongly 
related to aortic distensibility. This confirms the purported theory that arterial stiffness, 
at least in part, governs hyperaemic although to a lesser extent, resting blood flow. 
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2.3 INTRODUCTION 
A large body of evidence now supports arterial stiffness as an independent prognostic 
marker for, not only cardiovascular events (Vlachopoulos et al. 2010), but all-cause 
mortality (Ben-Shlomo et al. 2014). This predictive capacity has been demonstrated in 
a variety of longitudinal cohorts including ‘healthy’ community population studies 
(Mattace-Raso et al. 2006; Mitchell et al. 2010; Willum-Hansen et al. 2006) in addition 
to those with diabetes (Levisianou et al. 2013; Roos et al. 2013), hypertension 
(Boutouyrie et al. 2002; Laurent et al. 2001), chronic kidney disease (Blacher et al. 
2002; Shoji et al. 2001; Zoungas et al. 2007) and established coronary artery disease 
(Kaneko et al. 2013). On the strength of this research, consensus statements from both 
the European (Laurent et al. 2006) and American (Townsend et al. 2015) cardiology 
societies have espoused the role of arterial stiffness measurements not only as key 
research tools and endpoints in cardiovascular trials, but also for prognostication in the 
clinic.  
 
Arterial stiffness remains a nebulous umbrella term which incorporates the structural 
and functional changes that describes the large arteries’ response to intravascular 
pressure. Mechanistically, contemporary arterial haemodynamic theories suggest a 
stiffer arterial system will result in less cushioning of the arterial pulse and a faster 
forward pulse wave. A faster pulse wave will arrive at points of functional 
discontinuity quicker, such as arterial bifurcations, and generate reflected waves which 
return at end-systole rather than diastole. This will increase afterload and myocardial 
oxygen demand but in the context of reduced diastolic pressure, potentially reduce 
coronary blood flow.   
 
Evidence of this physiology is sparse and comes almost exclusively from animal work 
with conflicting results – some associating arterial stiffness with reduced coronary 
blood flow (Watanabe et al. 1992), others with increased coronary blood flow (Saeki 
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et al. 1995). Using applanation tonometry derived pulse wave velocity and 
intracoronary Doppler FloWire measurements, Leung et al. (Leung et al. 2006) were 
the first to demonstrate in humans that a stiffer aorta governs not only hyperaemic 
coronary blood flow (hCBF) but, to a lesser extent, resting coronary blood flow (rCBF) 
as well.  
 
Cardiovascular magnetic resonance has evolved in recent years to offer a 
comprehensive evaluation of not only cardiac but also novel indices of vascular 
dynamic structure and function (Redheuil 2014). The aim of this study was to evaluate 
the aorto-coronary relationship using the gold standard measure of coronary blood 
flow, intracoronary Doppler FloWire against CMR-derived aortic distensibility in 
patients with no more than minor angiographic coronary disease.  




2.4.1.1 Inclusion criteria 
The study was approved by the Human Research Ethics Committee and the 
Investigational Drugs Subcommittee at the Royal Adelaide Hospital. 
Patients referred to the Royal Adelaide Hospital Cardiovascular Investigation Unit for 
a clinically indicated diagnostic coronary angiogram were eligible for participation.  
Informed consent was obtained prior to the commencement of the procedure and 
following an angiographically ‘normal’ angiogram (no more than luminal 
irregularities), subjects were enrolled into the study.  While this involved consent prior 
to the knowledge that they meet the angiographic inclusion criteria, it negated the need 
to take them off the table for the consenting process and allowed the administration of 
procedural sedation (intravenous fentanyl). 
 
2.4.1.2 Exclusion criteria 
Exclusion criteria included age > 75 years, use of vasoactive medications < 48 hours 
of angiography (calcium channel blockers, nitrates, beta blockers), established 
coronary disease (angina, history of myocardial infarction, prior revascularisation), 
atrial fibrillation/flutter, aortopathy (history of intervention, dissection or aneurysm), 
magnetic resonance chamber incompatibility (pacemakers, aneurysm clips, 
claustrophobia), impaired LV function (LVEF < 45%), severe valvular heart disease, 
renal impairment (estimated glomerular filtration rate < 30 mL/min/1.73m2) and 
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2.4.1.3 Demographics 
Prescribed medications and risk factors were recorded.  Risk factors were defined as 
cigarette smoking (previously or currently smoking tobacco), hypercholesterolemia 
(use of cholesterol-lowering therapy or total cholesterol level > 5.2mmol/L), 
hypertension (blood pressure > 140/90mm Hg or on medical antihypertensive therapy 
or subject to lifestyle intervention), obesity (BMI > 30kg/m2), diabetes, and family 
history of cardiovascular disease (index event in a first-degree relative, male ≤ 55 years 
and female ≤ 60).  
Fasting blood was obtained at the time of coronary angiography and sent to a central 
laboratory for total cholesterol, low-density lipoprotein, high-density lipoprotein and 
triglyceride levels, high sensitivity C reactive protein (hsCRP, Beckman Immage 
Immunochemistry System, Fullerton, California), fasting glucose, complete blood 
examination as well as renal and liver function. 
 
2.4.2 Invasive coronary protocol 
2.4.2.1 Intracoronary setup 
After diagnostic angiography, measures of myocardial blood flow and coronary flow 
reserve were performed according to standardised practice (Anderson et al. 1995) 
(Figure 2.1). The study vessel in all cases was the proximal segment of the left anterior 
descending (LAD) coronary artery. A 6Fr XB3.5 left guiding catheter was engaged in 
the ostium of the left main coronary artery.  Therapeutic heparin anticoagulation was 
administered at 80IU/kg. A 2.7Fr coaxial infusion microcatheter (Progreat, Terumo, 
Tokyo, Japan) was placed within the study vessel at the origin of the LAD. A 0.014-
inch Coronary Doppler FloWire (ComboWire XT, Volcano Corporation, San Diego, 
California) was then advanced through the microcatheter into the LAD.  The FloWire 
was positioned in the mid-section of the study vessel and manipulated until a stable 
Doppler flow signal was obtained.  
 









FIGURE 2.1: Invasive coronary protocol setup. XB3.5 6Fr guiding 
catheter (a), housing a Progreat Infusion microcatheter (b) and a 
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2.4.2.2 Haemodynamics 
Invasive central haemodynamics were acquired prior to the commencement of the 
intracoronary protocol. This included central systolic, diastolic and mean arterial 
pressure. This was then analysed offline to calculate central pulse pressure (cPP). 
 
2.4.2.3 Coronary blood flow 
The assessment of coronary blood flow (CBF) was undertaken as per previously 
validated studies (Anderson et al. 2005; Doucette et al. 1992). An infusion of 
intracoronary 5% dextrose was run for 5 minutes.  At the completion of the infusion, 
baseline Averaged Peak Velocity (APV) was obtained. This was defined as the steady 
segment of APV over ten cardiac cycles. A coronary angiogram was then performed 
using 9mL of non-ionic contrast (Omnipaque, GE Healthcare, Waukesha, USA) 
injected through a Medrad infusion pump (IMaxeon, New South Wales) at 5mL/s.  
Angiographic images were then stored offline. 
Continuous instantaneous peak velocity and APV indices were continuously acquired 
at a sampling rate of 200Hz using the ComboMap console (Volcano Corporation) and 
extracted for offline analysis. Haemodynamic data (systemic blood pressure and heart 
rate) and ECG rhythm strip were recorded continuously throughout the study for off-
line analysis.   
 
2.4.2.4 Coronary flow reserve 
Following the acquisition of the angiogram for coronary blood flow (CBF) 
quantification, a further infusion of 5% dextrose was run for five minutes. 
Intracoronary nitro-glycerine (200μg) was administered to minimize epicardial artery 
vasomotion.   
After obtaining an optimal and stable velocity signal, a bolus of 48microg of 
intracoronary adenosine was administered (Duffy et al. 1999; Farouque et al. 2002).   
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Continuous instantaneous peak velocity and APV indices, haemodynamic data 
(systemic blood pressure and heart rate) and ECG rhythm strip were recorded 
continuously throughout the study for off-line analysis.  Baseline APV was defined as 
the steady segment of APV over ten cardiac cycles immediately before the adenosine-
induced rise in APV. Peak APV was the highest APV after the adenosine bolus.  
 
2.4.2.5 Offline analysis 
2.4.2.5.1 Coronary blood flow 
An independent and trained observer carried out the offline angiographic analysis 
blinded to the CMR analysis. As per previously published methods (Goodhart & 
Anderson 1998; Zeiher et al. 1991), an automated edge-detection program was used 
to obtain the diameter of the study vessel (CMS software, Medis Corp, Leiden). A 
region of interest approximately 5mm in length and within 10mm from the end of the 
infusion catheter was selected for quantitative coronary angiography (QCA) of the 
baseline angiogram (Figure 2.2). 
Coronary blood flow was then calculated from the formula (Deanfield et al. 2005):  
π x [Coronary Diameter]2 x Average Peak Velocity x 0.125  
where diameter is measured in mm and Average Peak Velocity (APV) is measured in 
cm/s. As basal CBF is closely related to the rate-pressure product (RPP) (Czernin et 
al. 1993), an index of myocardial oxygen consumption, values for basal flow in each 
subject were corrected for the respective rate-pressure product. This was performed by 
multiplying basal flow by the mean RPP of the cohort, divided by the RPP in the 
















FIGURE 2.2: A region of interest 5mm in length (distance between 
proximal and distal yellow bars) and within 10mm from the end of the 
infusion catheter. Semi-automated edge-detection software allowed 
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2.4.2.5.2 Coronary flow velocity reserve 
Coronary flow velocity reserve (CFVR) was determined offline as a ratio of peak APV 
/ resting APV (Figure 2.3).  A normal response is considered to have occurred if the 






FIGURE 2.3. Representative images of Volcano console Doppler 
FloWire tracing, (top) resting APV and (bottom) peak APV following 
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2.4.3 Non-invasive cardiac magnetic resonance protocol 
All cardiovascular magnetic resonance (CMR) studies were performed utilising the 
Siemens Avanto 1.5 Tesla magnetic resonance imaging scanner (Siemens Medical 
Imaging, Erlangen, Germany) located within the Cardiovascular Investigation Unit of 
the Royal Adelaide Hospital. All CMR studies were performed with subjects in a 
supine position with a phased-array surface coil positioned over the thorax.  
 
2.4.3.1 Cardiac structure and function 
Initial long axes reference views were used to plan seven to ten parallel short-axis 
slices from the mitral annulus to and inclusive of the left ventricular apex (Figure 1.4). 
Images were acquired during expiratory breath hold with retrospectively ECG-gated 
steady state free precession (SSFP) sequences. Acquisition time was determined to 
include 90% of the R-R interval, image matrix 256 x 150, field of view (FOV) 380mm, 
repetition time (TR) 52ms, echo time (TE) 1.7ms, flip angle 70°. Slice thickness was 
6 mm with inter-slice gaps of 4mm. 
Offline analysis was performed to evaluate LV size and function utilizing proprietary 
software (Argus software, Siemens Medical Imaging, Erlangen, Germany). 
Endocardial contours were manually traced at end-diastole (start of R-wave) and at 
end-systole (visually smallest cavity). As per local protocol and established guidance 
(Hudsmith et al. 2005), non-contiguous papillary muscles were included within the 
blood pool. The most basal LV slice was determined as the slice where at least 50% 
of the cavity was surrounded by ventricular myocardium. The most apical slice was 
determined by the slice within visible blood pool. End-systolic and end-diastolic 
















FIGURE 2.4. Representative image of short axis images 
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2.4.3.2 Aortic distensibility  
Following the cardiac protocol, aortic imaging was performed using the same phased-
array surface coil placed on the thorax in addition to a spine-coil-array positioned 
within the patient bed.  Images were acquired during expiratory breath hold with 
retrospectively ECG-gated SSFP sequences.  Acquisition time was determined to 
include 90% of the R-R interval, image matrix 256 x 150, FOV 320mm, TR 40ms, TE 
1.4ms, Flip Angle 40°. Slice thickness was 6 mm. Sagittal oblique aortic imaging was 
initially acquired from the level of the aortic sinuses to the renal arteries.  Using the 
right pulmonary artery as a reference level, a perpendicular cross-sectional cine image 
was acquired of the ascending aorta (AA) and proximal descending aorta (PDA). A 
further SSFP cine image was acquired of the distal descending aorta (DDA) 
approximately 5cm beyond the level of the diaphragm (Figure 2.5). 
Brachial artery blood pressure was taken simultaneously using a CMR compatible 
automated non-invasive sphygmomanometer.  Three results during both the cardiac 
and vascular protocols were obtained, and the measurements averaged.  Outliers were 
discarded and repeat readings taken as required. 
Aortic distensibility (AD) was evaluated offline by manually tracing aortic cross-
sectional images at the level of the ascending aorta, proximal descending aorta and 
distal descending aorta.  Maximal and minimal lumen areas were calculated and 




The pulse pressure was calculated from the difference between the systolic and 
diastolic blood pressures and measured in mmHg. The aortic areas were measured in 
mm2 and after multiplying by 1000, aortic distensibility is reported in its final unit of 
mmHg-1. 
 
aortic area at end systole (mm2) – aortic area at end diastole (mm2) 
brachial pulse pressure (mmHg) x aortic area at end diastole (mm2) 
 










FIGURE 2.5 Representative image of sagittal or ‘candy cane’ view of 
aorta (a), from which cross-sectional planes can be acquired at the 
level of the pulmonary artery to generate ‘Ascending Aorta’ [AA] and 
Proximal Descending Aorta [PDA] (b), and 5cm below the diaphragm 
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2.4.4 Statistical Analysis 
Baseline characteristics are represented as mean ± standard deviation unless stated 
otherwise. Comparison of mean values between groups were by paired t-test or two-
way ANOVA.  
The relationship between continuous variables was determined by simple linear 
regression. Adjustment was performed by partial correlation. Analysis of covariance 
was applied in the presence of both continuous and categorical variables. 
Statistical significance was defined as a two-sided p<0.05.  Statistical analyses were 
performed using SPSS statistical software (v24, IBM SPSS, New York, USA) and 




The reproducibility of aortic distensibility measures has previously been published by 
our group (Nelson et al. 2009) in a similar cohort of individuals. In that study, 
coefficients of variation (CV) were 1 and 2% for intra and inter-observer variability 
respectively. Reproducibility of intracoronary flow measurements was not assessed as 
this technique is well established, our group has had extensive experience in this space 
(Anderson et al. 2005; Worthley et al. 2009; Worthley et al. 2007), and to avoid the 
inherent risk of protracted instrumentation of the coronary vessels following ‘near 
normal’ clinical findings.  Contemporary studies have reported a biological variation 
in measures of Doppler FloWire CBF to yield a CV <3.5% (Leung et al. 2006). 
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2.5 RESULTS 
2.5.1 Sample size 
Consent was obtained in 51 consecutive patients. Of those, 32 patients had evidence 
of >30% luminal stenosis and thus were not enrolled in the study. Eighteen subjects 
successfully completed the invasive coronary protocol. In one subject, the guiding 
catheter was not able to safely engage the left main and thus the invasive protocol was 
abandoned.  Three subjects were unable to complete the non-invasive CMR protocol 
and thus 15 individuals had both invasive and non-invasive datasets for comparison 
(Figure 2.6).  
 
2.5.2 Cohort 
The clinical characteristics of the cohort are listed (Table 2.1).  The majority of patients 
were male (n = 9, 60%) and the mean age was 53 ± 13 years. Consistent with the 
attempt to identify a population less likely to have angiographic coronary disease, the 
majority of patients had fewer than three traditional risk factors for coronary disease 
(73%), the most prevalent being hypertension (53%). 
The most common class of medication was angiotensin converting enzyme (ACE) 
inhibitors or angiotensin II receptor blockers (ARBs) (67%) although the majority 



















(n = 51) 
Excluded: 
• >30% luminal stenosis (n = 32) 
Successful invasive and  
non-invasive protocols 
(n = 15) 
  
Attempted invasive study  
(n = 19) 
Abandoned: 
• Unable to sit guiding catheter safely in LM (n = 1) 
  
Attempted non-invasive study 
(n = 18) 
Abandoned: 
• Claustrophobia (n = 3) 
















Clinical characteristic Cohort 
Mean age ± SD [years] 53 ± 13 
Male sex – no. (%) 9 (60) 
Diagnostic angiogram indication – no. (%)  
Chest pain for investigation 11 (73) 
Dyspnoea for investigation 2 (13) 
Positive stress test 2 (13) 
Mean BMI ± SD [kg/m2] 29.1 ± 4.1 
Risk factors – no. (%)  
Family history 3 (20) 
Cigarette smoking 2 (13) 
Hypertension 8 (53) 
Dyslipidaemia 7 (46) 
Diabetes 4 (26) 
≤ 3 traditional risk factors 11 (73) 
Medications – no. (%)  
Aspirin  6 (40) 
ACE/ARB 10 (67) 
Statin 7 (47) 
Diuretic 2 (13) 
≤ 3 medications 14 (87) 
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Laboratory tests (Table 2.2) revealed normal kidney and liver function in addition to 
gender-appropriate haematological indices without viscosity. Lipid profile overall was 
only minimally outside the reference ranges – mean LDL 2.3 ± 0.6mmol/L, mean HDL 
1.1 ± 0.2mmol/L and TG 1.1 ± 0.8mmol/L.  There were no new diagnoses of diabetes 
with a mean cohort fasting glucose of 4.1 ± 0.6mmol/L. Mean c-reactive protein for 






Laboratory characteristics Cohort 
Lipid profile ± SD [mmol/L]  
Total cholesterol 4.2 ± 0.6 
Triglycerides 1.2 ± 0.7 
LDL-C 2.6 ± 0.5 
HDL-C 1.1 ± 0.4 
GGT ± SD [mmol/L] 61 ± 14.1 
Hb ± SD [mg/dL] 131 ± 14 
Fasting glucose ± SD [mmol/L] 4.7 ± 0.7 
C-reactive protein [mg/L] 2.7 ± 1.8 
eGFR [mL/min/1.73m2] 71 ± 11.2 
 
TABLE 2.2 Laboratory characteristics. Abbreviations: low-density 
lipoprotein (LDL), high-density lipoprotein (HDL), gamma-glutamyl 
transferase (GGT), haemoglobin (Hb), estimated glomerular filtration 
rate (eGFR)  
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2.5.3 Invasive studies 
Aside from the inability to safely (for research purposes) engage the left main coronary 
ostium in one patient, the invasive protocol was uneventful and well tolerated. One 
patient experienced four seconds of AV block following adenosine although this was 
asymptomatic and without appreciable change in invasive blood pressure. The LAD 
was studied in all patients given the ease of instrumentation.  
A summary of the invasive indices is listed (Table 2.3). The mean LAD diameter was 
3.33 ± 0.6mm. Baseline APV was 14.7 ± 5.7cm/s producing a resting CBF of 62.2 ± 
16.0mL/min.  Peak APV was 46.8 ± 20.3cm/s producing a hyperaemic CBF of 192.7 
± 66.2mL/min. An intact microvascular response was observed in each subject with 
all CFVR > 2.5. 
The mean CFVR for the cohort was 3.15 ± 0.48 (Range, 2.5 – 4.9). Individual APV 
















Variables Mean ± SD 
Baseline haemodynamics  
bSBP [mmHg] 136 ± 12 
bDBP [mmHg] 83 ± 9 
bPP [mmHg] 54 ± 8 
HR [bpm] 67 ± 11 
Rate pressure-product 8599 ± 2016 
Invasive indices  
QCA LAD diameter [mm] 3.33 ± 0.6 
Resting CBF [mL/min] 62.2 ± 16.0 
Hyperaemic CBF [mL/min] 192.7 ± 66.2 
CFVR 3.15 ± 0.48 
cPP [mmHg] 61 ± 11 
Cardiac structure and function  
LVEDV [mL] 113.7 ± 10.8 
LVESV [mL] 34.6 ± 7.1 
LVEF [%] 66.7 ± 4.9 
LV mass [g] 106.4 ± 16.6 
Aortic distensibility [10-3mmHg-1]  
AA 3.89 ± 1.72 
PDA 4.08 ± 1.80 
DDA 4.42 ± 1.67 
 
TABLE 2.3 Investigative variables. Abbreviations: systolic blood pressure 
(SBP), diastolic blood pressure (DBP), brachial pulse pressure (bPP), 
heart rate (HR), quantitative coronary angiography (QCA), left anterior 
descending (LAD), coronary blood flow (CBF), coronary flow velocity 
reserve (CFVR), central pulse pressure (cPP), left ventricular end 
diastolic and systolic volume (LVEDV, LVESV), left ventricular ejection 
fraction (LVEF).  
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2.5.4 Non-invasive studies 
Aside from the three patients with claustrophobia, the CMR protocol was well 
tolerated and uneventful. The approximate time spent in the chamber was 20 minutes. 
 
2.5.4.1 Cardiac structure and function 
All subjects had normal left ventricular cavity size (LVEDV 113.7 ± 10.8mL.  
Reference ranges: males 115-198mL; females 88-168mL) and systolic function 
(LVEF 66.7 ± 4.7%. Normal range: 58-76%) (Maceira et al. 2006). 
Although hypertension was the most prevalent risk factor and our cohort had a mean 
brachial SBP of 135 ± 12mmHg, there was no evidence of left ventricular hypertrophy 
(LV mass 106.4 ± 16.6g. Reference ranges: males 108-184g; females 72-144g). 
 
2.5.4.2 Aortic distensibility 
Measures of AD were relatively consistent across all three measured levels: AA (3.89 
± 1.72·10-3mmHg-1), PDA (4.08 ± 1.8·10-3mmHg-1) and DDA (4.42 ± 1.67·10-
3mmHg-1). There was a numerical reduction in AD moving proximally along the aorta, 
a phenomenon associated with ageing our group has reported on previously (Nelson 
et al. 2009) although this did not reach statistical significance (p = 0.127).   
 
2.5.5 Comparison of invasive and non-invasive aortic stiffness measures 
Central pulse pressure correlated strongly with all levels of aortic distensibility: vs. 
AA (R2 = 0.525, p = 0.002), PDA (R2 = 0.560, p = 0.001) and DDA (R2 = 0.509, p = 
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2.5.5.1 Resting coronary blood flow 
All measures of aortic distensibility were associated with rCBF: AA, R2 0.373 (p = 
0.016); PDA, R2 0.361 (p = 0.018); and DDA, R2 = 0.350 (p = 0.020). After adjusting 
for age and gender, the relationships remained statistically significant at all levels 
(p<0.05).   
Univariate analysis revealed an association between rCBF and cSBP (R -0.578, p = 
0.024) although minimal association with cPP (R -0.359, p = 0.189) or cDBP (R -
0.233, p = 0.404). There was no relationship with measures of brachial blood pressure. 
Resting CBF did not correlate with indices of cholesterol (TG, LDL, HDL), 
inflammation (CRP), obesity (BMI) or renal function.  
 
2.5.5.2 Hyperaemic coronary blood flow 
A modest inverse relationship was observed between cPP and hCBF, R2 0.345 (p = 
0.021), however after adjustment for age and gender, this was no longer statistically 
significant (p = 0.223). There was a strong correlation between hCBF and all levels of 
aortic distensibility: AA, R2 0.453 (p = 0.006); PDA, R2 0.455 (p = 0.005); and DDA, 
R2 0.464 (p = 0.005). These relationships remained highly statistically significant after 
adjustment for age and gender (p<0.05).  
Univariate analysis revealed an association between hCBF and cSBP (R -0.667, p = 
0.007) as well as hCBF and cPP (R -0.727, p = 0.002) although minimal association 
with cDBP (R -0.233, p = 0.404).  
Hyperaemic CBF did not correlate with indices of cholesterol (TG, LDL, HDL), 
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2.5.5.3 Coronary flow velocity reserve and aortic stiffness 
A strong association was observed between cPP and CFVR, R2 0.532 (p = 0.002). 
Similarly, robust relationships were observed between CFVR and the non-invasive 
measures of aortic stiffness at all levels of the aorta: AA, R2 0.511 (p = 0.003); PDA, 
R2 0.451 (p = 0.006); and DDA, R2 0.442 (p = 0.007). All of these relationships 
remained highly statistically significant after adjustment for age and gender (p < 0.01).  
There was no relationship between measures of either central or brachial blood 
pressures and CFVR. 
Coronary flow velocity reserve did not correlate with indices of cholesterol (TG, LDL, 




 rCBF hCBF CFVR 
Unadjusted      
AA 0.611 (0.016) 0.673 (0.006) 0.715 (0.003) 
PDA 0.600 (0.018) 0.675 (0.006) 0.672 (0.006) 
DDA 0.591 (0.020) 0.682 (0.005) 0.665 (0.007) 
cPP -0.438 (0.103) -0.587 (0.021) -0.729 (0.002) 
Adjusted    
AA 0.565 (0.044) 0.655 (0.011) 0.695 (0.006) 
PDA 0.545 (0.046) 0.634 (0.015) 0.623 (0.017) 
DDA 0.569 (0.042) 0.670 (0.009) 0.670 (0.009) 
cPP -0.154 (0.616) -0.348 (0.223) -0.599 (0.024) 
 
TABLE 2.4 Correlation between coronary blood flow and indices of arterial 
stiffness. R value with p value in brackets. Statistically significant association 
denoted by bolding of text. rCBF adjusted for age, gender and rate pressure 
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2.5.5.4 Effect of arterial stiffness on degree of hyperaemic response 
Figure 2.8 demonstrates the relationship between rCBF and hCBF against measures 
of aortic distensibility. The resting and hyperaemic slopes converge when plotted 
against all levels of aortic distensibility. There was a statistically significant difference 
between the slopes of the respective resting and hyperaemic CBF regression lines; AA, 
p = 0.017; PDA, p = 0.018; and DDA, p = 0.015, suggesting a stiffer aorta is associated 
with a reduced hyperaemic response to adenosine.  These relationships persisted after 

























FIGURE 2.8 Resting and hyperaemic CBF versus aortic distensibility at 
the AA (top), PDA (middle) and DDA (bottom). Differences between the 
slopes of rCBF and hCBF lines were all <0.05. 
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2.6 DISCUSSION 
To our knowledge, this is the first study to evaluate the relationship between invasive 
indices of coronary blood flow and CMR derived measures of arterial stiffness.   
 
Aortic stiffness and coronary blood flow. 
This study demonstrates that hyperaemic and to a lesser extent, resting coronary blood 
flow are associated with measures of aortic stiffness in patients with no more than 
minor coronary artery disease. As evidenced by the linear relationships, a stiffer aorta 
is associated with reduced resting and hyperaemic blood flow.  
 
Differential impact on rCBF 
All three levels of measured aortic distensibility correlated with both resting and 
hyperaemic blood flow. The association, however, was more robust with hCBF than 
it was with rCBF. A similar finding was observed with cPP, a coarser marker of 
stiffness, where its association no longer maintained statistical significance following 
adjustment for other known determinants of rCBF. With modest correlation 
coefficients and borderline statistical significance, rCBF therefore appears to be 
predominantly governed by factors other than large artery stiffness such as myogenic 
autoregulation. Although difficult to tease out with CFVR given its ‘whole of vessel’ 
functional assessment, and particularly with this cohort all having a CVFR > 2.5, it 
remains of interest whether aortic stiffness would play a more ‘dominant’ role in 
governing rCBF when either the microvascular reserve is fully ‘compensated’ or if the 
microvasculature is dysfunction. Extending this out to epicardial disease, Leung et al. 
demonstrated a tighter relationship between aPWV and rCBF in the presence of a flow 
limiting stenosis (R2 = 0.453) compared to post PCI when the lesion had been 
effectively treated (R2 = 0.261). Whether this represents exhaustion of the 
microcirculatory reserve to accommodate supply/demand, or concomitant 
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microcirculatory dysfunction, or features of both, large artery stiffness may have a 
greater impact on rCBF in states of ‘disease’ than in ‘health’. 
 
Hyperaemic response to adenosine 
The convergence of the hCBF and rCBF curves when plotted against aortic 
distensibility support earlier work from Leung et al. (Leung et al. 2006) that a stiffer 
aorta conveys a reduced hyperaemic response to adenosine. Leung et al. demonstrated 
this relationship in both pre and post PCI coronary vessels, however our study has 
extended this observation to subjects with near normal coronary arteries.  
Although our contention is that a stiff aorta is less capable of accommodating an 
increase in flow, it is plausible that there are other contributors to this relationship. 
Increased aortic stiffness has been associated with endothelial function and thus 
endothelial-mediated adenosine effects may be reduced by synchronous microvascular 
dysfunction.  
An extension of this relationship has broad clinical implications. In our subjects with 
the least distensible aortas, their CFVRs approached 2.5 - the threshold considered 
significant for ischaemia. In an individual with a chest pain syndrome and only minor 
obstructive coronary disease, a very stiff aorta may be enough to exhaust perfusion 
reserve and could provide a causal link to ‘microvascular angina’. As proposed by 
Kingwell et al. (Kingwell et al. 2002) , extending this to individuals with epicardial 
disease, a mild to moderate stenosis may behave like a severe stenosis in the setting of 
a stiff aorta. 
 
Blood pressure and coronary blood flow 
Univariate correlation revealed significant associations between cSBP and both resting 
and hyperaemic blood flow. Given CBF predominantly occurs in diastole, an 
association between SBP and both rCBF and hCBF invokes an indirect explanation. 
Systemic hypertension is associated with changes in the microvasculature such as 
  Chapter 2: Invasive proof of concept 
 93 
rarefaction (reduced number) and peri-arteriolar fibrosis (Feihl et al. 2008). It may 
therefore be that these chronic changes associated with elevated SBP may impact on 
both rCBF and hCBF and thus be a surrogate for microvascular function and intrinsic 
resistance. Supporting this is evidence that CFVR is reduced in patients with 
hypertension compared to normotensive controls (Rimoldi et al. 2014). Our data 
suggests this process may only partially associate with arterial stiffness, as there was 
minimal correlation between SBP and aortic distensibility in this cohort. An 
assessment of endothelial function, also known to be reduced in hypertension, may 
provide some insight as a potential mediator of the SBP and CBF relationship (Bolad 
& Delafontaine 2005).  
Furthermore, there was no association between cDBP and indices of coronary blood 
flow suggesting there may be a greater contribution from diastolic resistance on 
coronary flow than from central diastolic driving pressure per se. Simultaneous 
assessment of coronary blood flow and pressure would have allowed a better 
understanding of this interaction. 
The lack of association between any peripheral measure of blood pressure and 
coronary flow indices again highlights the key role central pressure assessment has not 
only in elucidating putative mechanisms, but why its predictive strength may be far 
superior to brachial measures (McEniery et al. 2014). 
 
Measures of arterial stiffness 
Aortic stiffness increased in a linear manner moving from the abdomen towards the 
aortic valve and, although not statistically significant, is a well described phenomenon 
with ageing (Hundley et al. 2001; Nelson et al. 2009; Rogers et al. 2001). Conceivably 
the proximal aorta may be incrementally more important to the aorto-coronary 
relationship than the abdominal aorta given its predisposition to stiffening, in addition 
to its geographical proximity to the coronary ostia; however, in our cohort all levels 
correlated with similar strength to the observed measures of CBF and MPR. This may 
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be reflective of the relatively similar values for distensibility that were obtained at all 
three sites or possibly that we were underpowered to detect these differences.  
Alternatively, it could be that the aorto-coronary relationship is reflective of ‘net’ large 
artery function and thus all measures will confer agreement. 
 
Limitations 
As with other studies in this field, the invasive and involved nature of the protocol 
means the sample size is small. Despite this limitation, our correlations were 
statistically robust. Although the CMR component of the study was performed within 
two hours of the invasive protocol, the assessment of distensibility and coronary blood 
flow was not simultaneous and although unlikely, potentially affected by different 
loading and haemodynamic conditions. An inherent limitation of aortic distensibility 
assessment is the reliance on bPP rather than central distending pressure. Although we 
had access to this value by virtue of the invasive arm of the protocol, our work in 
distensibility to date has utilised bPP, and as with other larger studies in this area, 
provides a reasonable approximation in most individuals.  
 
To complete the translation from invasive to non-invasive validation, it would have 
been ideal to have performed a comparison between coronary blood flow with Doppler 
FloWire and myocardial blood flow with CMR perfusion imaging (CMR-PI). This 
would have required patients to have consented to gadolinium administration after 
having undergone coronary angiography within a matter of hours. This was felt to be 
unethical in view of these patients already having received a diagnosis of non-
obstructed coronary arteries. Other studies in this space, however, have shown robust 
correlation indices of myocardial perfusion in both ischaemic and non-ischaemic 
myocardium against invasive Doppler FloWire (Kurita et al. 2009), invasive QCA 
(Mordini et al. 2014) and PET (Morton et al. 2012). A further potential limitation in 
the study relates to the certainty of obtaining maximal hyperaemia. More recent 
  Chapter 2: Invasive proof of concept 
 95 
evidence suggests some patients do not obtain maximal hyperaemia at this dose and 
that doses as high as 200µg are recommended by some (Adjedj et al. 2015). 
 
Conclusion 
To our knowledge, this is the first study to establish the purported relationship between 
arterial stiffness and coronary blood flow using CMR derived aortic distensibility and 
invasive Doppler coronary FloWire in essentially ‘normal’ coronary arteries.
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3.2 ABSTRACT 
Background: Invasive evidence supports an association between large artery function 
and indices of myocardial blood flow. Further evaluation of this relationship has been 
limited by the invasive nature of current techniques, requirement for multi-modality 
or sequential studies, or by inaccurate, inadequate imaging resolution. This study 
sought to validate the use of cardiovascular magnetic resonance (CMR) to evaluate 
both aortic distensibility and myocardial blood flow as a method to demonstrate the 
aorto-coronary relationship in a completely non-invasive, simultaneous manner. 
Methods: Patients referred for a clinically indicated CMR perfusion imaging (CMR-
PI) study were invited to participate. Aortic distensibility was evaluated and after 
excluding studies with perfusion defects or scar, semi-quantitative and quantitative 
perfusion analysis was performed using proprietary software. Signal-intensity time 
curves were generated from short-axis slices allowing myocardial perfusion reserve 
(MPR) as well as both absolute resting and hyperaemic blood flow (rMBF, hMBF) to 
be obtained. 
Results: Fifty-three subjects (61.2 ± 10.4 years), the majority being male (62%), were 
included in the study. Aortic distensibility was mildly reduced across the cohort 
(average 3.43 ± 1.58·10-3mmHg-1), however all had a normal response to adenosine 
(MPR 2.9 ± 0.65). Aortic distensibility was associated with rMBF (R2 0.231 – 0.281, 
p < 0.01), hMBF (R2 0.282 – 0.409, p < 0.01) and MPR (R2 0.421 – 0.517, p < 0.01). 
Furthermore, CMR-PI was repeatable with robust intra-class coefficients: MPR (0.96); 
rMBF (0.83); and hMBF (0.91). 
Conclusion:  This is the first study to utilise CMR derived indices of both myocardial 
blood flow and aortic distensibility to evaluate the aorto-coronary relationship. Aortic 
distensibility correlated strongly with hMBF and MPR although only modestly with 
rMBF. This repeatable and non-invasive technique may facilitate a broader evaluation 
of this physiology in different subgroups, and potentially in a serial manner over time.  
  Chapter 3: Non-invasive proof of concept 
 102 
3.3 INTRODUCTION 
Aortic stiffness has emerged as an independent predictor of cardiovascular outcomes 
in a broad cohort of patients (Ben-Shlomo et al. 2014). Moreover, it provides 
incremental prognostic capacity above standard risk stratification algorithms 
(Vlachopoulos et al. 2010) and now appears in European guidelines (Van Bortel et al. 
2012). Although associated with neurological (van Sloten et al. 2015) and renal (Ford 
et al. 2010; Townsend et al. 2018) sequelae due to increased transmission of pulsatility 
at a microvascular level (O'Rourke & Safar 2005), it is the putative impact on the heart 
that is likely to drive its cardiovascular predictive capacity.  
 
Mechanistically a stiffer aorta results in a faster pulse wave which results in an earlier 
return of reflected waves at end-systole rather than diastole. The net effect is an 
increase in left ventricular cardiac work, an increase in myocardial oxygen demand 
and with time, compensatory hypertrophy. The earlier return of the reflected wave fails 
to augment diastolic pressure leading to an increase in pulse pressure but importantly, 
a reduction in coronary perfusion pressure.  
 
Seminal work in canines provided evidence of this relationship (Ohtsuka et al. 1994; 
Watanabe et al. 1992), however more recently, Leung et al. (Leung et al. 2006) 
confirmed the association between resting and hyperaemic blood with large artery 
stiffness. Although compelling, we recently have extended their observations using 
cardiac magnetic resonance (CMR) derived aortic distensibility in individuals with no 
significant epicardial coronary disease (Chapter 2). A similar relationship was found 
whereby a stiffer artery confers not only reduced rCBF but also a blunted response to 
adenosine. As with Leung et al. this study still required an invasive arm to evaluate 
measures of coronary flow which limits its use to small scale, cross-sectional cohorts.  
With the advent of improved 1st pass perfusion techniques in CMR it has now become 
possible to quantitate absolute myocardial blood flow (MBF) and myocardial 
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perfusion reserve (MPR) using adenosine as the hyperaemic stimulus and gadolinium 
as the contrast agent. A number of studies have shown these values to approximate 
those obtained in animal models with microspheres (Christian et al. 2009; Jerosch-
Herold et al. 2002) and more recently, in larger human studies (Arnold et al. 2011; 
Cheng et al. 2008; Heydari et al. 2015; Selvanayagam et al. 2005) 
 
The aim of this study was to perform simultaneous measurements of aortic stiffness 

























3.4.1.1 Inclusion criteria 
The study was approved by the Human Research Ethics Committee at the Royal 
Adelaide Hospital. Patients referred for a CMR perfusion imaging (CMR-PI) scan at 
the Royal Adelaide Hospital to evaluate for evidence of ischaemic heart disease, either 
chest pain or dyspnoea, were invited to participate. Subjects were enrolled 
consecutively between January 2012 until the September 2013.  Patients had abstained 
from caffeine and xanthine-containing products for at least 24 hours prior to scanning 
as per local protocol. 
 
3.4.1.2 Exclusion criteria  
Exclusion criteria included age >75 years, use of vasoactive medications <48 hours of 
angiography (calcium channel blockers, nitrates, beta blockers), established coronary 
disease (angina, history of myocardial infarction, prior revascularisation), atrial 
fibrillation/flutter, aortopathy (history of intervention, dissection or aneurysm), 
magnetic resonance chamber incompatibility (pacemakers, aneurysm clips, 
claustrophobia), impaired LV function (LVEF < 45%), severe valvular heart disease, 
renal impairment (estimated glomerular filtration rate < 30mL/min/1.73m2) or 
atrioventricular nodal disease (Grade II or higher) were excluded. 
 
3.4.1.3 Demographics 
Prescribed medications and risk factors were recorded.  Risk factors were defined as 
cigarette smoking (previously or currently, smoking tobacco), hypercholesterolemia 
(use of cholesterol-lowering therapy or total cholesterol level > 5.2mmol/L), 
hypertension (blood pressure > 140/90mm Hg or on medical antihypertensive therapy 
or subject to lifestyle intervention), obesity (BMI > 30kg/m2), diabetes (plasma 
haemoglobin A1c > 6.5%, or on glycaemic medications), and family history of 
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cardiovascular disease (index event in a first-degree relative, male ≤ 55 years and 
female ≤ 60).  
 
3.4.2 Cardiac magnetic resonance protocol 
All cardiovascular magnetic resonance (CMR) studies were performed utilizing the 
Siemens Avanto 1.5 Tesla magnetic resonance imaging scanner (Siemens Medical 
Imaging, Erlangen, Germany) located within the Cardiovascular Investigation Unit of 
the Royal Adelaide Hospital. All CMR studies were performed with subjects in a 
supine position with a phased-array surface coil positioned over the thorax.  
 
3.4.2.1 Cardiac structure and function 
Methods for evaluating left ventricular structure and function are covered in Chapter 
2. In brief, short-axis slices from the mitral annulus to and inclusive of the left 
ventricular apex were acquired during expiratory breath hold. 
Offline analysis was performed to evaluate LV size and function utilizing proprietary 
software (Argus software, Siemens Medical Imaging, Erlangen, Germany). 
Endocardial contours were manually traced at end-diastole (start of R-wave) and at 
end-systole (visually smallest cavity). End-systolic and end-diastolic volumes were 
obtained and thus left ventricular ejection fraction could be calculated. 
 
3.4.2.2 Aortic distensibility  
Following the cardiac protocol, aortic imaging was performed using the same phased-
array surface coil placed on the thorax in addition to a spine-coil-array positioned 
within the patient bed.  Images were acquired during expiratory breath hold with 
retrospectively ECG-gated SSFP sequences. Acquisition time was determined to 
include 90% of the R-R interval, image matrix 256 x 150, FOV 320mm, TR 40ms, TE 
1.4ms, Flip Angle 40°. Slice thickness was 6 mm. 
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Sagittal oblique aortic imaging was initially acquired from the level of the aortic 
sinuses to the renal arteries.  Using the right pulmonary artery as a reference level, a 
perpendicular cross-sectional cine image was acquired of the ascending aorta (AA) 
and proximal descending aorta (PDA) as well as a further SSFP cine image of the 
distal descending aorta (DDA) approximately 5cm beyond the level of the diaphragm.  
 
In addition, with plans to use sequences acquired already as part of a clinically 
indicated scan, aortic measurements were also performed on the vertical long axis 
(VLA) image. This sequence is obtained from an axial scout image by defining a 
sagittal oblique plane from the LV apex through the mitral valve. The resultant image 
is the VLA and includes a ‘two chamber’ picture of the myocardium with a lateral 
view of the LA and LV (Figure 3.1). From a thoracic cavity perspective, this transects 
the aortic arch around the level of the great vessels and approximates a level of the 
thoracic aorta (TA) between the conventional distensibility fiduciary points of AA and 
PDA.  Given this sequence is planned on myocardial structures – i.e. visibility of the 
four intracardiac chambers – there is the potential for this acquisition to be slightly 
oblique with respect to the aorta. This would generate a cross section of the aorta in 
the shape of an ellipse rather than a circle. Although vessels that appear ellipsoid at 
low pressure often distend to a circle under high pressure (Melbin & Noordergraaf 
1971) the assumption in the distensibility formula is that of ‘circular’ expansion. Major 
and minor axes were therefore drawn and if the ellipticity index was <0.9 















FIGURE 3.1 Expanded from Figure 2.5. Representative sagittal or 
‘candy cane’ view of aorta which shows the point at which the vertical 
long axis plane (b) transects the aortic arch allowing calculation of 
‘Thoracic Aorta’ (TA) distensibility. Images (c) and (d) reflect the 
‘traditional’ cross sectional planes and are acquired at the level of the 
pulmonary artery to generate ‘Ascending Aorta’ [AA] and Proximal 
Descending Aorta [PDA] (c), and 5cm below the diaphragm to 
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Brachial artery blood pressure was taken simultaneously using a CMR compatible 
automated non-invasive sphygmomanometer.  Three results during both the cardiac 
and vascular protocols were obtained, and the measurements averaged.  Outliers were 
discarded and repeat readings taken as required. 
 
Aortic distensibility was evaluated offline by manually tracing aortic cross-sectional 
images at the level of the ascending aorta, proximal descending aorta, distal 
descending aorta and thoracic aorta. Maximal and minimal lumen areas were 
calculated and distensibility derived by a previously published formula (Groenink et 




The pulse pressure was calculated from the difference between the systolic and 
diastolic blood pressures and measured in mmHg. The aortic areas were measured in 












aortic area at end systole (mm2) – aortic area at end diastole (mm2) 
brachial pulse pressure (mmHg) x aortic area at end diastole (mm2) 
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3.4.2.3 CMR Perfusion imaging  
3.4.2.3.1 Adenosine infusion protocol 
As per local protocol, a physician with a cardiac defibrillator was present for all stress 
perfusion imaging. Advanced resuscitation medications were also available including 
aminophylline for adenosine receptor antagonism, glyceryl trinitrate (GTN) for 
ongoing chest pain and atropine for symptomatic AV block. A 20G cannula was 
inserted into each antecubital fossa – one for adenosine and one for contrast.  
Adenosine (AdenoScan, Sanofi-Aventis, Surrey, UK) was infused at 140µg/kg/min 
using a precise syringe pump (Graesby 3500, Minneapolis, Minnesota, USA) to a 
target duration of 3 minutes. The infusion was ceased if the patient developed 
symptomatic AV block, severe hypotension (<90mmHg) or bronchospasm. 
 
3.4.2.3.2 Image acquisition 
During the last minute of the adenosine infusion, the gadolinium-based contrast agent, 
Magnevist (dimeglumine gadopentetate, Bayer, Leverkusen, Germany) was 
administered in the contralateral arm. This was at a dose of 0.2mmol/kg body weight 
and a rate of 7ml/s followed by a 30 mL saline flush at the same rate (Kramer et al. 
2008; Lyne et al. 2007).   
Perfusion imaging was performed with a T1-weighted fast low-angle singe shot 
gradient echo (GRE) sequence and was acquired every cardiac cycle during first pass. 
Perfusion pulse sequence parameters were as follows: echo time 1.04ms; repetition 
time 165ms; saturation recovery time 100ms; voxel size 2.7 x 2.2 x 10mm; flip angle 
12°. Parallel acquisition method using generalised auto-calibrating partially parallel 
acquisition (GRAPPA) was utilised (Griswold et al. 2002) which has been shown to 
increase signal to noise ratio and improve image quality. Perfusion images were 
obtained at three short axis planes - basal, mid and apical levels - of the left ventricle 
(Cerqueira et al. 2002).   
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The protocol was subsequently repeated 20 minutes later without adenosine for ‘rest’ 
images. Throughout the CMR protocol heart rate and ECG were monitored 
continuously. A CMR compatible cuff allowed blood pressure to be acquired at 5-
minutely intervals.   
 
3.4.2.3.3 Visual analysis 
Visual analysis of each perfusion study was undertaken off-line and a consensus 
reached between two experienced observers (KST, AJN). Rest and stress perfusion 
and the late gadolinium enhancement images of three short axis sections (base, mid 
and apex) were viewed side by side. If the signal intensity on stress perfusion appeared 
lower in an area of myocardium for at least three dynamic images compared with 
remote myocardium, it was considered to be ischaemic (Ingkanisorn et al. 2006). If 
the same signal intensity abnormality was seen in the rest and stress perfusion images 
and there was no evidence of scar on late contrast enhanced images, the defect was 
considered an artefact. Similarly, if the perfusion defect lasted for less than 3 dynamic 
images it was also considered artefactual (Ingkanisorn et al. 2006).  
For this proof of concept project, studies demonstrating any evidence of matched 
(infarcted, non-viable myocardium) or reversible defect (ischaemia) on their perfusion 
maps were subsequently excluded. 
 
3.4.2.3.4 Quantitative analysis 
Studies without evidence of ischaemia were then subject to quantitative analysis.  The 
endocardial and epicardial contours of three short axis sections (base, mid and apex) 
were traced (QMASS, v7 .2, Medical Imaging Solutions, Leiden, Netherlands) and 
corrected manually for displacements such as breathing (Figure 3.2). Short axis 
sections were not further segmented into coronary territories as these were ‘normal’ 
studies and thus only global, transmural measures of signal intensity were required. 
 









FIGURE 3.2 Representative perfusion images demonstrating passage 
of gadolinium contrast over time at basal (a) – (c), mid (d) – (e) and 
apical (g) – (i) levels. Endocardial borders are depicted in red, 
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Within each section, signal intensity was measured by defining regions of interest that 
excluded the inner 10% and outer 30% of the myocardium to get stronger weighting 
of the subendocardium (where perfusion changes are more likely to occur) and reduce 
influence from the LV as previously described (Nagel et al. 2003).   
 
The subendocardial signal intensity-time curves were generated for all segments by 
obtaining signal intensity on consecutive images before and during arrival of contrast 
material. The signal intensity-time curve for the left ventricle was generated on the 





FIGURE 3.3 Signal-intensity of contrast passage (arbitrary 
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Myocardial perfusion reserve 
The maximal initial upslope of the signal intensity-time curve was determined by using 
a sliding window with a four- point linear fit for the myocardium and a three-point fit 
for the left ventricle as previously described (Al-Saadi et al. 2000).  For each segment, 
the myocardial perfusion reserve (MPR) was calculated by the quotient of maximal 
upslope at hyperaemia over maximal upslope rest (Figure 3.4).  This was performed 
for each of the three slices and then averaged for a ‘global’ MPR.  
 
Myocardial blood flow 
Deconvolution of the myocardial signal intensity time (SIT) curve and the blood pool 
SIT curve (as the arterial input function) was performed and fitted to a Fermi function. 
The maximum point on the resultant curve (as described in Chapter 1), closely 
approximates the absolute myocardial blood flow and has been extensively described 
(Cheng et al. 2008; Jerosch-Herold et al. 2002; Jerosch-Herold et al. 2000; 
Selvanayagam et al. 2005). Signal intensity time curves were generated in each short 
axis slice at rest and at hyperaemia allowing calculation of global values of resting 
(rMBF) and hyperaemic MBF (hMBF).    
As basal CBF is closely related to the rate-pressure product (RPP) (Czernin et al. 
1993), an index of myocardial oxygen consumption, values for basal flow in each 
subject were corrected for the respective RPP. This was performed by multiplying 
rMBF by the mean RPP of the cohort, divided by the RPP in the individual patient as 



















FIGURE 3.4 Signal intensity-time curve comparing enhancement during 
hyperaemia (orange) vs. rest (black). Slopes of maximal intensity drawn on 











  Chapter 3: Non-invasive proof of concept 
 115 
3.4.3 Repeatability 
Interobserver variability was performed on 20 de-identified scans and subject to 
Bland-Altman analysis (Bland & Altman 1986). Resting and hyperaemic MBF as well 
as MPR were all assessed.  Aortic distensibility reproducibility has been previously 
published by our group (Nelson et al. 2009). 
 
3.4.4 Statistical Analysis 
Baseline characteristics are represented as mean ± standard deviation where normally 
distributed, or median and IQR for parameters with non-Gaussian distribution.  
Regional variation in measures of aortic distensibility was assessed using 1-way 
ANOVA. The comparison of CBF and MPR against CMR measures of aortic 
distensibility was performed by regression analysis.  
Reproducibility of CMR-PI measures was performed with Bland-Altman analysis. 
Statistical significance was defined as a two-sided p < 0.05.  Statistical analyses were 
performed using SPSS statistical software (v22, SPSS Inc. Chicago, Il) and graphs 
were drawn using GraphPad Prism 7 (GraphPad Software Inc, San Diego). 
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3.5 RESULTS 
3.5.1 Sample size 
Consent was obtained in 84 consecutive patients. Of those, seven patients were unable 
to complete their clinically indicated CMR-PI with six patients suffering 
claustrophobia and one patient sustaining intolerable chest heaviness after only 30 
seconds of adenosine infusion. Of the 77 patients who completed the scan, three had 
poor image quality limiting even visual assessment of perfusion defects, five had 
reversible perfusion defects consistent with ischaemia, four had matched perfusion 
defects consistent with prior infarct and three were found to have presumed new left 
ventricular dysfunction. 
The remaining 62 patients were subjected to both quantitative perfusion and aortic 
distensibility analysis.  Of these, seven had suboptimal image quality owing largely to 
poor breath holding and two had an ellipsoid thoracic aorta on the VLA image plane. 
This left 53 subjects with complete data (Figure 3.5). 
 
3.5.2 Cohort 
The clinical characteristics of the cohort are listed (Table 3.1).  The majority of patients 
were male (n = 33, 62%) with a mean age of 61 ± 10 years. As expected, the majority 
of patients were referred through with chest pain for investigation (87%) with a smaller 
number reporting dyspnoea as their main indication (13%). The most prevalent risk 
factors were hypertension (73%) and dyslipidaemia (68%) with just over a third being 
diabetic (36%). Consistent with these individuals being referred for an imaging-based 
functional test, over half had 3 or more traditional risk factors for coronary disease 
(51%). The most commonly prescribed medication was aspirin (64%) followed by 
either an ACE or an ARB (59%) with just less than half on statins (45%). Just less than 
a third were on a diuretic (25%), calcium channel blocker (30%) or beta blocker (20%).  
 
 


























FIGURE 3.5 Cohort build 





(n = 84) 
Excluded: 
• Unable to tolerate scan: 
o Claustrophobia (n = 6) 
o Adenosine infusion-related 
§ Intolerable chest heaviness (n = 1) 
Complete CMR-PI +  
Aortic Distensibility dataset 
(n = 53) 
 
Completed CMR-PI 
(n = 77) 
Excluded: 
• Poor image quality – visual (n = 3) 
• Reversible perfusion defect (n = 5) 
• Matched perfusion defect (n = 4) 
• LV dysfunction (n = 3) 
 
CMR-PI + Aortic Distensibility 
analysis 
(n = 62) 
Excluded: 
• Poor image quality – quantitative (n = 7) 
• Ellipsoid thoracic aorta (n = 2) 








Clinical characteristic Cohort 
Mean age ± SD [years] 61.2 ± 10.4 
Male sex – no. (%) 33 (62) 
Stress test indication – no. (%)  
Chest pain for investigation 46 (87) 
Dyspnoea for investigation 7 (13) 
Mean BMI ± SD [kg/m2] 29.5 ± 3.2 
Risk factors – no. (%)  
Family history 14 (26) 
Cigarette smoking 18 (34) 
Hypertension 39 (73) 
Dyslipidaemia 36 (68) 
Diabetes 19 (36) 
≥ 3 risk factors 27 (51) 
Medications – no. (%)  
Aspirin  34 (64) 
ACEi/ARB 31 (59) 
Statin 24 (45) 
Diuretic 13 (25) 
Calcium channel blocker 16 (30) 
Beta blocker 13 (25) 
 
TABLE 3.1 Clinical characteristics. Abbreviations: BMI – body mass 
index; ACEi – angiotensin converting enzyme inhibitor; ARB – 
angiotensin receptor II blocker 
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Laboratory investigations (Table 3.2) revealed normal kidney, liver function and red 
blood cell indices. Lipid profile overall was consistent with a primary prevention 
cohort: mean LDL 2.6 ± 0.5mmol/L; mean HDL 1.1 ± 0.4mmol/L; and TG 1.2 ± 
0.7mmol/L. Despite one third being classed as diabetic, the fasting glucose for the 




Laboratory characteristics Cohort 
Lipid profile ± SD [mmol/L]  
Total cholesterol 4.2 ± 0.6 
Triglycerides 1.2 ± 0.7 
LDL 2.6 ± 0.5 
HDL 1.1 ± 0.4 
GGT ± SD [mmol/L] 61 ± 14.1 
Hb ± SD [mg/dL] 131 ± 14 
Fasting glucose ± SD [mmol/L] 4.7 ± 0.7 
C-reactive protein [mg/L] 2.7 ± 1.8 
eGFR [mL/min/1.73m2] 71 ± 11.2 
 
TABLE 3.2 Laboratory characteristics. Abbreviations: LDL – low-density 
lipoprotein; HDL – high density lipoprotein; GGT – gamma-glutamyl 
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3.5.3 Cardiac Structure and Function 
All subjects had normal left ventricular cavity size (LVEDV 121.4 ± 13.4mL. 
Reference ranges: males 115-198mL; females 88-168mL) and systolic function 
(LVEF 62.7 ± 5.3%. Normal range: 58-76%) (Maceira et al. 2006). 
Left ventricular mass was within normal limits (LV mass 114.8 ± 19.5g. Reference 
ranges: males 108-184g; females 72-144g). 
 
3.5.4 Aortic distensibility 
3.5.4.1 Overall measures 
Aortic distensibility for our cohort was similar to our cohort in Chapter 2 with a mild 
increase in stiffness compared to ‘healthy’ controls (Nelson et al. 2009). As previously 
described, there was a linear reduction in aortic stiffness moving from the abdominal 
aorta proximally to the aortic valve.  Of the ‘traditional’ measures of aortic 
distensibility, the lowest distensibility was observed at the level of the AA (3.11 ± 
1.60·10-3mmHg-1) followed by the PDA (3.41 ± 1.57·10-3mmHg-1), and the DDA 
(3.76 ± 1.84·10-3mmHg-1). 
The average distensibility (AA, PDA and DDA) was 3.43 ± 1.58·10-3mmHg-1. The 
mean of our new measure at the level of the TA was 3.23 ± 1.58·10-3mmHg-1 which 
was numerically and anatomically between the AA and PDA.  
Although there were numerical differences between all measures of distensibility 
(Figure 3.6), this did not reach statistical significance (p = 0.71).  
 
3.5.4.2 Agreement with TA distensibility 
There was strong agreement between TA and all other measures of distensibility on 
regression analysis: AA (R2 0.849, p<0.0001); PDA (R2 0.821, p<0.0001); DDA (R2 
0.747, p<0.0001); and average distensibility (R2 0.938, p<0.0001) .  
 
 










FIGURE 3.6 Column graph of aortic distensibility 
measures at the level of AA (ascending aorta), PDA 
(proximal descending aorta), DDA (distal descending 
aorta) and TA (thoracic aorta). Average of the 
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3.5.5 CMR Perfusion imaging  
As described in the cohort build (Figure 3.5), just over 10% of the total population 
consented could not have either visual or quantitative perfusion analysis owing to 
suboptimal image quality. The vast majority of patients reported at least one symptom 
consistent with a hyperaemic response (n = 51, 96%), e.g. flushing, headache, 
dyspnoea, chest tightness.  
There was a significant difference between rMBF (0.92 ± 0.17mL/min/g) compared 




FIGURE 3.7 Ladder plot of subject-level MBF response 















Variables Mean ± SD 
Baseline haemodynamics  
SBP [mmHg] 146 ± 21 
DBP [mmHg] 88 ± 12 
PP [mmHg] 58 ± 13 
HR [bpm] 61 ± 14 
Cardiac structure and function  
LVEDV [mL] 121.4 ± 13.4 
LVESV [mL] 39.1 ± 9.2 
LVEF [%] 62.7 ± 5.3 
LV mass [g] 114.8 ± 19.5 
Aortic distensibility [10-3mmHg-1]  
AA 3.11 ± 1.60 
PDA 3.41 ± 1.57 
DDA 3.76 ± 1.84 
Average (AA + PDA + DDA) 3.43 ± 1.58 
TA 3.23 ± 1.64 
Stress perfusion imaging  
Resting RPP 8960 ± 2620 
Stress RPP 11810 ± 2130 
rMBF [mL/min/g] 0.92 ± 0.17 
hMBF [mL/min/g] 2.95 ± 1.03 
MPR 2.91 ± 0.65 
 
TABLE 3.3 CMR-PI variables. Abbreviations: SBP – systolic blood 
pressure; DBP – diastolic blood pressure; PP – pulse pressure; HR – heart 
rate; LVEDV – left ventricular end-diastolic volume; LVESV – left 
ventricular end-systolic volume; LVEF – left ventricular ejection fraction; 
AA – ascending aorta; PDA – proximal descending aorta; DDA – distal 
descending aorta; TA – thoracic aorta; RPP – rate-pressure product; 
rMBF – resting myocardial blood flow; hMBF – hyperaemic myocardial 
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3.5.6 Association with indices of myocardial perfusion 
3.5.6.1 Resting myocardial blood flow 
All ‘traditional’ measures of aortic distensibility were modestly associated with rMBF 
(Figure 3.8): AA, R2 0.231 (p = 0.0003); PDA, R2 0.280 (p < 0.0001); and DDA, R2 
= 0.276 (p < 0.0001). After adjusting for age and gender, the relationships remained 
statistically significant at all levels (p < 0.01).  
Thoracic aortic distensibility was also modestly related to rMBF, R2 0.281 (p < 0.0001) 
and after adjustment for age and gender, remained significant (p < 0.01). 
Resting CBF did not correlate with indices of cholesterol (TG, LDL, HDL), 
inflammation (CRP), obesity (BMI) or renal function. 
 
3.5.6.2 Hyperaemic myocardial blood flow 
Of the ‘traditional’ measures of aortic distensibility, both AA and DDA were strongly 
associated with hCBF (Figure 3.8); AA, R2 0.391 (p < 0.0001); and DDA, R2 0.410 (p 
< 0.0001).  PDA remained strongly associated although this was more modest than the 
others, R2 = 0.282 (p < 0.0001). After adjusting for age and gender the relationships 
remained statistically significant at all levels (p<0.01). 
Thoracic aortic distensibility was strongly related to hCBF R2 0.409 (p < 0.0001) and 
after adjustment for age and gender, remained significant (p < 0.01). 
Hyperaemic CBF did not correlate with indices of cholesterol (TG, LDL, HDL), 
inflammation (CRP), obesity (BMI) or renal function. A modest, inverse correlation 
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FIGURE 3.8 Resting and hyperaemic CBF versus aortic distensibility 
at (a) AA, (b) PDA, (c) DDA and (d) TA. Differences between the slopes 
of rCBF and hCBF lines were all p < 0.001. Adjusted R2 values (rCBF 
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3.5.6.3 Myocardial perfusion reserve 
All levels of aortic distensibility were strongly associated with MPR (Figure 3.9): AA, 
R2 0.487 (p < 0.001); PDA, R2 0.421 (p < 0.001); DDA, R2 0.517 (p < 0.001); and TA 
R2 0.497 (p < 0.001). All of these relationships remained highly statistically significant 
after adjustment for age and gender (p<0.001) (Table 3.4). 
Myocardial perfusion reserve did not correlate with indices of cholesterol (TG, LDL, 
HDL), inflammation (CRP), obesity (BMI) or renal function.  
Modest, inverse correlations were observed between MPRI and both SBP (r = -0.345, 
p = 0.011) and PP (r = -0.425, p = 0.001). 
 
 
 rMBF hMBF MPR 
Unadjusted      
AA 0.481 (<0.001) 0.625 (<0.001) 0.681 (<0.001) 
PDA 0.529 (<0.001) 0.531 (<0.001) 0.649 (<0.001) 
DDA 0.525 (<0.001) 0.641 (<0.001) 0.719 (<0.001) 
TA 0.526 (<0.001) 0.639 (<0.001) 0.751 (<0.001) 
Adjusted    
AA 0.433 (0.002) 0.561 (<0.001) 0.622 (<0.001) 
PDA 0.479 (<0.001) 0.452 (0.001) 0.586 (<0.001) 
DDA 0.458 (0.001) 0.582 (<0.001) 0.675 (<0.001) 
TA 0.465 (0.001) 0.578 (<0.001) 0.710 (<0.001) 
 
TABLE 3.4 Correlation coefficients between coronary blood flow and indices 
of arterial stiffness (r value with p value in brackets). rCBF adjusted for age 








  Chapter 3: Non-invasive proof of concept 
 127 
 
FIGURE 3.9. Myocardial perfusion reserve versus 
aortic distensibility at (a) AA, (b) PDA, (c) DDA and )d) 
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3.5.6.4 Effect of arterial stiffness on degree of hyperaemic response 
As described earlier (see Chapter 2), the aorto-coronary relationship between aortic 
distensibility, rMBF and hMBF is demonstrated in Figure 3.8. Across all levels of 
measured aortic distensibility, these slopes converge as arterial stiffness increases, i.e. 
a stiffer aorta confers a reduced hyperaemic response to adenosine. Statistically this is 
confirmed by a significant difference in the slopes of each line across all four levels 
when both were corrected for age and gender, p<0.0001. 
 
3.5.7 Repeatability  
Twenty consecutive studies were subjected to post-processing interobserver 
repeatability analysis. This was performed by another experienced observer (SD) 
blinded to the initial result and the outcome from distensibility analysis. 
Intra-class coefficients were 0.96 for MPR, 0.83 for rMBF and 0.91 for hMBF. 
Bland-Altman analysis demonstrated consistent levels of agreement across the 
spectrum of measures: MPR bias -0.02 ± 0.16 (95%CI -0.32 – 0.29); rMBF bias -0.04 




















FIGURE 3.10 Bland-Altman analysis of inter-observer 
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3.6 DISCUSSION 
To the best of our knowledge this study confirms for the first time the relationship 
between myocardial blood flow and aortic distensibility using CMR-derived indices.  
 
Myocardial perfusion and arterial stiffness 
Confirming our earlier invasive proof of concept, myocardial blood flow was again 
correlated with aortic distensibility at all measured levels. The regression coefficients 
were more robust for hMBF than they were for rMBF suggesting large artery stiffness 
has only a minor role in governing resting blood flow but may be a significant 
determinant of hyperaemic flow. Similar results were reported by Nemes et al. who 
have utilised transoesophageal echocardiography to evaluate both diastolic coronary 
flow velocities and aortic distensibility simultaneously (Nemes et al. 2007). In a study 
of 55 subjects, there was a moderate association with hyperaemic coronary flow (r -
0.41, p < 0.01), a modest relationship with CFVR (r -0.21, p < 0.01) and a trend with 
resting coronary flow velocity (r -0.16, p = 0.23). 
In our study, the strongest observed relationship was between aortic distensibility and 
MPR.  This measure, analogous to CFVR, indexes to baseline myocardial blood flow 
and may provide a more physiological relevant measure of aortic reservoir function, 
as a measure of capacity to increase flow from baseline.  
 
Feasibility and repeatability. 
Of the subjects who were able to tolerate the CMR-PI scan, quantitative analysis was 
technically possible on the vast majority of subjects (85%). Although time consuming 
at >2 hours per patient for MBF, the analysis yielded comparable values to those 
observed in other similar studies (Cheng et al. 2008; Papanastasiou et al. 2016). Bland-
Altman analysis revealed minimal interobserver bias and standard deviations of 
repeated observations were within clinically relevant boundaries of <0.2mL/min/g for 
rMBF, and <0.3mL/min/g for hMBF.  Bland-Altman analysis of MPR demonstrated 
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high levels of repeatability with a low standard deviation and the tightest confidence 
intervals of all three indices. This is likely to result from the simplicity of the formula 
which is a quotient of slopes as opposed to a signal-intensity time curve which 
undergoes mathematical constraint and is sensitive to noise (Lee, DC & Johnson 
2009).  
 
Hyperaemic response to adenosine  
As expected from the exclusion criterion, all individuals in the study had a normal 
response to adenosine with MPR values >1.5. As observed in the invasive proof of 
concept, the convergence of blood flow curves at the lower values of distensibility 
support the notion that a stiff aorta has less capacity to increase flow in response to a 
hyperaemic stimulus. Synchronous microvascular dysfunction remains a potential 
alternate, or at least contributing explanation for this observed phenomenon.  
Subjects with the stiffest aortas had perfusion reserve values which approached the 
threshold for an ischaemic diagnosis (1.1 to 1.5 in the literature (Barmeyer et al. 2007; 
Nagel et al. 2003)). Given clinically indicated CMR-PI scans are subject to only visual 
inspection for a perfusion defect, these changes would not be detected unless 
quantitative analysis is performed. In this setting, a reduction in MPR may be evidence 
of global hypoperfusion. A recent study utilising CMR-PI demonstrated a reduced 
global MPR in high coronary risk individuals with non-obstructive epicardial disease 
compared to normal controls (Zorach et al. 2018). The conclusion was that of 
underlying microvascular disease although a key contributor to this phenomenon could 
also be reduced aortic reservoir capacity. Hypothetically, a completely rigid aorta 
(with a theoretical distensibility of 0) would near approximate a hypo-perfused MPR 
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Validation of ‘thoracic aorta’ distensibility 
We have described for the first time, the utility of a ‘thoracic aorta’ distensibility which 
can be evaluated in patients undergoing routine cardiac structure and function 
examinations. Predictably, the values obtained were closely related to the anatomical 
‘neighbours’ on the aorta, AA and PDA. The standard ‘VLA’ sequence is acquired as 
part of initial planning and transected the aortic arch at a perpendicular plane in >90% 
of our subjects making this suitable for distensibility analysis. Of note, our initial pilot 
work had suggested up to 25% of patients would have oblique transection and thus be 
excluded. The younger mean age of this cohort may have resulted in less ‘unwinding’ 
of the arch and thus a greater proportion having a perpendicular plane through the 
aorta. Although the dedicated sequences can be acquired quickly if desired, analysis 
of the VLA sequence would facilitate evaluation of distensibility on patients who have 
had clinically indicated structure and function scans and have had a brachial blood 
pressure measured shortly before or after. 
 
Limitations 
Although post-processing repeatability was performed, test-retest agreement was not. 
This would have been preferable however would have involved a re-exposure to 
gadolinium in individuals who have been given a ‘normal’ test result. This was felt to 
be unethical. Other studies in this space have shown intra-class coefficients of between 
0.80 and 0.89 with repeatability performed approximately 3 months apart (Goykhman 
et al. 2012). In a test-retest scenario, co-efficients of variation were 5% (R = 0.94) for 
non-ischaemic and 9% (R = 0.93) for ischaemic segments suggesting overall excellent 
reproducibility (Chih et al. 2010). 
The post-processing time required for quantification of myocardial blood flow is 
significant. Approximately 20 minutes is required to trace the endo- and epicardial 
tracings per slice and thus with three slices, 60 minutes per time point and a total of 2 
hours for rest and stress imaging. The mathematical manipulation is a further 20 
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minutes per study and thus this is not a technique which is ready for clinical 
application. The development of semi-automated techniques, however, will generate 
significant reductions in processing time, and will facilitate its expansion into the 
clinical arena. 
As described above, although the relationship between distensibility and measures of 
perfusion was linear, it is impossible to exclude not only diffuse coronary disease as 
these individuals did not proceed to angiography, nor underlying endothelial 
dysfunction and microvascular disease as a cause of reduced hyperaemic flow. 
There is some uncertainty in the literature as to whether 140microg/kg/min is an 
adequate dose of adenosine to induce maximal hyperaemia (Karamitsos et al. 2010). 
Local protocols dictate that adenosine is administered through a large bore cannula via 
an antecubital vein and symptoms of hyperaemia documented. In this cohort, the vast 
majority of patients reported at least one symptom of hyperaemia with a significant 
change in mean rate-pressure product. Although it is possible some subjects 
experienced a submaximal hyperaemic response, the independent predictors for this 
are those with LV dysfunction and age >65, the former being an exclusion for this 
study and less than a quarter of our study being > 65 years of age. 
 
Conclusion 
This is the first study to utilise CMR derived indices of both myocardial blood flow 
and aortic distensibility to evaluate the aorto-coronary relationship. In this cohort, 
aortic distensibility correlated strongly with both hyperaemic MBF and MPR 
although only modestly with resting MBF.
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4.2 ABSTRACT 
Background: The links between large artery function and myocardial blood flow have 
been previously established either with invasive techniques, or in ‘normal’ cohorts. 
We sought to evaluate the aorto-coronary relationship using cardiovascular magnetic 
resonance perfusion imaging (CMR-PI) and aortic distensibility in subjects with 
demonstrable perfusion defects and corresponding significant lesions at angiography.   
Methods: The CMR-PI database at the Royal Adelaide Hospital was used to identify 
subjects with a single perfusion defect and corresponding angiography. Aortic 
distensibility was evaluated from standard planning sequences as previously 
described. Myocardium was divided into equi-angular segments and adjudicated as 
‘ischaemic’ or ‘non-ischaemic’ based on angiography findings. Resting and 
hyperaemic blood flow (rMBF, hMBF) as well as myocardial perfusion reserve (MPR) 
were obtained from the signal-intensity time curves. 
Results: Of the 3,729 CMR-PI studies performed, 229 had a single reversible 
perfusion defect ratified at angiography, with a complete set of perfusion and 
distensibility data available for 86 subjects. Mean age was 67.1 ± 9.8 years. The 
majority of lesions were in the LAD (49%) with a total of 507 ‘ischaemic’ and 1041 
‘non-ischaemic’ segments analysed. Aortic distensibility correlated in ischaemic and 
non-ischaemic myocardium, respectively; rMBF (R2 0.154 and 0.107, p < 0.01); 
hMBF (R2 0.292 and 0.258, p < 0.01) and MPR (R2 0.483 and 0.504, p < 0.001). 
Conclusion: The similar aorto-coronary regression coefficients suggests large arterial 
stiffness continues to govern myocardial blood flow despite critical epicardial disease. 
The linear reduction in myocardial blood flow observed with increasing aortic stiffness 
not only provides a mechanism for amplifying the functional significance of a 
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4.3 INTRODUCTION 
Arterial stiffness is now an established, independent predictor of adverse 
cardiovascular outcomes (Ben-Shlomo et al. 2014). This has been shown in a number 
of cohorts including otherwise ‘healthy’ individuals (Mattace-Raso et al. 2006; 
Mitchell et al. 2010; Willum-Hansen et al. 2006), hypertensives (Boutouyrie et al. 
2002; Laurent et al. 2001; Terai et al. 2008) and in those with both established chronic 
kidney (Blacher et al. 2002; Pannier et al. 2005) and coronary artery disease (Kaneko 
et al. 2013). The basis for the strength of this predictive capacity, however, remains 
mechanistically unclear.  
 
Although its neurological and renal sequelae are well described (O'Rourke & Safar 
2005), given its deleterious effects on both sides of the myocardial supply-and-demand 
equation, there may be a central, coronary component to its predictive strength. With 
a stiffer aorta, the pulse wave travels faster and returns earlier in the cardiac cycle. It’s 
arrival in systole increases afterload on the left ventricle driving compensatory left 
ventricular hypertrophy and increases myocardial oxygen demand.  The earlier pulse 
wave arrival negates diastolic ‘augmentation’ thereby reducing the trans-coronary 
pressure gradient at the level of the aorta, putatively reducing flow to the myocardium.  
 
Recent studies (Leung et al. 2006), including our own (unpublished, Chapters 2 and 
3), have shown a stiffer aorta is associated with reduced resting coronary blood flow 
but critically results in a blunted response to hyperaemia, even in relatively ‘normal’ 
coronary arteries. In the context of epicardial disease, the inability to increase flow as 
observed in aortic stiffness, may render a fixed stenosis functionally more significant. 
Supportive evidence comes from Kingwell et al. (Kingwell et al. 2002) who 
demonstrated a number of measures of large artery stiffness to be independent 
predictors of ischaemic threshold on treadmill testing. 
  Chapter 4: Arterial stiffness and ischaemic myocardium 
 141 
We aimed to evaluate whether the relationship between arterial stiffness and coronary 
blood flow continued to hold in both ischaemic and non-ischaemic myocardium as 
assessed with cardiac magnetic resonance perfusion imaging (CMR-PI) in patients 




4.4.1.1 CMR database 
The study was approved by the Human Research Ethics Committee at the Royal 
Adelaide Hospital. Since its establishment in 2008, The Royal Adelaide Hospital is 
home to one of the largest CMR departments in Australia and performs close to 1500 
studies per year.  For a number of years, it was the sole provider of adenosine and 
dobutamine stress CMR studies in South Australia, Northern Territory and large parts 
of western New South Wales and Victoria making it a quaternary referral centre for 
CMR. The CMR department maintains a prospectively collected database of 
indications, baseline clinical characteristics and results of all scans undertaken for both 
research and clinical purposes.  
 
4.4.1.2 Inclusion criteria 
The Royal Adelaide Hospital CMR database was queried for stress imaging scans from 
2008 until 2016. This was subsequently narrowed to CMR-PI and then to all those 
reported as having a ‘reversible perfusion defect’. 
As part of local protocol, all patients abstained from caffeine and xanthine-containing 
products for at least 24 hours prior to scanning. 
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4.4.1.3 Exclusion criteria  
In order to obtain a cohort of patients whose myocardium could be dichotomised into 
‘ischaemic’ or ‘non-ischaemic’ for comparison, other contributors to abnormal 
myocardial blood flow were excluded. From a patient characteristic perspective, those 
with a documented history of established coronary disease (angina, history of 
myocardial infarction, prior revascularisation) or severe valvular disease were 
excluded. Patients with evidence of late gadolinium enhancement (e.g. scar), left 
ventricular systolic dysfunction (LVEF < 50%) or multiple perfusion defects – 
matched or reversible – were excluded.  
In order to confirm the veracity of the reversible perfusion defect, those who a) did not 
have angiography at the Royal Adelaide Hospital, b) were medically managed upfront 
or c) had evidence of < 50% visual angiographic stenosis at angiography (false 
positive) were excluded. Given the complexity of hibernating myocardial blood flow 
in chronically occluded territories (Cheng et al. 2008; Selvanayagam et al. 2005), 
chronic total occlusions (evidence of collateralisation) were also excluded. 
 
4.4.1.4 Demographics 
Prescribed medications and risk factors were collected at time of CMR.  Risk factors 
were defined as cigarette smoking (previously or currently smoking tobacco), 
hypercholesterolemia (use of cholesterol-lowering therapy or total cholesterol level > 
5.2 mmol/L), hypertension (blood pressure > 140/90mmHg or on medical 
antihypertensive therapy or subject to lifestyle intervention), obesity (BMI > 30kg/m2), 
diabetes (plasma haemoglobin A1c > 6.5%, or on glycaemic medications), and family 
history of cardiovascular disease (index event in a first-degree relative, male ≤ 55 years 
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4.4.2 Cardiac magnetic resonance protocol 
All cardiovascular magnetic resonance (CMR) studies were performed utilising the 
Siemens Avanto 1.5 Tesla magnetic resonance imaging scanner (Siemens Medical 
Imaging, Erlangen, Germany) located within the Cardiovascular Investigation Unit of 
the Royal Adelaide Hospital. All CMR studies were performed with subjects in a 
supine position with a phased-array surface coil positioned over the thorax.  
 
4.4.2.1 Cardiac structure and function 
Methods for evaluating left ventricular structure and function are covered in Chapter 
2. In brief, short-axis slices from the mitral annulus to and inclusive of the left 
ventricular apex were acquired during expiratory breath hold. 
Offline analysis was performed to evaluate LV size and function utilizing proprietary 
software (Argus software, Siemens Medical Imaging, Erlangen, Germany). 
Endocardial contours were manually traced at end-diastole (start of R-wave) and at 
end-systole (visually smallest cavity). End-systolic and end-diastolic volumes were 
obtained and thus left ventricular ejection fraction could be calculated. 
 
4.4.2.2 Aortic distensibility  
Methods for evaluating aortic distensibility from already acquired cardiac structure 
and function studies is covered in detail in Chapter 3. In brief, the vertical long axis 
(VLA) planning image transects the aorta at the level of the arch between the 
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Aortic distensibility was evaluated offline by manually tracing aortic cross-sectional 
images at the level of the ‘thoracic aorta’ (TA).  Major and minor axes were drawn on 
each VLA image and if the ellipticity index was <0.9 (minor/major), the patient was 
excluded from the study. Maximal and minimal lumen areas were calculated and 





The baseline heart rate (HR), systolic blood pressure (SBP) and diastolic blood 
pressure (DBP) taken at commencement of CMR imaging was used for distensibility 
calculation. The pulse pressure was calculated from the difference between the systolic 
and diastolic blood pressures and measured in mmHg. The aortic areas were measured 
in mm2 and after multiplying by 1000, aortic distensibility is reported in its final unit 
of 10-3mmHg-1. 
 
4.4.2.3 CMR perfusion imaging  
4.4.2.3.1 Adenosine infusion protocol 
As per local protocol, a physician with a cardiac defibrillator was present for all stress 
perfusion imaging. All patients received adenosine (AdenoScan, Sanofi-Aventis, 
Surrey, UK) at a dose of 140µg/kg/min using a precise syringe pump (Graesby 3500, 





aortic area at end systole (mm2) – aortic area at end diastole (mm2) 
brachial pulse pressure (mmHg) x aortic area at end diastole (mm2) 
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4.4.2.3.2 Image acquisition 
CMR perfusion imaging acquisition has been covered in detail in Chapter 3. In brief, 
during the last minute of the adenosine infusion, the gadolinium-based contrast agent, 
Magnevist, (dimeglumine gadopentetate, Bayer, Leverkusen, Germany) was 
administered. Perfusion imaging was performed with a T1-weighted fast low-angle 
single shot gradient echo (GRE) sequence and was acquired every cardiac cycle during 
first pass. Perfusion images were obtained at three short axis planes - basal, mid and 
apical levels - of the left ventricle (Cerqueira et al. 2002). 
Haemodynamic data was acquired at five-minutely intervals throughout the adenosine 
protocol and recorded. 
 
4.4.2.3.3 Visual analysis 
Confirmation of the clinically documented perfusion defect was performed by an 
experienced observer (KST, AJN) blinded to the original report. Rest and stress 
perfusion and the late gadolinium enhancement images of three short axis sections 
(base, mid and apex) were viewed side by side. If the signal intensity on stress 
perfusion appeared lower in an area of myocardium for at least three dynamic images 
compared with remote myocardium, it was confirmed to be ischaemic (Ingkanisorn et 
al. 2006). If the same signal intensity abnormality was seen in the rest and stress 
perfusion images and there was no evidence of scar on late contrast enhanced images, 
the defect was considered an artefact and the patient excluded. Similarly, if the 
perfusion defect lasted for less than three dynamic images, it was also considered 
artefactual and the subject was excluded (Ingkanisorn et al. 2006).  
 
4.4.2.3.4 Semi-quantitative analysis 
Following visual confirmation, semi-quantitative analysis was undertaken. The 
endocardial and epicardial contours of three short axis sections (base, mid and apex) 
were traced (QMASS, v7 .2, Medical Imaging Solutions, Leiden, Netherlands) and 
  Chapter 4: Arterial stiffness and ischaemic myocardium 
 146 
corrected manually for displacements (e.g. breathing). As per Figure 4.1, each short 
axis slice was divided into six equiangular segments in a clockwise manner beginning 
at the anteroseptal insertion of the right ventricle (Barmeyer et al. 2007). Segments 
were then assigned to coronary territories according to the 18-segment model of the 
American Society of Echocardiography (Lang et al. 2015). Segments 1, 2 and 6 were 
assigned to the left anterior descending (LAD); 2,3 and 4 to the left circumflex (LCx) 
and segments 4 and 5 to the right coronary artery (RCA). Within each section, signal 
intensity was measured by defining regions of interest that excluded the inner 10% and 
outer 30% of the myocardium to get stronger weighting of the subendocardium 
(Figure 4.2) and reduce influence from the LV as previously described (Nagel et al. 
2003).  
 
The subendocardial signal intensity-time curves were generated for all segments by 
obtaining signal intensity on consecutive images before and during arrival of contrast 
material. The signal intensity-time curve for the left ventricle was generated on the 
basal section as a measure of input function (Figure 4.3). The maximal initial upslope 
of every signal intensity-time curve was determined by using a sliding window with a 
four- point linear fit for the myocardium and a three-point linear fit for the left ventricle 
















FIGURE 4.1. Representative figure of 6 equi-angular 
segments at basal (a), mid (b) and apical (c) levels. 
Segments 1 (anterior), 2 (anterolateral) and 6 
(anteroseptal) were assigned to the LAD; 2 (anterolateral), 
3 (lateral) and 4 (inferior) to the LCx and segments 4 











FIGURE 4.2 Representative figure of basal level perfusion 
sequences acquired at rest (a-c) and hyperaemic (d-f) phases. 
Earlier images (a,d) compared with later images (c,f) 
demonstrating contrast enhancement from blood pool to 
myocardium progressively. Perfusion defect noted at peak 














FIGURE 4.3 Signal intensity-time curve by region. Segments 
4 (inferior) and 5 (inferoseptal) demonstrate reduced velocity 
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4.4.2.3.5 Quantitative analysis 
Myocardial Blood Flow (MBF) was determined in each equiangular section and then 
averaged per coronary territory in mL/min/g. This was performed by deconvolution of 
the signal intensity time curves constrained to a Fermi function using an arterial input 
from the left ventricular blood pool signal, specifically accounting for any delay in the 
arrival of the tracer (Jerosch-Herold et al. 2004; Jerosch-Herold et al. 2002; Jerosch-
Herold et al. 2000; Selvanayagam et al. 2005). This was performed on both rest and 
stress images to generate resting MBF (rMBF) and hyperaemic MBF (hMBF). As 
basal CBF is closely related to the rate-pressure product (RPP) (Czernin et al. 1993), 
an index of myocardial oxygen consumption, values for basal flow in each subject 
were corrected for the respective RPP. This was performed by multiplying rMBF by 
the mean RPP of the cohort, divided by the RPP in the individual patient (Uren, Melin, 
et al. 1994). 
For each of the 18 segments, myocardial perfusion reserve (MPR) was calculated by 
dividing the maximal upslope value at stress over rest. Although multiple cut-offs exist 
in the literature, an MPR of 1.5 achieves a >90% sensitivity for detecting ischaemia 
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4.4.3 Quantitative coronary angiography 
Angiography films for each patient were obtained.  Analysis of all angiography films 
were de-identified and analysed without knowledge of the CMR results. 
Quantitative coronary angiography (QCA) was performed on end-diastolic frames 
using orthogonal views.  Where orthogonal views obtained at time of clinically driven 
angiography were inadequate to accurately perform QCA, patient was excluded. As 
per previously published methods (Goodhart & Anderson 1998; Zeiher et al. 1991), 
reference diameter, lesion length and minimal luminal diameter were measured using 
proprietary software (CMS software, Medis Corp, Leiden). The lesion diameter was 
then generated in a semi-automated manner at the interpolation line between the 
normal segments proximal and distal to the stenosis (de Feyter et al. 1991; Garrone et 




FIGURE 4.4 Representative image of a coronary angiogram 





  Chapter 4: Arterial stiffness and ischaemic myocardium 
 152 
4.4.4 Linkage of CMR and angiography findings 
Based on QCA evidence of the presence and location of a lesion, each of the 18 
myocardial segments were dichotomized as either ‘ischaemic’ or ‘non-ischaemic’. i.e. 
if mid LAD was stenosed, mid and apical segments 1, 2 and 6 were determined to be 
‘ischaemic’ (i.e. a total of 6 ischaemic and 12 non-ischaemic segments). ‘Ischaemic’ 
and ‘non-ischaemic’ averages for rMBF, hMBF and MPR were calculated on a per 
patient level. 
 
4.4.5 Statistical Analysis 
Baseline characteristics are represented as mean ± standard deviation where normally 
distributed, or median and interquartile range (IQR) for parameters with non-Gaussian 
distribution.  
The relationship between continuous variables was determined by simple linear 
regression, and adjustment for age and gender was by partial correlation. Analysis of 
covariance was used when both continuous and categorical variables were present. 
Statistical significance was defined as a two-sided p<0.05.  Statistical analyses were 
performed using SPSS statistical software (v24, IBM SPSS, New York, USA) and 
graphs were drawn using GraphPad Prism 7 (GraphPad Software, La Jolla California 
USA).  
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4.5 RESULTS 
4.5.1 Sample  
For a detailed cohort build, see Figure 4.5.  Of the 3,729 CMR-PI studies evaluated, 
344 had reversible perfusion defects. From there, 105 were excluded on the basis of 
multiple perfusion defects, LV dysfunction or evidence of late gadolinium 
enhancement. A further ten were of insufficient image quality to undertake 
quantitative analysis. After linking with medical history, a further 62 subjects were 
unable to be paired with angiography data. After angiography, nine patients were 
excluded with evidence of a chronic total occlusion, 15 had false positive scans and 
28 had false negative CMR-PI scans. After successful CMR-PI analysis, a further 19 
were unable to have distensibility analysis due to either poor image quality or being 
off plane/eccentric. The final sample consisted of 86 patients with CMR-PI, 











































FIGURE 4.5 Cohort build 
FIGURE 4.5 Cohort build 
 
Adenosine CMR-PI studies 
(n = 3,729) 
Excluded: 
• ‘Normal’ (n = 3,142) 
• Fixed perfusion defect (n = 172) 
• Rim artefact (n = 71) 
 
CMR-PI, distensibility  
and follow up 
(n = 86) 
Reversible perfusion defect 
(n = 344) 
Excluded: 
• Imaging grounds: 
o Poor image quality (n = 10) 
• Subject characteristics: 
o Late gadolinium enhancement (n = 66) 
o LV dysfunction (n = 31) 
o Multiple perfusion defects (n = 8) 
 
Quantitative analysis 
(n = 229) 
Excluded: 
• No follow up invasive angiography: 
o Refused invasive investigation (n = 1) 
o Initial medical management (n = 20) 
o Angiography performed externally (n = 37) 
o Insufficient imaging for QCA (n = 4) 
• CTO (n = 9) 
• Incorrect MRI findings: 
o False positive 
§ Incorrect territory (n = 13) 
§ Lesion < 50% (n = 2) 
o False negative 
§ Multi-vessel disease (n = 21) 
§ Left main (n = 7) 
• Distensibility not obtainable: 
o VLA off plane (n = 19) 




The clinical characteristics of the cohort are listed (Table 4.1).  The majority of patients 
were male (n = 54, 63%) with a mean age of 67 ± 9.8 years. As expected, the majority 
of patients were referred through with chest pain for investigation (91%) with only a 
few reporting ‘dyspnoea’ as their presenting complaint (9%). The most prevalent risk 
factors were hypertension (84%) and dyslipidaemia (79%) with nearly half of patients 
diagnosed with diabetes (47%). The overall population was relatively high risk with 
close to two thirds having three or more traditional risk factors (64%). The most 
commonly prescribed medication was an ACE or an ARB (72%) followed by aspirin 
(69%). Just over half were on a statin (56%) and although nearly 50% were diagnosed 













































Clinical characteristic Cohort 
Mean age ± SD [years] 67 ± 9.8 
Male sex – no. (%) 54 (63) 
Stress test indication – no. (%)  
Chest pain for investigation 79 (91) 
Dyspnoea for investigation 7(8) 
Mean BMI ± SD [kg/m2] 27.7 ± 6.6 
Risk factors – no. (%)  
Family history 26 (30) 
Cigarette smoking 39 (45) 
Hypertension 72 (84) 
Dyslipidaemia 68 (79) 
Diabetes 40 (47) 
≥ 3 risk factors 55 (64) 
Medications – no. (%)  
Aspirin  59 (69) 
ACE/ARB 61 (72) 
Statin 48 (56) 
Diuretic 21 (24) 
Calcium channel blocker 36 (41) 
Beta blocker 38 (44) 
Insulin 4 (5) 
OHG 14 (16) 
 
TABLE 4.1 Clinical characteristics. Abbreviations: BMI – body mass 
index; ACEi – angiotensin converting enzyme inhibitor; ARB – 
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Laboratory investigations (Table 4.2) revealed normal kidney function and 
haemoglobin. Lipid profile overall was reasonable for a cohort without established 
CVD and with less than half treated with a statin: mean LDL 2.5 ± 1.1mmol/L, mean 





Laboratory characteristics Cohort 
Lipid profile ± SD [mmol/L]  
Total cholesterol 5.3 ± 1.5 
Triglycerides 1.8 ± 1.1 
LDL-C 2.5 ± 1.1 
HDL-C 1.2 ± 0.4 
Hb ± SD [mg/dL] 135 ± 14 
eGFR [mL/min/1.73m2] 78 ± 10 
 
TABLE 4.2 Laboratory characteristics. Abbreviations: LDL – low-density 
lipoprotein; HDL – high density lipoprotein; Hb – haemoglobin; eGFR – 
estimated glomerular filtration rate 
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4.5.3 Cardiac Structure and Function 
All subjects had normal left ventricular cavity size (LVEDV 122.9 ± 32.6mL. 
Reference ranges: males 115-198mL; females 88-168mL) and systolic function 
(LVEF 69.9 ± 7.1%. Normal range: 58-76%) (Maceira et al. 2006). 
Left ventricular mass was within normal limits (LV mass 104.1 ± 23.5g. Reference 
ranges: males 108-184g; females 72-144g). 
 
4.5.4 Aortic distensibility 
Aortic distensibility was reduced consistent with increased arterial stiffness in this 
cohort. Although there are no established ‘reference’ ranges for our TA level, the mean 
of this cohort, (2.34 ± 0.82·10-3mmHg-1) is reduced compared to the ‘normal’ CMR-
PI cohort of Chapter 3 (3.23 ± 1.64·10-3mmHg-1). This is consistent with the overall 
increased burden of traditional vascular risk factors and hitherto unknown, presence 
of CAD in this cohort. 
 
 
4.5.5 Coronary artery evaluation 
Coronary angiography metrics are listed (Table 4.3). The majority of patients had a 
right-dominant circulation (94%). All lesions were severe with a mean stenosis of 81 
± 6.9% by QCA. All lesions were treated, the majority with percutaneous coronary 
intervention (98%) with two patients undergoing coronary artery bypass grafting due 


















Coronary characteristics Value 
Right dominant circulation - no. (%) 81 (94) 
Ischaemic vessel – no. (%)  
LAD 42 (49) 
LCx 15 (17) 
RCA 29 (34) 
Quantitative coronary angiography - Mean ± SD  
Minimal lumen diameter [mm] 0.75 ± 0.5 
Reference diameter [mm] 3.23 ± 0.7 
Stenosis [%] 81 ± 14.7 
Mean stenosis length [mm] 17.8 ± 6.1 
Treatment of lesion – no. (%)  
Stent  83 (97) 
POBA 1 (1) 
CABG 2 (2) 
 
TABLE 4.3 Coronary characteristics. Abbreviations: LAD – left anterior 
descending; LCx – left circumflex; RCA – right coronary artery; POBA – 
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4.5.6 CMR perfusion imaging 
Only 3% of the population with single perfusion defects had inadequate image quality 
to perform quantitative perfusion analysis. This is less than expected in view of the 
highly selected nature of the cohort from which rim artefacts and non-diagnostic scans 
had already been excluded. 
The majority of patients reported at least one symptom of hyperaemia (n = 81, 94%), 
e.g. flushing, headache, dyspnoea, chest tightness.  
After linking location of ischaemic lesion with subtended segments, there were 507 
‘ischaemic’ segments’ and 1041 ‘non-ischaemic’ segments.  
 
4.5.6.1 Myocardial blood flow 
Resting myocardial blood flow was significantly lower in the ischaemic compared to 
non-ischaemic segments (0.80 ± 0.14 vs. 1.06 ± 0.19mL/min/g, p < 0.0001). 
Hyperaemic myocardial blood flow was significantly lower in the ischaemic compared 
to the non-ischaemic segments (1.05 ± 0.27 vs. 3.34 ± 0.81mL/min/g, p < 0.0001). 
 
4.5.6.2 Myocardial perfusion reserve 
As expected from the visual perfusion defect, MPR was significantly lower in the 



































FIGURE 4.6 Ladder plot of resting and hyperaemic MBF. 






































CMR Variables Mean ± SD 
Baseline haemodynamics  
SBP [mmHg] 151 ± 19 
DBP [mmHg] 83 ± 13 
PP [mmHg] 67 ± 16 
HR [bpm] 73 ± 12 
Cardiac structure and function  
LVEDV [mL] 122.9 ± 32.6 
LVESV [mL] 38.7 ± 17.8 
LVEF [%] 69.9 ± 7.1 
LV mass [g] 104.1 ± 23.5 
Aortic distensibility [10-3mmHg-1] 2.34 ± 0.82 
Stress perfusion imaging  
Resting RPP 9004 ± 2355 
Stress RPP 12630 ± 3025 
Segments analysed  
Ischaemic  507 
Non-ischaemic 1041 
 
TABLE 4.3 CMR variables. Abbreviations: SBP – systolic blood pressure; 
DBP – diastolic blood pressure; PP – pulse pressure; HR – heart rate; 
LVEDV – left ventricular end-diastolic volume; LVESV – left ventricular 
end-systolic volume; LVEF – left ventricular ejection fraction; AA – 
ascending aorta; PDA – proximal descending aorta; DDA – distal 
descending aorta; TA – thoracic aorta; RPP – rate-pressure product. 
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4.5.7 Associations with indices of myocardial perfusion 
4.5.7.1 Resting myocardial blood flow 
There was an overall modest correlation between rMBF and aortic distensibility. 
Comparing ischaemic and non-ischaemic myocardium, a stronger relationship was 
observed between rMBF and aortic distensibility in ischaemic segments (R2 0.207, p 
<0.0001) compared with non-ischaemic segments (R2 0.113, p = 0.0015). 
After adjusting for age and gender, relationships remained statistically significant, 
although the strength of the association weakened (Table 4.4). 
Resting MBF did not correlate with indices of cholesterol (TG, LDL, HDL), measures 
of obesity (BMI) or renal function (GFR).  
 
4.5.7.2 Hyperaemic myocardial blood flow 
There was a strong correlation observed between hMBF and aortic distensibility. 
Comparing ischaemic and non-ischaemic myocardium, a stronger relationship was 
observed between hMBF and aortic distensibility in ischaemic segments (R2 0.367, p 
<0.0001) compared with non-ischaemic segments (R2 0.319, p = 0.0015). After 
adjusting for age and gender, these relationships remained statistically significant with 
minimal weakening of the association (Table 4.4).  
Neither ischaemic or non-ischaemic hMBF correlated with indices of cholesterol (TG, 
LDL, HDL), measures of obesity (BMI) or renal function (GFR). 
Weak correlations were observed between ischaemic hMBF and both SBP (r -0.234 
0.032) and PP (r -0.266, p = 0.013) although not DBP (r -0.027 p = 0.8). 
Similarly, weak correlations were observed between non-ischaemic hMBF and both 
SBP (r -0.283, p = 0.009) and DBP (r -0.231, p = 0.035) but not PP (r -0.178, p = 0.1) 
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4.5.7.3 Myocardial perfusion reserve 
A strong correlation was observed between MPR and aortic distensibility. Relatively 
similar agreement was observed between aortic distensibility and MPR in both 
ischaemic (R2 0.483, p < 0.0001) and non-ischaemic (R2 0.504, p < 0.0001) 
myocardium.  
Corrected for age and gender, these relationships held with minimal change in the 
strength of the association (Table 4.4). 
Neither ischaemic or non-ischaemic MPR correlated with indices of cholesterol (TG, 
LDL, HDL), measures of obesity (BMI) or renal function (GFR). 
Weak correlation was observed between MPR and both SBP (r -0.228, p = 0.037) and 
PP (r -0.296, p = 0.006) although not with DBP (r 0.014, p = 0.9)  
 
 
 rMBF hMBF MPR 
 I NI I NI I NI 
Unadjusted         











Adjusted       












TABLE 4.4 Correlation between myocardial blood flow and MPR with aortic 
distensibility (r value with p value below). rCBF, hCBF and MPR adjusted for 


















FIGURE 4.7 Relationship between both resting and hyperaemic MBF in ischaemic (a 
– c) and non-ischaemic (d - f) myocardium. Significant differences in slopes between 
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4.5.7.4 Diabetic subgroup 
Given the propensity for abnormal microvascular function in diabetic patients, a pre-
specified analysis was performed in the 40 subjects diagnosed with diabetes. With the 
adjustments for age and gender, similar associations were observed between aortic 
distensibility and CMR-PI indices. In ischaemic segments, the relationships were as 
follows; rMBF (R2 0.381, p = 0.012); hMBF (R2 0.450, p = 0.004) and MPR (R2 0.513, 
p = 0.001). In non-ischaemic segments, the relationships were as follows; rMBF (R2 
0.338, p = 0.021); hMBF (R2 0.573, p < 0.001) and MPR (R2 0.674, p < 0.001).  
 
4.5.7.5 Impact of stenosis severity 
Although dichotomised into ‘ischaemic’ and ‘non-ischaemic’ on the grounds of an 
angiographically significant lesion and subtended perfusion territory, stenosis severity 
is a continuous variable. In univariate analysis however, stenosis percentage did not 
correlate with rMBF (r -0.256, p = 0.31), hMBF (r -0.123, p = 0.36) or MPR (r -0.184, 
p = 0.47). Moreover, when adjusted for in regression analysis between indices of 
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4.6 DISCUSSION 
This is the first study to compare the interaction between aortic stiffness and 
myocardial perfusion in ‘ischaemic’ and ‘non-ischaemic’ myocardium using magnetic 
resonance imaging.  
 
Hyperaemic response to adenosine 
A less distensible aorta conferred a reduced hyperaemic response to adenosine in both 
‘ischaemic’ and ‘non-ischaemic’ territories. This is evidenced by convergence of the 
flow curves at the lower values of distensibility. Of particular interest in the ischaemic 
cohort is that the slopes of resting and hyperaemic flow intersect at a distensibility 
value above zero. This would imply the potential for values of hyperaemic flow that 
are at, or potentially below, resting flow in the least distensible aortas. A reduction in 
hyperaemic flow is described in coronary ‘steal’ phenomenon (Akinboboye et al. 
2001) whereby adjacent non-ischaemic territories draw blood away from ischemic 
myocardium. This phenomenon is driven by a reduction in microvascular resistance 
generated by dilation of intact, non-ischaemic microvasculature, particularly in the 
context of collateral vessels (angiographically visible or not). Extending this 
observation, the near complete loss of aortic reservoir capacity in individuals with the 
least distensible aortas may render ischaemic territories at greater vulnerability 
through complete reliance on autoregulatory control of flow. Although maximal 
hyperaemia with adenosine is felt to be supraphysiological, this provides an additional 
theoretical basis for a reduction in ischaemic threshold proposed by Kingwell et al. 
(Kingwell et al. 2002). A key alternate explanation is that a less distensible aorta may 
be a marker for more diffuse coronary disease which could generate a graded reduction 
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Arterial stiffness vs. ischaemic and non-ischaemic perfusion 
The regression between rMBF and hMBF with aortic distensibility was similar 
throughout the myocardium although numerically more constant and robust in the 
‘ischaemic’ territories. A similar trend was described by Leung et al. and suggests 
arterial stiffness may be a more consistent determinant of blood flow in the context of 
significant epicardial disease where other contributors to MBF are exhausted, or fully 
compensated. Percentage stenosis in our cohort did not correlate with rMBF, nor did 
it affect the relationship with stiffness after adjustment in the regression analysis. It is 
possible that given the majority of this cohort had ‘severe’ stenoses, further curvilinear 
reduction in flow would have been difficult to detect. Moreover, such small 
incremental change is probably at the limits of measurement for both QCA (a 2D 
approximation for a 3D process) and CMR-PI.  
 
A less distensible aorta was associated with reduced overall absolute myocardial blood 
flow as evidenced by the ongoing, linear aorto-coronary relationship in both 
‘ischaemic’ and ‘non-ischaemic’ myocardium. This is consistent with the findings of 
Chapter 3 in subjects with normal myocardial perfusion. Applied clinically, a 
reduction in overall myocardial blood flow has the potential to extend ischaemia in 
watershed territories and may provide a mechanistic basis to the association between 
aortic stiffness and the development of collateral formation (Baykan et al. 2015; de 
Marchi 2014).  
 
Although more broadly spread, the slope of the aorto-coronary regression in the ‘non-
ischaemic’ territory was steeper suggesting a greater reduction in MBF for each 
stepwise reduction in distensibility. This flattening of the ‘ischaemic’ curve may 
reflect a threshold of the aorto-coronary relationship’s contribution to blood flow in 
the context of an already maximally dilated microcirculation from a critical epicardial 
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stenosis. A broader cohort of subjects with moderate and severe epicardial disease with 
greater hyperaemic potential may allow further graded, delineation of this relationship.  
Performance of quantitative assessment 
Quantitative analysis of myocardial blood flow was possible in the vast majority of 
studies with <5% excluded on imaging grounds. This is significantly better 
performance than could be expected in an unselected population as equivocal findings 
and rim artefacts were already excluded upstream and are a common cause of false 
positive results. Similarly, those with claustrophobia or intolerance to the CMR 
chamber would not have completed their study and thus wouldn’t have been recorded 
in the database.  
 
Implications 
An intervention to reduce arterial stiffness may facilitate an increase in hyperaemic 
myocardial blood flow. Traditionally this has not been a target for anti-anginal agents 
although conceivably a rightward shift on this curve could increase the anginal 
threshold in patients with either diffuse or non-revascularisable coronary disease. 
Evaluating the performance of agents not only on arterial stiffness indices but its 
relationship with myocardial blood flow may allow greater insights into which are 
more likely to have specific anti-ischaemic benefit. The ability to use CMR-PI as a 
‘one stop shop’ to evaluate both parameters simultaneously would make this an 
attractive modality for clinical trials, particularly if able to semi-automate the 
quantitative analysis. The protocol in this study required gadolinium which, although 
generally safe, is not completely without risk. Risk of gadolinium deposition (mainly 
cutaneous and cerebral) is increased in populations with chronic and acute kidney 
disease although has been described in those with preserved renal function in the 
context of repeated administration (Layne et al. 2018). With over 10 million contrast 
enhanced MRI scans performed globally, mainly for musculoskeletal and neurological 
indications, this will need surveillance and may ultimately limit widespread and 
  Chapter 4: Arterial stiffness and ischaemic myocardium 
 170 
repeated examinations. Of growing interest, therefore, is the ability to perform blood 
flow measurements without contrast using a technique called ‘arterial spin labelling’ 
(Wacker et al. 2003; Zhang et al. 2005). This technique has been extensively employed 
in cerebral blood flow studies (Detre et al. 2009), and ultimately may provide similar 
information and obviates the concerns surrounding gadolinium (Zun et al. 2011).  
 
Limitations 
Compared to our earlier work, and that of Leung et al., the strength of the relationship 
between stiffness and MBF, even in the ‘non-ischaemic’ or normal territories, was less 
robust. Although carefully traced and planimetered, the equiangular nature of 
myocardial segmentation results in some territories containing both ischaemic and 
non-ischaemic myocardium. This may have affected the strength of the observed 
signal.  Similarly, the acquisition of three slices through the LV, although standard for 
CMR-PI, is only a representative estimate of the total myocardium. Superior results 
for quantitative assessment have recently been seen with contemporary 3D techniques 
although at present these remain labour intensive (Motwani et al. 2014).  
 
This cohort was highly selected to include patients with demonstrable perfusion 
defects and a lesion confirmed at angiography. Using the presence of a visual perfusion 
defect as the entrance point of this study will have excluded a number of patients with 
hypoperfusion evident only on quantitative analysis. The presence of a visual 
perfusion defect in our study seemed to select a cohort with severe angiographic 
stenosis (mean 81%).  Two patients from 227 were reported to have a visual perfusion 
defect and were subsequently excluded as there was no obvious corresponding 
stenosis. Post hoc exploratory analysis in these two patients however, revealed normal 
quantitative myocardial perfusion measures suggesting an error of visual analysis 
only. To extend the hypothesis that more diffuse or non-severe lesions may subtend 
ischaemic myocardium with stiffer aortas would require analysis of visually ‘normal’ 
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CMR-PI scans and a subsequent evaluation for coronary artery disease, likely CT 
coronary angiography, in those with abnormal scans. With semi-automated 
techniques, this analysis will be possible in the future. 
 
Conclusion 
This is the first study to demonstrate the relationship between aortic stiffness and both 
ischaemic and non-ischaemic myocardial perfusion indices using cardiovascular 
magnetic resonance. Aortic stiffness appears to have a more significant contribution 
to resting and hyperaemic blood flow in ischaemic compared to non-ischaemic 
myocardium. In this highly selected cohort, percentage stenosis was of a severe to 
critical nature in most patients and was not associated with rMBF or hMBF.
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5.2 ABSTRACT 
Background: Large artery stiffness has been associated with both a reduction in 
myocardial perfusion and an increase in myocardial oxygen demand. The impact of 
increased arterial stiffness on blood flow within ‘infarct’ and ‘non-infarct’ 
myocardium following ST elevation myocardial infarction (STEMI) is unknown. 
Methods: Subjects underwent cardiovascular magnetic resonance on day three and 
day ninety post primary percutaneous coronary intervention for STEMI. Left 
ventricular myocardium was dichotomised into ‘infarct’ or ‘non-infarct’. Aortic 
distensibility (AD), resting and hyperemic blood flow (rMBF, hMBF) and myocardial 
perfusion reserve (MPR) were obtained from first pass perfusion imaging. Myocardial 
injury was evaluated by infarct size (IS) and microvascular obstruction (MVO) using 
delayed enhancement sequences, in addition to creatine kinase levels. 
Results: Twenty-seven subjects (mean age 59.7 ± 10 years, male 89%) were recruited. 
LAD infarcts were most common (41%) with cohort peak creatine kinase 2282 ± 
1520units/L. Smoking was prevalent (59%) although only 22% had > 2 traditional risk 
factors. Baseline left ventricular ejection fraction was 44.7 ± 9.9%. MVO was present 
in 25 subjects (mean area 534 ± 493mm2) with mean cohort IS 26.9 ± 10.8%. Mean 
cohort AD was 3.59 ± 1.52·10-3mmHg-1. In both ‘infarct’ and ‘non-infarct’ 
myocardium at early imaging, AD was associated with hMBF (R 0.547 and 0.557 
respectively, p < 0.01) and MPR (R 0.626 and 0.578 respectively, p < 0.01). These 
relationships remained similar at three months. There was no relationship between AD 
and rMBF at either time point. On multivariate analysis (IS, MVO, creatine kinase), 
AD independently predicted late MPR in the ‘infarct’ territory, and was associated 
with change in MPR from baseline (R 0.44, p = 0.02). 
Conclusion:  A stiff aorta was associated with reduced early and late hyperemic 
response to adenosine in both the ‘infarct’ and ‘non-infarct’ myocardium. On 
multivariate analysis, AD was independently associated with change in MPR from 
baseline.  
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5.3 INTRODUCTION 
An evolving body of evidence now supports increased arterial stiffness as a key risk 
factor for cardiovascular events. The mechanisms behind this association appear to be 
driven by both increased cardiac work and resultant left ventricular hypertrophy, but 
potentially also through a reduction in coronary blood flow.  
 
Initially described in animal models of aortic banding, an increase in arterial stiffness 
resulted in a widening of pulse pressure, an augmentation of systolic pressure and a 
reduction in coronary perfusion pressure, particularly at the subendocardial level 
(Ohtsuka et al. 1994; Watanabe et al. 1992). In humans, Leung et al. (Leung et al. 
2006) subsequently demonstrated that although resting coronary blood flow was at 
least partially governed by large arterial mechanics, the hyperaemic response to 
adenosine both pre and post successful percutaneous coronary intervention (PCI) was 
significantly reduced in a stiff aorta. Others have shown a relationship between pulse 
wave velocity, a surrogate of arterial stiffness, and both echo (Saito et al. 2008) and 
invasive measures of coronary flow velocity reserve (Fukuda et al. 2006). 
 
Our group has recently demonstrated the utility of cardiac magnetic resonance imaging 
to evaluate the relationship between aortic stiffness and myocardial perfusion. This 
technique is non-invasive, radiation-free and can provide near simultaneous 
assessment of both parameters. Chapter 3 (normal subjects) and Chapter 4 (subjects 
with established symptomatic stable coronary artery disease) confirmed a strong 
relationship between arterial stiffness and both resting and hyperaemic myocardial 
blood flow. Moreover, the relationship appeared to strengthen in ischaemic territories 
suggesting arterial stiffness may have a more dominant governance of blood flow 
under these conditions. 
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As described in Chapter 1, myocardial blood flow is tightly controlled by 
autoregulatory microvascular function. Post myocardial infarction, the 
microvasculature is often compromised, either through distal embolisation or oedema 
generated prior to or during PCI. Patients with reduced hyperaemic blood flow 
following revascularisation have worse functional and clinical outcomes (Ibanez et al. 
2015; Wakatsuki et al. 2000). Recent animal model and human studies have shown 
reduced coronary flow velocity reserve in both infarct and non-infarct territories and 
have ascribed this to microvascular dysfunction. Other invasive studies post infarct 
have shown increased microcirculatory resistance (Ahn et al. 2016) in infarct 
territories consistent with microvascular dysfunction. 
 
We hypothesised that the aorto-coronary relationship is likely to be overwhelmed by 
both local and systemic contributors to blood flow early but may have returned by 
three months. We hypothesised that a stiff aorta may mitigate improvement in 
hyperaemic flow following successful revascularisation as described in the stable 
setting by Leung et al. We sought to evaluate the aorto-coronary relationship in 
patients who have recently sustained a ST segment elevation myocardial infarction 
(STEMI). We evaluated these patients at baseline (within three days) and again at three 
month follow up to see how this relationship evolved and its interaction with indices 














The study was approved by the Human Research Ethics Committee at the Royal 
Adelaide Hospital. As part of a larger study (Wong et al. 2012), subjects with acute 
STEMI who underwent primary angioplasty between April 2009 and July 2011 were 
prospectively recruited.  As part of the larger trial, participants underwent CMR 
perfusion (CMR-PI) and delayed enhancement (CMR-DE) imaging on day three and 
again at three months. A retrospective analysis was performed on individuals who 
participated at both time points. 
 
5.4.1.2 Inclusion criteria 
STEMI was defined as chest pain for at least 30 minutes and an ECG demonstrating 
ST-segment elevation of >0.1mV in two or more contiguous leads.  CMR imaging was 
acquired at both day three and again at three months post STEMI.  Vasoactive 
medications were not withheld in view of clinical indication. Patients had abstained 
from caffeine and xanthine-containing products for at least 24 hours prior to scanning 
as per local protocol.  
 
5.4.1.3 Exclusion criteria  
Exclusion criteria included atrial fibrillation/flutter, aortopathy (history of 
intervention, dissection or aneurysm), CMR chamber incompatibility (pacemakers, 
aneurysm clips, claustrophobia), pre-existing LV systolic dysfunction (LVEF < 45%), 
severe valvular heart disease, severe airways disease (chronic obstructive pulmonary 
disease or asthma on inhalers), renal impairment (estimated glomerular filtration rate 
< 30 mL/min/1.73m2) or atrioventricular nodal disease (Grade II or higher) were 
excluded. 
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Patients were excluded from the retrospective analysis if there was a prior history of 
established ischaemic heart disease, evidence of reversible ischaemia in a non-culprit 
territory or if aortic distensibility measurements could not be obtained. 
 
5.4.1.4 Demographics 
Discharge medications from index hospitalisation and risk factors were recorded.  Risk 
factors were defined as cigarette smoking (previously or currently smoking tobacco), 
hypercholesterolemia (use of cholesterol-lowering therapy or total cholesterol level > 
5.2 mmol/L), hypertension (blood pressure > 140/90mmHg or on medical 
antihypertensive therapy or subject to lifestyle intervention), obesity (BMI > 30kg/m2), 
diabetes (plasma haemoglobin A1c > 6.5%, or on glycaemic medications), and family 
history of cardiovascular disease (index event in a first-degree relative, male ≤ 55 years 
and female ≤ 60 years).  
 
5.4.1.5 STEMI characteristics 
As part of the larger study (Wong et al. 2012) evaluating novel predictors of functional 
outcome post STEMI, clinically relevant metrics around the STEMI hospitalisation 
were recorded. These included peak creatine kinase (CK), door-to-balloon time and 
pain-to-balloon time. 
 
5.4.2 Cardiac magnetic resonance protocol 
All CMR studies were performed utilizing the Siemens Avanto 1.5 Tesla magnetic 
resonance imaging scanner (Siemens Medical Imaging, Erlangen, Germany) located 
within the Cardiovascular Investigation Unit of the Royal Adelaide Hospital. All CMR 
studies were performed with subjects in a supine position with a phased-array surface 
coil positioned over the thorax.  
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5.4.2.1 Cardiac structure and function 
Methods for evaluating left ventricular structure and function are covered in Chapter 
2. In brief, short-axis slices from the mitral annulus to and inclusive of the left 
ventricular apex were acquired during expiratory breath hold. 
Offline analysis was performed to evaluate LV size and function utilizing proprietary 
software (Argus software, Siemens Medical Imaging, Erlangen, Germany). 
Endocardial contours were manually traced at end-diastole (start of R-wave) and at 
end-systole (visually smallest cavity). End-systolic and end-diastolic volumes were 
obtained and thus left ventricular ejection fraction could be calculated. 
 
5.4.2.2 Aortic distensibility  
Methods for evaluating aortic distensibility from already acquired cardiac structure 
and function studies is covered in detail in Chapter 3. In brief, the vertical long axis 
(VLA) planning image transects the aorta at the level of the arch between the 
previously described levels of the ‘Ascending Aorta’ and ‘Proximal Descending 
Aorta’.  
Aortic distensibility was evaluated offline by manually tracing aortic cross-sectional 
images at the level of the ‘thoracic aorta’ (TA).  Major and minor axes were drawn on 
each VLA image and if the ellipticity index was <0.9 (minor/major), the patient was 
excluded from the study. Maximal and minimal lumen areas were calculated and 







aortic area at end systole (mm2) – aortic area at end diastole (mm2) 
brachial pulse pressure (mmHg) x aortic area at end diastole (mm2) 
 
  Chapter 5: Arterial stiffness and infarct myocardium 
 183 
The baseline heart rate (HR), systolic blood pressure (SBP) and diastolic blood 
pressure (DBP) taken at commencement of CMR imaging was used for distensibility 
calculation. The pulse pressure was calculated from the difference between the systolic 
and diastolic blood pressures and measured in mmHg. The aortic areas were measured 
in mm2 and after multiplying by 1000, aortic distensibility is reported in its final unit 
of 10-3mmHg-1. 
 
5.4.2.3 CMR Perfusion Imaging (CMR-PI) 
5.4.2.3.1 Adenosine infusion protocol 
As per local protocol, a physician with a cardiac defibrillator was present for all stress 
perfusion imaging. All patients received adenosine (AdenoScan, Sanofi-Aventis, 
Surrey, UK) at a dose of 140µg/kg/min using a precise syringe pump (Graesby 3500, 
Minneapolis, Minnesota, USA) via a cannula in the antecubital vein. 
 
5.4.2.3.2 Image acquisition 
CMR perfusion imaging acquisition has been covered in detail in Chapter 3. In brief, 
during the last minute of the adenosine infusion, the gadolinium-based contrast agent, 
Magnevist (dimeglumine gadopentetate, Bayer, Leverkusen, Germany), was 
administered. Perfusion imaging was performed with a T1-weighted fast low-angle 
single shot gradient echo (GRE) sequence and was acquired every cardiac cycle during 
first pass. Perfusion images were obtained at three short axis planes - basal, mid and 
apical levels - of the left ventricle (Cerqueira et al. 2002). 
Haemodynamic data was acquired at five-minutely intervals throughout the adenosine 
protocol and recorded. 
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5.4.2.3.3 Myocardial blood flow and perfusion reserve 
The endocardial and epicardial contours of three short axis sections (base, mid and 
apex) were traced (QMASS, v7 .2, Medical  Imaging Solutions, Leiden, Netherlands) 
and corrected manually for displacements (e.g. breathing). Each short axis slice was 
divided into six equiangular segments in a clockwise manner beginning at the 
anteroseptal insertion of the right ventricle (Barmeyer et al. 2007). 
Segments were then assigned to coronary territories according to the 18-segment 
model of the American Society of Echocardiography (Lang et al. 2015). Segments 1, 
2 and 6 were assigned to the left anterior descending (LAD); 2,3 and 4 to the left 
circumflex (LCx) and segments 4 and 5 to the right coronary artery (RCA). Within 
each section, signal intensity was measured by defining regions of interest that 
excluded the inner 10% and outer 30% of the myocardium to get stronger weighting 
of the subendocardium and reduce influence from the LV as previously described 
(Nagel et al. 2003) (Figures 4.1 and 4.2). 
 
The subendocardial signal intensity-time curves were generated for all segments by 
obtaining signal intensity on consecutive images before and during arrival of contrast 
material. The signal intensity-time curve for the LV was generated on the basal section 
as a measure of input function (Figure 4.3). The maximal initial upslope of every 
signal intensity-time curve was determined by using a sliding window with a four- 
point linear fit for the myocardium and a three-point linear fit for the LV as previously 
described (Al-Saadi et al. 2000).  
 
Myocardial Blood Flow (MBF) was determined in each equiangular section and then 
averaged per coronary territory in mL/min/g. This was performed by deconvolution of 
the signal intensity time curves (Selvanayagam et al. 2005) constrained to a Fermi 
function using an arterial input from the left ventricular blood pool signal, specifically 
accounting for any delay in the arrival of the tracer (Jerosch-Herold et al. 2004; 
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Jerosch-Herold et al. 2002; Jerosch-Herold et al. 2000). This was performed on both 
rest and stress images to generate resting MBF (rMBF) and hyperaemic MBF (hMBF). 
As resting MBF is closely related to the rate-pressure product (RPP) (Czernin et al. 
1993), an index of myocardial oxygen consumption, values for basal flow in each 
subject were corrected for the respective RPP. This was performed by multiplying 
rMBF by the mean RPP of the cohort, divided by the RPP in the individual patient 
(Uren, Melin, et al. 1994). 
For each of the 18 segments, myocardial perfusion reserve (MPR) was calculated by 
dividing the maximal upslope value at stress over rest.  
Segments were denoted as ‘infarct’ or ‘non-infarct’ based on angiography findings and 
corresponding, subtended CMR segments.  
 
5.4.2.3.4 Myocardial injury assessment 
As part of our hypothesis, microvascular obstruction and larger infarct size may impact 
on coronary blood flow, and thus, aorto-coronary relationships. Although the larger 
study evaluated a number of procedural, invasive and non-invasive indices of 
myocardial injury (Wong et al. 2012), we evaluated only late gadolinium enhancement 
images for infarct size and microvascular obstruction (MVO). Although there are a 
number of sequences and techniques, our group and operators have experience in this 
metric. 
 
Delayed enhancement (CMR-DE) imaging was obtained by acquiring an inversion-
recovery segmented gradient echo T1 weighted sequence 15 minutes after the second 
contrast dose. The parameters were as follows: echo time (TE) 3.32ms; flip angle = 
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Infarct size 
Validated initially in the chronic phase of MI, delayed hyperenhancement has been 
shown to correlate well with fibrosis and be a marker of irreversible injury (Kim, RJ 
et al. 2000). In the acute phase, different pulse sequence parameters, timing of imaging 
post contrast administration and varied planimetry methods have traditionally resulted 
in overestimation of infarct size compared to necropsy studies (Saeed et al. 1999). 
Moreover, myocardial oedema may contribute to hyperenhancement in the absence of 
overt cell necrosis (Judd et al. 1995; Lima et al. 1995). In this study infarct size was 
determined in a semi-automated manner using the ‘full width at half the maximum 
(FWHM) criterion’ which has been validated against necropsy data (R = 0.94, 
p<0.0001) (Amado et al. 2004). In brief, this is performed by identifying a region of 
hyperenhancement and selecting a ‘seed’ or bright point. Using proprietary QMASS 
software (Medis, Leiden, Netherlands), this seed point is extended to all pixels with 
signal intensity of greater than 50% in all short axis slices. The maximum signal 
intensity inside this region is then determined, and the final infarct size is defined as 
the area with a signal intensity 50% above the maximum of the initial region. Infarct 
size was calculated at both time points as well as a ‘change’ in infarct size. 
 
Microvascular obstruction 
Microvascular obstruction was defined on LGE as regions of subendocardial 
hypoenhancement within a hyperenhanced region (Hombach et al. 2005). These were 
manually delineated on the short axis images using QMASS and summed together to 














FIGURE 5.1. Late gadolinium enhancement short axis (a) and 
vertical long axis (b) images demonstrating near transmural 
hyperenhancement in LAD territory – representative image 
analysis in (a) enhanced with orange; image (b) included for 
comparison in the VLA plane. Hypoenhanced ‘lakes’ of 
microvascular obstruction shown in both (a) and (b) with arrows. 
Myocardial perfusion imaging at rest (c) and stress (d) showing 
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5.4.3 Statistical Analysis 
Baseline characteristics are represented as mean ± standard deviation where normally 
distributed, or median and IQR for parameters with non-Gaussian distribution.  
The relationship between continuous variables was determined by simple linear 
regression, and adjustment for additional variables was by partial correlation. Analysis 
of covariance was used when both continuous and categorical variables were present.  
Comparisons of mean values between groups were by paired t-test or by ANOVA. 
Multiple linear regression was performed to determine predictors of late infarct 
territory MPR. Given the sample size, four variables with p<0.2 were included in 
regression model. Statistical significance was defined as a two-sided p<0.05.  
Statistical analyses were performed using SPSS statistical software (v24, IBM SPSS, 
New York, USA) and graphs were drawn using GraphPad Prism 7 (GraphPad 
Software, La Jolla California USA).  
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5.5 RESULTS 
5.5.1 Sample  
For a detailed cohort build, see Figure 5.2. Of the 61 patients recruited for the larger 
study, 11 did not participate in the CMR sub-study due to claustrophobia or limiting 
image quality. Of the 50 patients who underwent ‘early’ CMR (day 3 ± 1.5 days), 
seven had evidence of reversible ischaemia in a non-culprit territory, six withdrew 
consent and three had a relative contraindication to gadolinium with an eGFR ≤ 
30ml/min/1.73m2. Four patients had oblique imaging for aortic distensibility and a 
further two had inadequate quality ‘late’ CMR studies. This left a total of 27 




The clinical characteristics of the cohort are listed (Table 5.1).  The majority of patients 
were male (n = 24, 89%) with a mean age of 59.7 ± 10 years.  
Overall the population had a paucity of vascular risk factors with less than one quarter 
diagnosed with three or more traditional risk factors. The most prevalent risk factors 
were smoking (59%) followed by hypertension (44%) and dyslipidaemia (37%).  
Consistent with STEMI guidelines, all patients were treated with aspirin and a P2Y12 
inhibitor and the vast majority on statins and either an angiotensin converting enzyme 
(ACE) inhibitor or angiotensin receptor blocker (ARB). 
With regards to infarct characteristics, there were equal numbers of LAD and RCA 
events (n = 11) with the remainder occurring in the main body of the LCx. Infarct sizes 
were modest by CK measure and likely secondary to a combination of short pain-to-


































Recruited STEMI patients, day 3 
(n = 61) 
Excluded: 
• Imaging grounds: 
o Poor image quality (n = 1) 
§ Atrial fibrillation (n = 2) 
• Claustrophobia (n = 8) 
 
Completed ‘early’ CMR-PI + DE 
(n = 50) 
Excluded: 
• Reversible perfusion defect [non-culprit] (n = 7) 
• Withdrew consent for follow up study (n = 6) 
• Distensibility sequence oblique (n = 3) 
• Gadolinium (relatively) contraindicated 
o Reduction in GFR (n = 3) 
 
Completed ‘late’ CMR-PI + DE 
(n = 31) 
Excluded: 
• Imaging grounds 
o Poor image quality (n = 2) 
o Distensibility sequence oblique (n = 2) 
‘early’ + ‘late’ CMR-PI,  
DE + AD 
(n = 27) 







Clinical characteristic Cohort 
Mean age ± SD [years] 59.7 ± 9.6 
Male sex – no. (%) 24 (89) 
Mean BMI ± SD [kg/m2] 28.4 ± 8.2 
Risk factors – no. (%)  
Family history 4 (15) 
Cigarette smoking 16 (59) 
Hypertension 12 (44) 
Dyslipidaemia 10 (37) 
Diabetes 4 (15) 
≥ 3 risk factors 6 (22) 
Discharge medications – no. (%)  
Aspirin  27 (100) 
P2Y12 inhibitor 27 (100) 
ACE/ARB 25 (93) 
Statin 25 (93) 
Beta blocker 19 (70) 
Coronary anatomy  
Right dominant circulation - no. (%) 25 (93) 
Infarct related vessel – no. (%)  
LAD 11 (41) 
LCx 5 (19) 
RCA 11 (41) 
Infarct characteristics  
CK peak – Mean ± SD (units/L) 2282 ±1520 
Time - Median ± SD (mins)  
Door-to-balloon 82 ± 56 
Pain-to-balloon 228 ± 173 
TIMI flow pre - mean ± SD 0.9 ± 0.8 
TIMI flow post - mean ± SD 2.8 ± 0.4 
 
TABLE 5.1 Clinical and infarct characteristics. Abbreviations: P2Y12 
inhibitor (clopidogrel or ticagrelor); LAD – left anterior descending 
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Laboratory investigations (Table 5.2) revealed normal kidney function and 
haemoglobin. Baseline lipid profile overall revealed a mildly elevated LDL and mildly 
reduced HDL.   
 
 
Laboratory characteristics Cohort 
Lipid profile ± SD [mmol/L]  
Total cholesterol 5.3 ± 1.8 
Triglycerides 1.8 ± 1.2 
LDL-C 3.2 ± 1.5 
HDL-C 0.9 ± 0.5 
Hb ± SD [mg/dL] 136 ± 11 
eGFR [mL/min/1.73m2] 76 ± 13 
 
TABLE 5.2 Laboratory characteristics. Abbreviations: LDL – low-density 
lipoprotein; HDL – high density lipoprotein; Hb – haemoglobin; eGFR – 
estimated glomerular filtration rate 
 
 
5.5.3 Cardiac Structure and Function 
Subjects at ‘early’ CMR had mild systolic dysfunction (LVEF 44.7 ± 9.9%) which by 
‘late’ imaging at three months had improved to be low-normal (LVEF 50.9 ± 9.8%). 
This was driven by a numerical improvement in end-systolic volume  (84.4 ± 21.4 vs. 
72.9 ± 27.8mL). Left ventricular mass was within normal limits with no significant 
interval change between time points (LV mass 151.7 ± 34.9g. Reference ranges: Males 
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5.5.4 Aortic distensibility 
5.5.4.1 Overall measures 
Aortic distensibility was overall preserved in this cohort and was comparable to our 
‘normal’ cohort in Chapter 3 (3.59 ± 1.52 vs. 3.23 ± 1.64·10-3mmHg-1). This is 
consistent with the low burden of traditional vascular risk factors and a younger cohort 
age consistent with other contemporary STEMI studies (Berwanger et al. 2018). There 
was a small numerical reduction in distensibility between time points which did not 
reach statistical significance.  
 
5.5.5 CMR Perfusion imaging 
CMR perfusion imaging was well tolerated with majority of patients reporting at least 
one symptom of hyperaemia (e.g. flushing, headache, dyspnoea, chest tightness). 
There was no limiting hypotension or AV block. After correlating angiographic lesion 
location and subtended myocardium, there were 168 ‘infarct’ segments’ and 318 ‘non-
infarct’ segments. 
 
5.5.5.1 Myocardial blood flow 
Early rMBF was numerically less in the ‘infarct’ compared to ‘non-infarct’ segments 
although this did not reach statistical significance (0.88 ± 0.21 vs. 0.95 ± 
0.19mL/min/g, p = 0.210). In response to adenosine infusion at the early time point, 
hMBF was significantly lower in the ‘infarct’ compared to the ‘non-infarct’ segments 
(1.15 ± 0.32 vs. 1.51 ± 0.34mL/min/g, p < 0.001). 
By late imaging, the difference in rMBF in ‘infarct’ and ‘non-infarct’ segments had 
widened with both a reduction and increase in respective territories (0.80 ± 0.17 vs. 
1.11 ± 0.22mL/min/g, p <0.0001). Although hMBF had improved in both territories, 
late hMBF remained significantly higher in ‘non-infarct’ compared to ‘infarct’ 
segments (1.38 ± 0.32 vs. 2.74 ± 0.56mL/min/g, p <0.0001) 
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5.5.5.2 Myocardial perfusion reserve 
At the early time point, MPR was significantly lower in the ‘infarct’ compared to the 
‘non-infarct’ segments (1.21 ± 0.29 vs. 1.68 ± 0.40, p < 0.001). By late imaging, 
although MPR had improved in the ‘infarct’ territory, the ‘non-infarct’ territory 
remained significantly higher (1.58 ± 0.35 vs. 2.58 ± 0.57, p < 0.001).   
 
 
FIGURE 5.3 Ladder plots of resting and hyperaemic MBF at 
early (top) and late (bottom) time points. Infarct segments in 
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5.5.6 Myocardial injury 
The majority of patients had evidence of microvascular obstruction (n = 25, 93%) with 
a mean area of 534 ± 493mm2. Infarct size at baseline was 26.9 ± 10.8%, although by 
three months this had improved to 20.6 ± 9.3% (p < 0.001) at repeat imaging. 
 
 
 Early (3 days) 
Late 
(90 days) P value 
Resting haemodynamics    
SBP [mmHg] 137 ± 27 135 ± 19 0.846 
DBP [mmHg] 82 ± 17 81 ± 13 0.939 
PP [mmHg] 54 ± 13 53 ± 16 0.944 
HR [bpm] 68 ± 10 71 ± 9 0.415 
Cardiac structure and function    
LVEDV [mL] 150.9 ± 27.1 153.6 ± 42.8 0.211 
LVESV [mL] 84.4 ± 21.4 72.9 ± 27.8 0.061 
LVEF [%] 44.7 ± 9.9 50.9 ± 9.8 0.036 
LV mass [g] 151.7 ± 34.9 143.4 ± 29.5 0.218 
Aortic distensibility [10-3mmHg-1] 3.59 ± 1.52 3.47 ± 1.74 0.973 
Infarct size – [%] mean ± SD 26.9 ± 10.8 20.6 ± 9.3 <0.001 
MVO area – [mm2] ± SD 534 ± 493 -  
Stress perfusion imaging    
Resting RPP 9457 ± 2929 9814 ± 1910 0.598 
Stress RPP 12060 ± 3305 11681 ± 2913 0.201 
Infarct territory    
rMBF [mL/min/g] 0.88 ± 0.21 0.80 ± 0.17 0.007 
hMBF [mL/min/g] 1.15 ± 0.32 1.38 ± 0.31 0.001 
MPR 1.21 ± 0.29 1.58 ± 0.35 <0.001 
Non-infarct territory    
rMBF [mL/min/g] 0.95 ± 0.19 1.11 ± 0.22 <0.001 
hMBF [mL/min/g] 1.51 ± 0.34 2.74 ± 0.56 <0.001 
MPR 1.68 ± 0.40 2.58 ± 0.57 <0.001 
 
TABLE 5.3 CMR perfusion imaging and delayed enhancement outcomes. 
Abbreviations: SBP – systolic blood pressure; DBP – diastolic blood pressure; PP – 
pulse pressure; HR – heart rate; LVEDV – left ventricular end diastolic volume; left 
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5.5.7 Arterial stiffness and myocardial perfusion 
5.5.7.1 Myocardial blood flow 
There was no relationship between rMBF and distensibility in either ‘infarct’ or ‘non-
infarct’ territories at either early or late time points (Figure 5.4, grey dashed lines). 
At the early time point, hMBF (after correction for age and gender) was related to 
aortic distensibility in both ‘infarct’ (R2 0.299, p = 0.004) and ‘non-infarct’ territories 
(R2 0.310, p = 0.003) with equal strength (Figure 5.4, top panels). At the late time 
point however, hMBF was more strongly related to aortic distensibility in the ‘non-
infarct’ territories (R2 0.456, p < 0.001) than the ‘infarct’ territories (R2 0.338, p = 
0.001), although both were statistically significant (Figure 5.4, bottom panels).   
 
5.5.7.2 Myocardial perfusion reserve 
After correcting for age and gender, MPR was linearly correlated with measures of 
aortic distensibility at both early and late time points in both ‘infarct’ and ‘non-infarct’ 
territories (Figure 5.5): early ‘infarct’ R2 0.470 (p = 0.001); late ‘infarct’ R2 0.530 (p 
< 0.001), early ‘non-infarct’ R2 0.334 (p = 0.002); late ‘non-infarct’ R2 0.345 (p = 
0.002).   
 
 rMBF hMBF MPR 
 I NI I NI I NI 



























TABLE 5.4 Correlations at early and late time points between myocardial blood flow 
and MPR with aortic distensibility. I = infarct, NI = non-infarct (r value with p value 
below in parentheses). Bold denotes a significant relationship. rCBF adjusted for age 
















FIGURE 5.4 Relationships between indices of myocardial perfusion and aortic 
distensibility. ‘Infarct’ territories shown on left, ‘non-infarct’ territories on right. 
Early time point, above, late time point, below. 


















FIGURE 5.5 Relationship between MPR and aortic distensibility 
in ‘infarct’ (orange) and ‘non-infarct’ (black) territories at early 
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5.5.7.3 Stiff versus compliant 
In a pre-defined exploratory analysis, to further evaluate the impact of arterial stiffness 
on these measures, the cohort was divided into ‘stiff’ and ‘compliant’ at the mean 
value of aortic distensibility (Figure 5.6). At the early time point in ‘infarct’ territories, 
a stiff aorta was associated a blunted response to adenosine evidenced by reduced 
hMBF (0.97 ± 0.29 vs. 1.31 ± 0.26mL/min/g, p = 0.004) and MPR (1.06 ± 0.21 vs. 
1.36 ± 0.28, p = 0.004). Although there was a numerical difference between rMBF in 
stiff and compliant aortas, this did not reach statistical significance (0.83 ± 0.16 vs. 
0.94 ± 0.18mL/min/g, p = 0.124). By the late time point, the was no relationship with 
rMBF, however the association with hMBF remained (1.21 ± 0.25 vs. 1.52 ± 
0.36mL/min/g, p = 0.026). Although the MPR had improved in ‘infarct’ territories, a 
stiff aorta remained linked to reduced MPR (1.31 ± 0.20 vs. 1.82 ± 0.36 p <0.001). 
In ‘non-infarct’ territories, a stiff aorta was associated with reduced hMBF (1.38 ± 
0.25 vs. 1.64 ± 0.37mL/min/g, p = 0.049) and MPR (1.43 ± 0.27 vs. 1.92 ± 0.39, p = 
0.001) although did not affect rMBF (1.01 ± 0.16 vs. 0.90 ± 0.20mL/min/g, p = 0.133).  
In the ‘non-infarct’ territories however, a stiffer aorta was more strongly associated 
with hMBF (2.34 ± 0.31 vs. 3.11 ± 0.50mL/min/g, p < 0.001) and MPR (2.22 ± 0.38 
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FIGURE 5.6 Effect of a stiff vs. compliant aorta in both infarct 
and non-infarct territories, on rMBF (top), hMBF (middle) and 
MPR (bottom). *denotes significance <0.05, ** denotes 
significance <0.001 
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5.5.8 Other predictors of myocardial perfusion 
We sought to evaluate markers of myocardial injury which may impact on MBF and 
alter the aorto-coronary relationship.  
In the 24 individuals with MVO, at the early time point in ‘infarct’ territories, MVO 
area correlated with MPR (R -0.489, p = 0.021), and although demonstrating a trend, 
was not significantly associated with either rMBF (R -0.381, p = 0.181) or hMBF (R 
-0.348, p = 0.11). At the late time point, baseline MVO area again was associated with 
MPR (R -0.481, p = 0.023), although the trend with hMBF weakened (R -0.273, p = 
0.21) and was not present with rMBF (R -0.110, p = 0.6).  
Early (R 0.422, p = 0.049) and late infarct size (R 0.456, p = 0.033) correlated with 
MVO area, however there was no association with rMBF, hMBF or MPR.   
Peak CK also correlated with MVO area (R 0.494 p = 0.019), although not infarct size. 
With respect to myocardial perfusion, peak CK correlated with early MPR (R -0.446, 
p = 0.020) although not late MPR or other measures of blood flow. 
In other univariate analyses, aortic distensibility was correlated with MVO area (R-
0.394, p = 0.044) but not with CK or either time point of infarct size. 
There was no significant difference between indices of myocardial injury or perfusion 











  Chapter 5: Arterial stiffness and infarct myocardium 
 202 
5.5.9 Predictors of follow up MPR in infarct territory 
To understand the dominant predictor of late MPR in the ‘infarct’ territory, these 
variables were evaluated with multiple linear regression. On multiple linear regression, 
aortic distensibility remained an independent predictor of ‘infarct’ territory MPR at 
three months (Table 5.5). 
 
 Univariate Multivariate 
 b p value b p value 
MVO area -0.481 0.023 - 0.352 
Infarct size 
(early) -0.218 0.091 - 0.393 
Peak CK -0.150 0.128 - 0.257 
Distensibility 0.728 <0.001 0.562 0.003 
 
TABLE 5.5 Multiple linear regression for the prediction of 
MPR in infarct territory at 90 days. 
 
 
To assess whether MVO area or distensibility were predictive of MPR improvement, 
both were evaluated against D MPR. Regression analysis revealed no significant 
relationship between D MPR and MVO area (R -0.184, p = 0.314), however there was 

















FIGURE 5.7 Regression analysis between change in MPR and 
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5.6 DISCUSSION 
This is the first study to evaluate the relationship between aortic stiffness and 
myocardial blood flow in infarct and non-infarct territories. Moreover, it is the first to 
evaluate how this relationship changes over time from day three to three months.  
 
Arterial stiffness and resting myocardial blood flow 
Resting MBF was not related to aortic distensibility in ‘infarct’ or ‘non-infarct’ 
myocardium at either early or late time points. Despite successful revascularisation, 
the microcirculation post infarct is often dysfunctional owing to distal embolisation 
(De Caterina et al. 2012), vasoconstriction (Cuculi et al. 2013) and oedema (Rezkalla 
& Kloner 2002). Determinants of early ‘infarct’ territory local blood flow are likely to 
be governed by mediators driving autoregulation (e.g. myocardial oxygen demand) 
and the resilience of microcirculatory function at a time where intracoronary resistance 
is known to be increased (Wijnbergen et al. 2016). Nonetheless, earlier studies (Leung 
et al. 2006), including our own (unpublished, Chapter 2 and 3) have shown a modest 
association between arterial stiffness and rMBF in non-ischemic and recently re-
perfused myocardium. The disruption of a relationship post myocardial infarction 
suggests that any contribution to rMBF from large artery function is easily 
overwhelmed by local autoregulation or that at least some of the ‘physiological’ 
relationship may be determined by (or related to) an intact microcirculation. If a 
reduction in trans-coronary perfusion pressure was a significant determinant of rMBF, 
this effect ought to have been amplified at a time where microvascular resistance was 
at its greatest. This was not observed. At the late time point there had been no recovery 
of the relationship. Whether this reflects an ongoing, but potentially transient change 
in the relative determinants of rMBF, possibly through local remodelling or 
neurohormonal activity, remains to be seen.  
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The lack of association between rMBF and aortic stiffness in ‘non-infarct’ 
myocardium is  unsurprising. Evolving evidence demonstrates the systemic sequelae 
of myocardial infarction  such that the behaviour of ‘non-infarct’ myocardium appears 
different from truly ‘normal’ myocardium. Early invasive studies of post-infarct 
myocardium have been conflicting. Immediately following PCI, de Waard et al. (de 
Waard et al. 2016) found blood flow in remote myocardium to be increased compared 
to propensity-matched ‘control’ myocardium however Teunissen et al. (Teunissen et 
al. 2015) and Cuculi et al. (Cuculi et al. 2014), also within the first week, suggested 
no significant difference. In the post infarct setting, resting blood flow in these 
territories may be altered by increased filling pressures, compensatory hyperkinesis 
(Lew et al. 1985) and paracrine neurohormonal modulation of tone (Schafer et al. 
2002). Regardless, these factors are likely to significantly overwhelm an already 
modest contribution to blood flow by large arterial function.  
 
Arterial stiffness and hyperaemic blood flow 
A stiff aorta was associated with reduced hyperaemic response to adenosine in both 
‘infarct’ and ‘non-infarct’ myocardium. The relationship was similar at the early time 
point although strengthened in the ‘non-infarct’ compared to the ‘infarct’ myocardium 
by three months. The strengthening of the relationship in ‘non-infarct’ territories may 
represent recovery from an overwhelming post-infarct systemic inflammatory state 
characterised by circulating catecholamines and other neurohormonal vasoactive 
mediators such as vasopressin and angiotensin (Karlsberg et al. 1981; McAlpine et al. 
1988). Larger infarcts are associated with a greater systemic inflammatory milieu 
impacting on haemodynamics and vasomotor tone (Frangogiannis 2014; Pietila et al. 
1991), and thus theoretically may disrupt the aorto-coronary relationship to a greater 
extent. Adjustment for CMR derived infarct size at baseline and follow up, however, 
had no effect on the distensibility-hMBF correlation. An overall increase in non-infarct 
hyperaemic flow over time was observed which mirrored that of Teunissen et al. 
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(Teunissen et al. 2015). This supports the notion that a systemic, albeit transient, 
phenomenon could affect not only the absolute hyperaemic response, but also its 
relationship to large artery function. 
 
In the ‘infarct’ myocardium, the aorto-coronary relationship remained statistically 
significant although unlike the ‘non-infarct’ myocardium, did not strengthen at three 
months and remained less significant when compared to our other studies in ‘normal’ 
myocardium. A number of changes are likely to occur at a local infarct artery, and 
territory, level which extend beyond the systemic milieu proposed to affect a remote 
territory.  Hyperaemic blood flow relies on an intact microcirculatory response and 
patent capillaries, both of which can be significantly affected in the setting of a STEMI. 
At a microvascular level, vasoconstrictive mediators such as endothelin-1 (de Waard 
et al. 2016) are released from the endothelium and may mitigate a vasodilatory 
stimulation from adenosine. Peri-procedurally, microthrombi and atherosclerotic 
material released not only from the plaque event but also during instrumentation and 
stent deployment may plug capillaries and distal arterioles. Although well described 
in its fulminant form of ‘no reflow’ phenomenon (Wong et al. 2013), even PCI in 
stable coronary artery disease populations is associated with a transiently reduced 
CFVR (Uren, Crake, et al. 1994).  
At an epicardial level, the presence of a stent in the infarct related artery may also 
contribute to reduced hyperaemic flow through the modification of its geometry 
thereby rendering the vessel less responsive to vasoactive stimuli for at least for the 
first three to six months (Hamilos et al. 2008; Togni et al. 2007). Although only felt to 
be a minor contributor to the overall hyperaemic response, the increase in flow 
generated by the microvasculature is believed to drive a secondary flow-mediated 
dilatation in the epicardial vessel. In a culprit coronary artery, endothelial dysfunction 
or the presence of a stent, or both, may reduce this component of hyperaemic flow. 
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This potential contributor is likely to improve over time and may be mitigated by 
current generation drug eluting stents (Hamilos et al. 2014).   
Notwithstanding all of the above, a number of the phenomena are dynamic and 
improve by three months and yet the agreement between aorto-coronary 
haemodynamics remains more modest than in the non-infarct myocardium at this 
timepoint. This would suggest that these determinants may now be fixed and perhaps 
relate to irreversible myocardial damage and injury. 
 
Myocardial damage and injury 
Studies comparing CMR indices of myocardial injury with invasive measures of 
microvascular resistance (i.e. index of microcirculatory resistance) demonstrate a 
strong correlation between the presence of microvascular obstruction on CMR-DE 
imaging, larger infarct size and a persistent reduction in infarct territory hyperaemic 
blood flow (Cuculi et al. 2014). Supporting this is Teunissen et al. who demonstrated 
an increase in hyperaemic flow between one week and three months in the infarct 
territory however these values remained numerically less than both non-infarct and 
propensity matched control myocardium (Teunissen et al. 2015). At a 
pathophysiological level, if there has been significant myocyte necrosis and 
subsequently fewer functional microvessels, the myocardium may be less capable of 
reducing absolute microcirculatory resistance and thus, generate less absolute 
hyperaemic flow.  
 
Our univariate analysis showed a trend for an association between MVO and hMBF 
although no interaction with infarct size. Partial adjustment did not significantly affect 
the strength of the aorto-coronary relationship, in fact it numerically weakened it. 
Furthermore, in univariate analysis, aortic distensibility was also associated with MVO 
area. It may be that individuals with increased arterial stiffness are more vulnerable to 
developing MVO. This could be through observed perturbations associated with 
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arterial stiffness such as baseline reduced relative arteriolar density associated with 
compensatory hypertrophy or via the unfavourable supply and demand equation 
observed with increased cardiac work associated with arterial stiffness. Seminal work 
from Kass supports the latter where an animal model of LAD occlusion was better 
tolerated by compliant compared to stiff vasculature with observed worsening of 
regional wall motion and extension of ischaemia (Kass et al. 1996). Of note this was 
largely driven by an increased sensitivity to lowering mean arterial pressure rather than 
a reduction in coronary blood flow directly. 
A further explanation is that aortic stiffness may also be a generalised marker of 
vascular risk as it has been associated with both the presence of coronary artery disease 
and atherosclerotic burden generally (Danchin et al. 2004; Jankowski et al. 2004; 
McLeod et al. 2004).  
 
Aortic stiffness and myocardial perfusion reserve 
Myocardial perfusion reserve was strongly related to aortic stiffness in both ‘infarct’ 
and ‘non-infarct’ myocardium and over time this relationship strengthened. Not only 
did a stiff aorta predict less improvement in hMBF, but on multivariate analysis, aortic 
distensibility was an independent predictor of MPR improvement at three months. 
Myocardial perfusion reserve is, by definition, affected by both resting and hyperaemic 
flow. Although it has been calculated by the quotient of absolute hyperaemic and 
resting blood flow, the established technique is the quotient of the hyperaemic and 
resting maximal upslopes of the signal-time intensity curve. The simplicity of this 
MPR analysis obviates the need for mathematical deconvolution and constraint, both 
of which are known to be sensitive to noise (Lee, DC & Johnson 2009) and, together 
with more robust reproducibility (Chapter 3), may be a more reliable measure of 
physiological response than absolute hMBF alone. Moreover the use of a quotient or 
index, corrects for changes in signal between resting and stress sequences; a source of 
error that arises when evaluating either resting or hyperaemic indices in isolation. 
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An evolving body of data support the prognostic role of both coronary flow- and 
myocardial perfusion reserve as methods to evaluate microcirculatory dysfunction 
post infarct.  An early study evaluating hyperaemic reserve post infarct was performed 
with digital subtraction angiography post successful PCI and was shown to correlate 
strongly with regional myocardial function at early follow up (Suryapranata et al. 
1994). Some years later the use of stress echocardiography and LAD Doppler signals 
allowed the approximation of CFR which was shown to predict LV remodelling in a 
more robust manner than established angiographic indices (Rigo et al. 2004) and 
subsequently also predicted in-hospital outcomes (Meimoun et al. 2009). In the 
invasive setting, Doppler FloWire derived CFVR post infarct vessel PCI was shown 
to predict regional wall motion recovery in hospital (Mazur et al. 1998), global and 
regional recovery at six months (Bax et al. 2004) and more recently, hard 
cardiovascular endpoints at 12 months (Takahashi et al. 2007). Understanding the 




By dichotomising our segments into ‘infarct’ and ‘non-infarct’ on the basis of 
equiangular segmentation of subtended myocardium from the angiogram, border zone 
and non-infarct myocardium would have been included in some of the ‘infarct’ 
segments and vice-versa. In an attempt to simplify the analysis and adjudication of 
‘infarct’ and ‘non-infarct’, this may have added noise to the signal and reduced the 
strength of associations with dependent variables. The assessment of all CMR indices 
(with the exception of LV volumes and ejection fraction) are made on three slices per 
study and thus represents an approximation and over-represents the apical 
myocardium in an 18-segment model. 
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Assessment of presumed microvascular dysfunction was inferred from its association 
with CMR-DE MVO. Although highly correlated, the two are not the same and it 
would have been preferable to have performed a more specific marker of 
microcirculatory function such as IMR. To extend our observations across a spectrum 
of STEMI, it would have been of interest to study a larger cohort of patients without 
MVO on CMR-DE imaging. In this cohort, only a paucity of our cohort was free of 
MVO and we did not have sufficient numbers to perform a subgroup analysis.  There 
is little evidence to confirm the veracity of CMR-PI to evaluate myocardial blood flow 
in a known area of infarct (Panse et al. 2007; Wong et al. 2012). All of the validation 
data has been done in ‘normal’ or ischaemic myocardium. Although theoretically 
possible, the behaviour of gadolinium within oedematous and leaky myocardium is 
less predictable, and thus the Fermi modelling assumptions are likely to become 
inaccurate. The assessment of MPR, however, is less affected by these limitations and 
may provide some rationale for the observed consistency of those measurements in 
comparison to divergent MBF values. Further evidence of noise is the modest 
association between rMBF and MVO (R -0.3) which ought to be measuring similar 
physiological phenomena.  
 
Vasoactive medications were not held prior to CMR studies as cessation for the 
purpose of research imaging would have been unethical. Although the absolute values 
may differ, there was minimal difference in medications between patients and time 
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Conclusion 
This is the first study to interrogate the relationship between aortic stiffness and indices 
of myocardial perfusion following STEMI. A stiff aorta was associated with reduced 
early and late hyperaemic response to adenosine in both the infarct and non-infarct 
myocardium. Improvement in MPR was predicted by both MVO and aortic 
distensibility however on multivariable analysis, only aortic distensibility remained 
independently associated. A stiffer aorta may be a key predictor for worse outcomes 
post STEMI.
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6.1 AORTO-CORONARY HAEMODYNAMICS 
6.1.1 Resting blood flow 
In states of ‘health’, resting coronary blood flow (rCBF) is mainly governed by local 
autoregulatory mechanisms, the most dominant being cardiac work. Despite this, after 
indexing to RPP and correcting for age and gender, aortic distensibility was correlated 
with both rCBF and rMBF. In Chapter 4, associations between aortic stiffness and 
rMBF were overall less robust but remained statistically significant and stronger in the 
‘ischaemic’ territories. The relative difference between ‘ischaemic’ and ‘non-
ischaemic’ may represent changes in autoregulation, possibly from ‘hibernating’ 
myocardium or a difference in myocardial oxygen demand in critically ischaemic 
myocardium. This association was not observed in either ‘infarct’ or ‘non-infarct’ 
myocardium early or late post myocardial infarction. The ability to disrupt this 
relationship as late as three months post infarction suggests large artery function is 
only tenuously involved in governing rMBF. The persistence of microcirculatory 
dysfunction, some of which is likely to be irreversible, may be a key confounder in 
any aorto-coronary relationship. This is supported by the correlation between MVO 
area and distensibility and supports the notion that at least some of the aorto-coronary 
relationship is determined by, or related to, an intact microcirculation. 
 
Acknowledging the differences between these cohorts (and thus, regression analysis 
not performed), plotting rMBF and distensibility for the three cohorts on the same axis 
reveals a relatively consistent slope. In a hypothesis generating manner, this would 
suggest a consistent, albeit modest, relationship between large artery function and 
rMBF across both health and disease. Observed differences in aorto-coronary 
relationships within cohorts, therefore, might represent changes in the relative 
composition and activity from more local mediators of rMBF during states of 
ischaemia and. infarction.  
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Regardless, the agreement between distensibility and resting blood flow overall was 
modest at best, and far less robust than with hyperaemic flow. This easily disrupted 




FIGURE 6.1 Resting myocardial blood flow plotted against 
distensibility in all three cohorts: ‘normal’, ‘ischaemic’ and ‘infarct’. 
 
6.1.2 Response to adenosine: hyperaemic flow and adenosine 
Aortic distensibility was strongly associated with hyperaemic blood flow across all 
cohorts. This relationship was observed in individuals with near ‘normal’ coronaries, 
severe epicardial disease and following an infarct. In ‘ischaemic’ myocardium, the 
agreement was numerically stronger than ‘non-ischaemic’ myocardium however the 
divergence of the curves raises the potential for a ‘threshold’ effect from large artery 
function in a near maximally dilated microcirculation. In post-infarct myocardium, 
aortic stiffness continued to associate with hMBF, however this was less robust than 
with non-infarct myocardium at follow up. The failure to return to a ‘strong’ 
relationship at the follow up time point may be explained by a submaximal response 
to hyperaemia in remodelling myocardium or potentially an irreversible loss of 
microcirculatory function. As above, acknowledging these subjects come from 
different studies, and in the interest of hypothesis generation, plotting hMBF and 
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distensibility for the three CMR based studies demonstrates a similar slope of 
agreement. This is supporting evidence of a similar impact from distensibility on this 
perfusion metric across groups, but with variable contribution from other mediators of 
blood flow in both ischaemia and post-infarct. 
 
FIGURE 6.2 Hyperaemic myocardial blood flow plotted against 
distensibility in all three cohorts: ‘normal’, ‘ischaemic’ and ‘infarct’. 
 
6.1.3 Mechanistic basis for the aorto-coronary relationship 
These studies have demonstrated variable strengths in the correlation of large artery 
function with indices of myocardial blood flow in relative ‘health’, ischaemia and 
following infarction. Our investigations were not designed, nor are they able, to 
elucidate mechanisms for these associations, but provide fertile thought for further 
enquiry. Increased aortic stiffness is associated with a number of perturbations 
associated with potential impact on coronary blood flow. Firstly, arterial stiffening 
increases left ventricular afterload, which promotes hypertrophy and a relative 
reduction in arteriolar density per unit of myocardium, thereby predisposing to 
ischaemia. Secondly, there is observed increase in intracoronary diastolic resistance, 
which may be contributed to by both increased intraventricular pressures and wall 
stress observed with increased arterial stiffness. Thirdly, increased pulse pressure 
observed with arterial stiffness is believed to cause microvascular rarefaction and 
possible arteriosclerotic changes, rendering them less responsive to vasomotor stimuli 
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not only in distant vascular beds, but also the myocardium. Fourthly, an increase in 
late systolic pressure through aortic impedance or reflected wave phenomena, can  
reduce central diastolic pressure and thus, potentially reduce coronary diastolic driving 
pressure. Although all of these are potential contributors, it is also possible that aortic 
stiffness and microvascular disease occur together, and that aortic stiffness is an 
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6.2 CMR PERFUSION IMAGING 
This thesis has demonstrated CMR perfusion imaging to be a reproducible and robust 
modality for evaluating aorto-coronary haemodynamics. The ability to assess 
myocardial perfusion rather than coronary blood flow offers potential incremental 
insight as this represents the interface between tissue characteristics as well as blood 
supply. This clearly comes with limitations as the measures are less exact and prone 
to noise when compared to invasive, high fidelity imaging. Evidence of this are our 
regression coefficients in Chapter 2 (R2 ~ 0.5) compared to Chapter 3 (R2 ~ 0.3) in 
what were very similar cohorts. The assessment at a coronary or segment level is time 
consuming and, without any automation or standardisation, prone to inter-observer 
variability and inconsistency across centres. Perfusion imaging requires contrast, and 
thus comes with risks, particularly with repeated exposure and with underlying renal 
dysfunction. Newer sequences using arterial spin labelling may obviate this 
requirement. In the last 12 months, our group has also been exploring changes of 
hyperaemic flow within the coronary sinus (the vessel responsible for venous drainage 
of the myocardium) as a marker of perfusion reserve. Invasive studies and proof-of-
concept phase contrast CMR studies have shown changes in coronary sinus flow in 
response to adenosine (coronary sinus flow reserve) to approximate that with coronary 
artery flow reserve (CFR). In a small cohort of ‘normal’ patients, we have 
demonstrated a similar relationship with aortic distensibility and an intraclass 
correlation of >90% when compared with MPR.  
Nonetheless, if the aorto-coronary relationship is an endpoint worth evaluating, the 
assessment must evolve to be semi-automated and ultimately, gadolinium free. 
Together with ventricular structure and function, CMR provide a valuable, ‘one stop 








FIGURE 6.4 Top: CMR image demonstrating transection of 
coronary sinus (asterisk) with phase contrast cross-sectional image 
highlighted in orange. Middle: phase contrast flow curves of 
coronary sinus flow at rest (black) and at hyperaemia (orange). 
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6.3 FUTURE DIRECTIONS 
Ongoing work needs to take two directions. Firstly, a deeper understanding is required to 
decipher the underlying mechanistic basis for the aorto-coronary relationship and its 
interaction with microvascular function. Dissecting the relative contributions from aorto-
coronary driving pressure from coronary microcirculatory resistance will require invasive 
measures of both pressure, flow and coronary resistance, together with indices of arterial 
stiffness. Understanding the dominant contributions from both components in different 
disease states and under different conditions will allow a more complete understanding of 
how this relationship changes and how therapies could be directed. Secondly, further 
studies will need to demonstrate that altering the aorto-coronary relationship has 
relevance, i.e. reducing arterial stiffness can improve anginal threshold, or in the context 
of an infarct, improve flow. Both would need to be demonstrated independent of blood 
pressure effects. Agents directed at altering arterial stiffness, particularly in patients with 
a deleterious aorto-coronary relationship, may derive additional benefit if there are clear 
changes at an end-organ level. Furthermore, the greatest potential for end-organ benefit is 
likely to be at the level of the coronary circulation. Ongoing understanding at this interface 
may provide a greater impetus to move our focus of care in coronary artery disease away 
from the epicardial vessel to a more integrated assessment of large artery and 
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